Zebrafish (Danio rerio): un modello per studiare la rigenerazione cardiaca in-vivo ed in ex-vivo by Missinato, Maria Azzurra
 
 
TUSCIA UNIVERSITY-VITERBO-ITALY 
 
 
Department of Environmental Sciences 
 
 
PhD COURSE  
IN BIOLOGICAL AND BIOCHEMISTRY EVOLUTION 
(XXII Cycle) 
 
PhD thesis 
 
Zebrafish (Danio rerio): a model to study in-vivo and ex-vivo cardiac 
regeneration 
 
Scientific disciplinary sector: (BIO/06) 
 
 
 
 Coordinator 
Prof. Laura Zucconi 
 
 
 
 Tutor PhD Student 
 Prof. Nicla Romano Maria Azzurra Missinato 
 
 
 
 
 
 
 
 
UNIVERSITÀ DEGLI STUDI DELLA TUSCIA DI VITERBO 
 
 
Dipartimento di Scienze Ambientali (DISA) 
 
 
CORSO DI DOTTORATO DI RICERCA  
IN EVOLUZIONE BIOLOGICA E BIOCHIMICA 
(XXII Ciclo) 
 
Tesi di Dottorato di Ricerca 
 
Zebrafish (Danio rerio): un modello per studiare la rigenerazione cardiaca 
in-vivo ed in ex-vivo 
 
Settore Scientifico disciplinare: (BIO/06) 
 
 
 
 Coordinatore 
Prof.ssa Laura Zucconi 
 
 
 
 Tutor Dottoranda 
Prof.ssa Nicla Romano Maria Azzurra Missinato 
 
 
 
 
 
 
 
 
 
Steps 
As every blossom fades 
and all youth sinks into old age, 
so every life’s design, each flower of wisdom, 
attains its prime and cannot last forever. 
The heart must submit itself courageously 
to life’s call without a hint of grief, 
A magic dwells in each beginning, 
protecting us, telling us how to live. 
High purposed we shall traverse realm on realm, 
cleaving to none as to a home, 
the world of spirit wishes not to fetter us 
but raise us higher, step by step. 
Scarce in some safe accustomed sphere of life 
have we establish a house, then we grow lax; 
only he who is ready to journey forth 
can throw old habits off. 
Maybe death’s hour too will send us out new-born 
towards undreamed-lands, 
maybe life’s call to us will never find an end 
Courage my heart, take leave and fare thee well. 
(Hermann Hesse) 
 
 
 
 
To my nephew  Leonardo 
 
 
 
 
  
Gradini  
Come ogni fior languisce e  
giovinezza cede a vecchiaia, 
anche la vita in tutti i gradi suoi fiorisce, 
insieme ad ogni senno e virtù, e può durare eterna. 
Quando la vita chiama, il cuore  
sia pronto a partire ed a ricominciare, 
per offrirsi sereno e valoroso ad altri, nuovi vincoli e legami. 
Ogni inizio contiene una magia  
che ci protegge e a vivere ci aiuta. 
Dobbiamo attraversare spazi e spazi, 
senza fermare in alcun d'essi il piede, 
lo spirto universal non vuol legarci, 
ma su di grado in grado sollevarci. 
Appena ci avvezziamo ad una sede 
rischiamo d'infiacchire nell'ignavia: 
sol chi e' disposto a muoversi e partire 
vince la consuetudine inceppante. 
Forse il momento stesso della morte  
ci farà andare incontro a nuovi spazi: 
della vita il richiamo non ha fine.... 
Su, cuore mio, congedati e guarisci. 
(Hermann Hesse) 
 
 
 
A mio nipote Leonardo 
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ABSTRACT (English version) 
 
Despite continuing progress in medical therapies and in revascularization strategies at 
coronaries level, heart diseases remains a leading cause of mortality throughout industrialized 
countries. Mammals have an extremely limited capacity to repair damaged heart tissue after a 
myocardial infarction. Regeneration, the replacement of damaged or lost body parts, is a 
primary goal of stem cell research. In fact, during this process, differentiated cells reenter the 
cell cycle and proliferate to generate a mass of undifferentiated cells. Several vertebrates 
display different ability to regenerate organs and tissues, thus encouraging biologists to seek 
out models for heart regeneration. The robust capacity of zebrafish (Danio rerio) to 
regenerate a variety of tissues, position it as an ideal genetic model system for understanding 
the molecular and cellular events governing regeneration. Numerous works have shown that 
adult zebrafish can effectively regenerate in-vivo injured hearts submitted to partial surgical 
amputation of the ventricle area. In fact, during this process, new cardiomyocytes limit the 
scar formation and form new muscular tissue. However the molecular mechanisms that 
regulate this process remains unclear and resolving the genes, the microRNAs and the 
proteomic alterations that control these changes can illuminate how heart regeneration is 
naturally optimized. Activation of the regenerative potential of human tissue implicates a 
novel therapeutic approach to supplement, or replace, conventional pharmacotherapy and 
mechanical intervention.  
In this thesis, using qRT-PCR experiments, it was demonstrated that some microRNAs 
(miRNAs), as miR1 and miR-133, were down-regulated during the in-vivo regeneration of 
adult zebrafish hearts submitted to amputation of around 20% of the ventricle apex. Also, 
similar changing in microRNAs levels were observed during hypertrophic conditions induced 
ex-vivo. The adult zebrafish heart, containing numerous cardiac progenitors, resulted a good 
model to approach the general mechanisms of adult cardiac stem cell maintenance and 
cardiogenesis. Here, zebrafish was also used as model to test for a correlation between 
Fibroblast Growth factors (FGFs) signaling and cell proliferation in adult injured hearts. With 
In Situ Hybridization (ISH) experiments, here were reported the time and space expression of 
FGFs targets genes (erm, etv5, pea3, dusp6, sef sprouty4, and raldh2), involved in in-vivo 
heart regeneration. With the aim to optimize the media to reproduce the regeneration process, 
it was also tested the ability of zebrafish heart to survive in ex-vivo cultures after the 
amputation of ventricular apex. Regenerating hearts in ex-vivo conditions were able to survive 
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and make contractions, and surprisingly showed different degree of cell replication, 
incorporating BrdU, in dependence to the culture media. 
So far, there is no study regarding the proteomic aspect the heart regeneration in 
zebrafish. Proteomic offers an innovative approach to integrate the genomic study that alone 
is not sufficient to understand the all the cellular mechanisms. Here, for the fist time, it is 
reported a proteomic study of adult zebrafish heart, that allowed the identification of more 
than one hundred proteins, belonging to different biological classes as, enzymes, signal 
transduction, growth factors, cytoskeletal components, globin, and structural proteins. The 
identification of the proteins naturally expressed in the adult zebrafish heart is not only 
important as basic biological knowledge, but also, because it constitute a reference point to 
compare proteins expression during cardiac regeneration. In fact, applying innovative and 
sensible two-dimensional fluorescence difference gel electrophoresis (DiGE), combined with 
MALDI-TOF/TOF tandem mass spectrometry, here it was possible to identify proteins 
differentially expressed at 3 days after amputation of around 20% of the ventricle area, 
compared with hearts not injured. Among more than one hundred proteins spots detected in 
2D-gels, three (ATP synthase, hyaluronan mediated motility receptor, and desmuslin) were 
up-regulated in injured hearts. Information concerning the global alteration protein pattern 
during heart regeneration will be helpful for a better formulation of new diagnostic and 
therapeutic markers. Also, due to the similarities between the fish and mammalian genomes, 
this experimental system should also provide clues to understanding human pathophysiology 
and the new frontier of stem cell regeneration system.  
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ABSTRACT (Versione Italiana) 
 
Nonostante i continui progressi nelle terapie mediche e nelle strategie di 
rivascolarizzazione a livello delle coronarie, le malattie cardiache rimangono la principale 
causa di morte nei paesi industrializzati. I mammiferi mostrano una limitata capacità di 
riparare il tessuto cardiaco danneggiato dopo un infarto al miocardio. La rigenerazione, il 
rimpiazzo di parti corporee danneggiate o amputate, è l’obiettivo primario della ricerca sulle 
cellule staminali. Infatti, durante questo processo, cellule differenziate rientrano nel ciclo 
cellulare e proliferano per generare una massa di cellule indifferenziate. La capacità di 
rigenerare organi e tessuti varia ampiamente tra i vertebrati, incoraggiando i biologi a cercare 
modelli alternativi di rigenerazione cardiaca. La peculiare caratteristica del pesce zebra 
(Danio rerio) di rigenerare vari tessuti, lo ha promosso sistema modello genetico ideale per 
capire i meccanismi molecolari e cellulari alla base del processo rigenerativo. Numerosi lavori 
hanno dimostrato che il pesce zebra (o zebrafish) adulto può efficacemente rigenerare in-vivo 
il cuore soggetto a parziale amputazione del ventricolo. Durante questo processo, infatti, i 
cardiomiociti, stimolati a replicare da numerosi fattori di crescita, rimpiazzano la cicatrice con 
nuovo tessuto muscolare. Tuttavia, i meccanismi molecolari che regolano la rigenerazione 
rimangono poco chiari e, caratterizzare i geni, i microRNA e le alterazioni proteomiche che 
controllano questi cambiamenti, può offrire dati importanti su come la rigenerazione cardiaca 
sia naturalmente ottimizzata. L’attivazione del potenziale rigenerativo del tessuto umano 
comporterebbe un approccio terapeutico innovativo per supplementare o, addirittura 
rimpiazzare la farmacoterapia convenzionale e l’intervento meccanico. 
In questo lavoro di tesi, attraverso esperimenti di qRT-PCR, è stato possibile 
dimostrare che alcuni microRNA (miRNA), quali miR1 e miR133, vengono down-regolati 
durante la rigenerazione in-vivo del cuore adulto di zebrafish, sottoposto ad amputazione di 
circa il 20% dell’apice ventricolare. Inoltre, simili variazioni dei livelli dei microRNA sono 
state osservate durante condizioni d’ipertrofia indotte ex-vivo. Il cuore di zebrafish adulto, 
contenendo numerosi progenitori cardiaci, è risultato un modello vantaggioso per capire i 
meccanismi che regolano il mantenimento delle cellule staminali adulte e la cardiogenesi. In 
questo lavoro, il pesce zebra è stato utilizzato anche come modello per testare l’esistenza di 
una correlazione tra la segnalazione dei Fattori di Crescita dei Fibroblasti (FGF) e la 
proliferazione cellulare nei cuori adulti operati. Attraverso esperimenti di Ibridazione In Situ 
(ISH), sono state studiate le espressioni nel tempo e nello spazio di geni target degli FGF 
4 
 
(erm, etv5, pea3, dusp6, sef sprouty4, and raldh2), implicati nella rigenerazione cardiaca. Con 
lo scopo di ottimizzare il mezzo di coltura per riprodurre il processo rigenerativo, è stata 
inoltre testate la capacità dello zebrafish di sopravvivere in colture ex-vivo, dopo l’amputazioe 
dell’apice ventricolare. I cuori lasciati rigenerare in colture ex-vivo sono stati in grado di 
sopravvivere e di emettere contrazioni e, sorprendentemente, hanno mostrato diversi gradi di 
replicazione cellulare, incorporando BrdU, in dipendenza al terreno di coltura. 
Ad oggi, non sono presenti studi riguardanti l’aspetto proteomico della rigenerazione 
cardiaca in zebrafish. La proteomica offre un approccio innovativo per integrare lo studio 
genomico che da solo non è sufficiente per comprendere tutti i meccanismi cellulari. In questo 
studio, per la prima volta, è stato applicato un approccio proteomico per lo studio del cuore di 
zebrafish adulto. Ciò ha permesso l’identificazione di oltre cento proteine, appartenenti a 
diverse classi biologiche quali, enzimi, trasduttori di segnale, fattori di crescita, componenti 
citoscheletrici, globine e proteine strutturali. L’identificazione di proteine naturalmente 
espresse nel cuore di zebrafish adulto, non solo rappresenta un’importante conoscenza 
biologica di base, ma costituisce inoltre un punto di riferimento per il confronto delle 
espressioni proteiche durante la rigenerazione cardiaca. Infatti, in questo studio, applicando 
l’innovativa e sensibile tecnologia di elettroforesi bidimensionale differenziale (DiGE), 
combinata con spettrometria di massa tandem MALDI-TOF/TOF, e’ stato possibile 
identificare proteine diversamente espresse a 3 giorni dopo l’amputazione di circa il 20% 
dell’area ventricolare, rispetto a cuori di controllo non operati. Tra i più di cento spot proteici 
osservati con gel 2D, tre (ATP sintasi, recettore di motilità mediata da ialurone, e 
desmuslina), sono risultati up-regolati nei cuori in rigenerazione. Le informazioni riguardanti 
le alterazioni proteiche globali durante la rigenerazione cardiaca saranno utili per migliorare 
la formulazione di nuovi farmaci e marcatori terapeutici. Inoltre, data la forte somiglianza del 
genoma tra pesce e uomo, questo sistema sperimentale potrebbe offrire informazioni utili per 
capire le malattie umane e offrire nuove opportunità di rigenerazione mediante l’utilizzo di 
cellule staminali. 
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CHAPTER I: INTRODUCTION 
 
CARDIAC DISEASES AND NEW INSIGHT FOR REGENERATIVE MEDICINE  
In industrialized countries, cardiac diseases are the main causes of chronic heart 
failure, the leading cause of human mortality at present, and the expected largest cause of 
disease burden worldwide by 2020 (Gottlieb et al., 2007). Recent estimates indicate that end-
stage heart failure with 2-year mortality rates of 70-80% affects over 60,000 patients in the 
United States each year. The vast majority are cardiomyopathies (with diminished 
contractility, lower cardiac output, and generally thin ventricular walls) and channelopathies, 
as arrhythmias (anomalies of electrical conduction and heart rhythm) (Leinwand, 2003). 
Myocardial infarction (MI) results in large-scale loss of cardiac muscle (often a billion or 
more myocytes) whereas other heart diseases, such as hypertension, valve diseases and 
genetic disorders (for examples, cardiomyopathies), cause more sporadic myocyte loss 
(Laflamme and Murry, 2005). MI most commonly results from coronary occlusions, due to a 
thrombus overlying an atherosclerotic plaque. Unfortunately, nowadays heart failure carries a 
poor prognosis with few treatment options and no effective therapy. In fact, once overt heart 
failure develops, about 30-45% of patients die within 1 year, unless they receive a heart 
transplant, the unique clinical procedure to reverse the decline in cardiac function and to 
restore damaged myocardium (Hosenpud et al., 1999). However, this option is available to 
very few patients due to a shortage of donor hearts and in addition it suffers from well known 
side effects arising from the accompanying medications as well as graft failure over the long 
term. Drug therapy is limited for all causes of heart failure and is palliative at best, with 
definitive cure for the most severe cases limited to those fortunate enough to receive heart 
transplantation. Repair is one of the major mechanisms needed for survival and proper 
functioning; however, defective repair with scar formation is an inevitable consequence of 
tissue damage, compromising the functions of the organ to a certain degree. The concept of 
stem cell-based therapies originated with the idea of replenishing damaged tissues with stem 
cells to increase the tissue’s potential for repair (Scorsin et al., 1996; Oh et al., 2003; Cai et 
al., 2004; Wu et al., 2006a). 
The discovery of stem cells capable of generating angiogenic or contractile cells and 
structures offers new horizons to patients suffering from myocardial diseases, points to the 
potential of cell therapy as a future treatment strategy for heart failure (Connold et al., 1997; 
Smith, 1998; Penn et al., 2002). Actually several research groups are working in the potential 
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for stem cells-based translational approach to explore the possibility to efficiently regenerate 
the heart (Gojo et al., 1997; Davani et al., 2005; Smits et al., 2005). Recent reports from 
different laboratories have shown that the heart of human adult as well as that of other 
species contains a population of resident stem cells that may differentiate into myoblasts and 
eventually into adult myocytes (Hierlihy et al., 2002; Abbott and Giordano, 2003; Tateishi et 
al., 2007). Today, various types of stem cells obtained from different tissues are commonly 
used for myocardial regeneration (Chiu et al., 1995; Taylor et al., 1998; Ooi et al., 2006; Wu 
et al., 2007; Piao et al., 2007. For reviews see Marín-García and Goldenthal, 2006; Segers 
and Lee, 2008). Stem cells are classified in totipotent, pluripotent and multipotent, according 
to their ability to generate other cell types (Figure 1). More precisely, totipotency refers to 
the ability of a cell to form cells of all lineages including the extra-embryonic tissue. In 
mammals, the only cells with this capacity are the zygote and early blastomeres. Pluripotency 
is the term applied to cells that have the ability to differentiate into all the cell types of the 
body, except the extra-embryonic tissue (placenta) (Pera, 2001). Multipotent stem cells are 
those that have the ability to differentiate into a limited number of different cell types (Reyes 
and Verfaillie, 2001). The stem cells reside in specific regions of tissues to ensure the organ 
development throughout embryonic, fetal and adult life and divide in case of tissue loss and 
injury (Nichols, 2001; Thisse and Zon, 2002). A stem cell is clonogenic, capable of unlimited 
self-renewal by symmetric division, while maintaining a stable diploid karyotype (Linke et 
al., 2005). Under the control of growth factors and the tissue environment, it is also capable 
of asymmetric division, one daughter resembling its mother, and one daughter giving rise to 
multiple types of differentiated cells (Fijnvandraat et al., 2003). In contrast, the progenitor 
cells that have been identified in adult organs thus far do not meet all of these criteria (Case 
et al., 2008). 
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Figure 1 Stem cell hierarchy. Illustration of the stem cell hierarchy. Totipotency refers 
to the ability of a stem cell to form all cell types including extra embryonic tissue. Pluripotent 
stem cells are capable of unlimited self-renewal and can differentiate into any adult cell type 
(e.g. embryonic stem cells (ESCs) and induced pluripotent cells (iPS) cells). Multipotent stem 
cells have the ability to differentiate into a limited number of different cell types (e.g. 
hematopoietic stem cells (HSCs)). These multipotent stem cells can give rise to progenitor 
cells which can be multipotent (e.g. cardiac progenitor cells can differentiate into endothelial 
cells, smooth muscle cells or cardiomyocytes) or monopotent, giving rise to only one cell type 
(e.g. endothelial progenitor cells (EPCs)). From Sieveking and Martin, (2009). 
 
Several alternatives approaches, objectives of the regenerative medicine, not mutually 
exclusive, may be employed to induce heart regeneration as preventing cell death or 
repopulating myocardium with new contractile cells (Foley and Mercola, 2004) (Figure 2). 
The most investigated strategy is implantation of stem cells into the heart, although this 
method is invasive, often clinically unsuitable, and can introduce harmful scar tissue, 
arrhythmia, calcification, or microinfarction in the heart (Mathur and Martin, 2004). Cells can 
be injected directly through the coronary arteries or using an intraventricular approach (Zhan-
quan et al., 2007). Whit the aim of therapeutic neo-vascularization the cells need to be 
mobilized from their location with factors such as cytokines in response to an external 
stimulus, such as tissue ischemia (Wu et al, 2006b).  
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Figure 2 Repair of damaged heart muscle. From Grounds et al., (2002). 
 
Then they need to successfully home to the site of ischemia and participate in neo-
vessel formation. Stem cells treated groups shown improved left ventricular (L.V.) ejection 
fraction, reduced infarct scar size and decrease L.V. end-systolic volume. A recently 
developed “cell sheet engineering” technology has greatly improved the efficiency and 
efficacy of cell engraftment (Masuda et al., 2008). Cell-based cardiac repair offers the promise 
of rebuilding the injured heart from its component parts (Bai et al., 2007). Work began with 
the transplantation of authologous skeletal muscle satellite cells (commonly referred as 
myoblasts), progenitors committed cells that normally mediate regeneration of skeletal muscle 
(Baroffio et al., 1996; Leor et al., 1996), but recently the field has expanded to explore an 
array of cell types, including bone marrow cells, endothelian progenitors, mesenchymal stem 
cells, resident cardiac stem cells, and both mouse and human embryonic stem cells (Jia et al., 
1997; Sakai et al., 1999; Rangappa et al., 2002; Sachinidis et al., 2003; Kang et al., 2007) 
(Figure 3). Recent clinical trials injecting bone marrow or skeletal myoblasts into the injured 
heart have yielded mixed results in term of cardiac regeneration (Murry et al., 1996; Dorfman 
et al., 1998; Gulbins et al., 2001; Xu et al., 2007b) and are not able to convert into true 
cardiomyocytes that could replace those irreversibly loss by heart attack (Atkins et al., 1999).  
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Figure 3 Schematic depiction of the resident cardiac stem cell pool. The majority of Cardiac 
Progenitors Cells (CPC) represent typical adult stem cells may originate from the bone 
marrow. They can express c-kit or Sca-1, have SP properties, or be found in the perivascular 
niche. Other CPC may be remnants from embryologic heart development and express isl-1, 
display neural crest cell characteristics, or be found within the epicardium. To what extent the 
two groups and their cell populations overlap is not known. From Stamm et al., (2009). 
 
New insight in experimental cell therapy for heart failure has been given by Messina et 
al (2004) and Barile et al (2007): in these studies the Authors described the successful 
achievement of the engraftment and differentiation of the injected cells (adult, autologous, 
biopsies-derived human cardiac progenitors) in the infracted hearts of SCID mice, with their 
functional rescue in term of ejection fraction and echocardiogram. An alternative approach is 
therapeutically stimulating cardiomyocytes to re-enter the cell cycle and progress to mitosis 
and cytokinesis thought gene-mediated interventions targeting cell cycle regulators, or by 
injecting genes coding for mitotic cytokines (Bellafiore et al., 2006). In this way, the 
electromechanical syncytium is more likely to be preserved, since there would be no need for 
establishing new connections with implanted cells. In addition, the eventuality of rejection of 
allogenetic cells as well as the ethical problems derived from the use of human embryonic 
stem cells are avoided (Sugarman, 2007). Although adult mammalian cardiomyocytes show 
very little or no proliferation when cultured, FGF-1 treatment concomitant with p38 MPA 
kinase inhibition can stimulate their proliferation in culture. In other studies, the discovery of 
putative progenitors cells within the hearts of adult mammals has led to the suggestion that the 
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heart has the potential for homeostatic or regenerative renewal (Nemir et al., 2006). 
Experimental studies indicate that the delivery or mobilization of stem and progenitor cells 
may improve tissue perfusion and the contractile performance of the damage heart (Harding et 
al., 2007; Li et al., 2007b). Directional homing of stem cells is performed via the attraction of 
cells through the local delivery of various growth factors. Pre-clinical and clinical studies 
evaluating the therapeutic potential of various cell therapies have reported conflicting results, 
generating controversy (Min et al., 2002; Shizuru et al., 2005; Sieveking and Martin, 2009). 
The major barriers to the development of pharmacological agents or cell-based therapies for 
cardiac repair include obtaining not only an understanding of the identity of the resident 
cardiac stem/progenitors cells, but also the ability to generate a sufficient number of cells for 
therapeutic use (Goldenthal and García, 2003). Subsequent challenges involve the 
optimization of methods for the isolation and delivery of these cells, particularly concerning 
the timing of cell delivery. Thus, is important to understand how guide the differentiation of 
stem cells, control their survival and proliferation, identify factors that mediate their homing 
and modulate the heart’s innate inflammatory and fibrotic responses (Hescheler et al., 1997). 
The discovery of several types of cardiovascular progenitor cells within the heart provides a 
unique opportunity to establish pharmacological agents capable of stimulating an increase in 
the low level of cardiac repair in mammalian hearts, reducing the scar formation and 
increasing cardiac function (Li et al., 1996; Solloway and Harvey, 2003). 
 
MAMMALIAN HEART: OUTLINE OF STRUCTURE AND REGENERATIVE ABILITY 
The mammalian heart is a vascular tube construct consisting of more than 20 cell types 
forming connective, contractile and vascular structures. Specific progenitor cells contribute to 
formation of the heart during fetal growth. The progenitor cells at the anterior plate mesoderm 
give rise to the heart. During fetal life, heart is formed from two different committed 
progenitor cell groups determined according to the expression of specific transcription 
molecules, and can be classified into primary and secondary heart fields. The primary heart 
field rises from the anterior splanchnic mesoderm and it gives rises to the heart crescent and 
later contributes to left ventricle and atrium formation. The secondary cardiac field is also 
termed the anterior heart field and it originates from the pharyngeal mesoderm located 
medially at the cardiac crescent. Subsequently it contributes to right ventricle and outflow 
tract formation (Dyer & Kirby, 2009). The development of a four-chambered heart is a 
multistep process and depends on unique genetic programs that are highly diverse and unique 
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for each species. In mice and rats, cardiomyocytes replicate actively during fetal life, but in 
the perinatal period proliferation ceases and myocytes undergo an additional round of DNA 
synthesis with nuclear division (karyokinesis), without subsequent cell division (cytokinesis). 
This leads to binucleation, a form of endoreduplication known as acytokinetic mitosis. The 
process starts about day four after birth and ends after three weeks, when over 85% of 
cardiomyocytes are binucleated. With the exception of humans and pigs, in the mammalian 
species studies so far most cardiomyocytes are binucleated (Klug et al., 1995). Pigs have a 
majority of tetranucleated myocytes, and cells containing up to 32 nuclei have been reported, 
but in the human heart most myocytes are mononucleated, and no myocytes containing more 
than two nuclei have been reported. Mammalian species have little or no ability to replace lost 
cardiac muscle. This poor regenerative capacity is due in part to the failure of adult 
cardiomyocytes, the beating cells in the heart, to undergo proliferation (Quaini et al., 2004). In 
fact, the normal response of mammalian hearts to injury or hypoxia is hypertrophy—the 
growth of cardiomyocytes without cell division. Although there is evidence that a stem cell-
like population may exist in the adult mammalian heart, cell division in this organ is rare. For 
full-sized adult mammals, homeostasis maintains the status quo, calibrating organ size and 
function in response to changing physiological conditions, replacing damaged or senescent 
cells through direct structural cell proliferation, progenitor cell activity or hypertrophy of 
surrounding cells. Cardiac hypertrophy consists of hypertrophy of cardiomyocytes and 
hyperplasia of other cell types in the heart, such as fibroblasts (Poss et al., 2002). Indeed, 
although there is evidence that a stem cell–like population may exist in the adult mammalian 
heart, cell division in this organ is rare. Prolonged cardiac hypertrophy in humans can lead to 
dilation, poor contractility, and eventually heart failure and death. Hypertrophy initially results 
in response to load demands on the heart, and how it progress to cardiac failure is not 
understood at this time (Nicol et al., 2001). More recently, the discovery of cardiac stem cells 
and the finding that cardiomyocytes have certain capacities to proliferate challenged that 
concept and raised significant interest in investigating the molecular mechanisms of myocyte 
hyperplasia. According to a classical dogmas of mammalian heart regeneration, 
cardiomyocytes are terminally differentiated and become post-mitotic before or soon after 
birth and are generally considered to irreversibly withdraw from the cell cycle (Ahuja et al., 
2007). Analysis of cardiac myocytes growth during early mammalian development indicates 
that cardiac myocyte DNA synthesis occurs primarily in uterus, with proliferating cells 
decreasing from 33% at midgestation to 2% at birth. Throughout life a mixture of young and 
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old cells is present in the normal myocardium. It was believed that human cardiac myocytes 
could not self-regenerate after an injury such as acute MI and that the main adaptive response 
to myocytes loss was hypertrophy, an increase in cardiomyocytes diameter without 
undergoing cell division. However, this dogma is now being replaced by the idea that there is 
some in-vivo proliferation of cardiomyocytes after damage. Using a mouse genetic fate-
mapping strategy, Hsieh and colleagues (2007) showed strong evidence that stem or 
progenitor cells refreshed murine cardiomyocytes after heart injury, but not during up to one 
year of normal aging. Additionally, taking advantages of the incorporation of carbon-14 
produced during the Cold War into DNA, Bergmann and colleagues (2009) established a way 
to determine the age of cardiomyocytes. Using this method, they demonstrated that human 
cardiomyocytes renew themselves, although at a low frequency. In mammals hearts, after an 
acute MI, the remaining viable myocardium undergoes a series of structural changes termed 
cardiac remodeling, consisting in not only in myocardial hypertrophy, but also in myocytes 
cell loss via apoptosis, coagulative necrosis of the myocardium (myofibrillar 
hypereosinophilia and loss of nuclei), nuclear ploidy, defective regeneration, infiltration of 
inflammatory cells such as neutrophils, progressive expansion of the initial infarct area, 
dilation of the left ventricular lumen and progressive replacement of contractile myocytes by a 
fibrin deposition at the injury site thought a process that begins around the second week and 
reaches its maximum about three months after infarction. Then, fibrin is replaced by scar 
tissue, thought to be permanent, altering left ventricular function. The development, 
progression and pathogenesis of heart failure is complex and multifactorial. Importantly, 
remodeling begins with hours of the MI and is initiated by migration of inflammatory cells, 
mainly macrophages and neutrophilis as well as fibroblasts, which produce tumor necrosis 
factor (TNF) alpha and transforming growth factor (TGF) (Janczewski et al., 2002). These 
cytokines stimulates mast cells and cardiac fibroblast proliferation. At the organ level, MI 
results in thinning of the injured wall and dilatation of the ventricular cavity, a process called 
ventricular remodeling. These structural changes markedly increase mechanical stress on the 
ventricular wall and promote progressive contractile dysfunctions. The extent of heart failure 
after MI is directly related to the amount of myocardium lost. When the heart is submitted to 
an increased workload, for example after acute MI, the cardiomyocytes enlarge and increase 
their ploidy status. Since polyploidization implies DNA replication, it can be assumed that 
adult cardiomyocytes retain the ability to enter into the cell cycle. There are evidences that 
under certain circumstances adult cardiomyocytes re-enter the cell cycle and advances to 
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mitosis but the knowledge of the triggering phenomena and the cascade of events leading to 
cardiomyocyte mitosis is still poor. The four phases of the mammalian cell cycle are tightly 
regulated at several checkpoints, ensuring that all activities are completed before initiation of 
the next phase, providing in this way a mechanism for the identification of defective cells. 
Positive cell cycle regulators (as for example, cyclins, the CDKs, and proto-oncogenes) are 
highly expressed in embryonic and newborn hearts, and are down-regulated in the adult heart. 
Various studies have used the approach of genetically targeting the cell cycle regulators to 
encourage the cardiomyocyte to re-enter the cell cycle and progress into mitosis and 
cytokinesis (Maltsev et al., 1994). However, whether these cells are derived from a resident 
pool of cardiomyocyte stem cells or from a renewable source of circulating bone marrow 
derived stem cells that home to the damaged myocardium is at present not known. Myocytes 
regeneration is evidenced by a ~2-fold increase in expression of cell cycle markers (Ki67 and 
phosphohistone H3) and ~13% reduction in mean myocytes diameter. Increased circulating 
levels of hepatocytes growth factor (HGF), leukemia inhibitory factor (LIF), and macrophage 
colony-stimulating factor (M-CSF) were associated with mobilization of c-kit+, CD31+, and 
CD133+ progenitors cells and subsequent increase in myocardial c-kit+ cells. It has been 
shown that for newt myotubes in tissues culture, the presence of thrombin and serum 
stimulates myonuclei to re-enter s-phase via phosporylation of the retinoblastoma (mass of 
undifferentiated/de-differentiated proliferating cells in the growth zone under the wound 
epidermis formed after damage) of amputated newt limbs (Tanaka et al., 1999). Another 
integral component of the remodeling process appears to be the development of neo-
angiogenesis within the myocardial infarct scar, a process requiring activation of a latent 
collagenase and other proteinases. Loss of oxygenation to ventricular muscle, usually, because 
of occlusion of a coronary artery, will result in necrosis and stimulating the new angiogenesis. 
Moreover, recent observations suggest that a small number of human cardiomyocytes (15-
25%) retain the capacity to proliferate and regenerate in response to ischemic injury (Anversa 
et al., 2006).  
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ABILITY OF ORGAN REGENERATION IN AMPHIBIAN AND ZEBRAFISH AS 
COMPARISON WITH MAMMALS 
Regeneration is a complex biological process by which animals can restore the shape, 
structure and function of body parts lost after injury, or after experimental amputation. This 
process is an evolutionary conserved feature of vertebrate species and requires the concerted 
action of mechanisms inducing and regulating dedifferentiation, pattern generation, and, in 
certain instances, trans-differentiation events (Ausoni and Sartore, 2009). Natural scientists 
have actively pursued the problem of regeneration since the 17th century, largely by utilizing 
invertebrate and lower vertebrate species possessing exceptional regenerative capacities 
(Dinsmore, 1991). Newts are the primary experimental model used to study vertebrate 
regeneration, as they can re-grow a striking number of adult structures, including limbs, tail, 
spinal cord, jaws, tongue, lens and optic nerve (Brockes, 1997; Ferretti and Géraudie, 1998) 
(Figure 4). It has long been recognized that Urodele amphibians such as the newt, have a 
remarkable regenerative ability for many tissues. Consubstantial with survival, tissues and 
structures of vertebrates cope with everyday wear and tear by being continuously renewed 
with the progeny of resident or circulating cells, which exhibit a varying degree of plasticity 
(Wagers et al., 2002). The cellular mechanisms underlying the phenomenon of tissue turnover 
are highly dependent on the specific type of tissues, and differentiation, but not cell 
dedifferentiation. The restitution of tissues of structures by increased activity of normal 
turnover mechanisms is called “tissue restoration”. In contrast with tissues restoration, true 
regeneration in vertebrates is considered as a type of epimorphic regeneration. It involves the 
deployment of a complex set of de novo mechanisms including dedifferentiation of post-
mitotic cells, cell proliferation, pattern generation and, in some cases, trans-differentiation of 
adult specialized cells to rebuild parts of the body plan after amputation or injury. 
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Figure 4. Regenerating hearts and limbs. (Left) Following surgical removal of a portion of the 
zebrafish ventricle, cardiomyocytes (green cells) adjacent to the wound site (bright red) 
undergo proliferation, presumably due to signals (arrows) emanating from the wound (Right). 
In contrast to the heart, the newt limbs is composed of various differentiated cell types 
(indicated by cells of different colors). Following injury, cells adjacent to the wound 
epithelium dedifferentiates to form a blastema (green). These cells proliferate and 
subsequently to re-form a properly patterned limb. From Scott and Stainier, (2002). 
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Different vertebrate species have different cardiac regeneration rates: high in Teleost 
fish, moderate in Urodele amphibians, and almost negligible in mammals (Scadding, 1977). 
Some organs are capable of rapid homeostatic adjustments to tissues loss or gain. Mammals, 
including humans, exhibit only a few examples of tissues and organs regeneration, most 
notably the ability of liver hepatocytes to regenerate damaged liver tissue. Progenitor cell 
populations have been identified within most mammalian organs, including skin, blood, bone, 
reproductive tissues, skeletal muscle, kidney, lung, liver, intestine, heart and brain. 
Unfortunately, not all of our organs are equally competent to regenerate, and it is known that 
heart and central nervous system are particularly resistant to regeneration after injury and that 
they form scar tissue (Poss et al., 2002). For example, the liver will increase mass through 
compensatory cell proliferation after partial hepatectomy, or reduce mass through apoptosis 
after experimentally induced hyperplasia, to maintain the appropriate size. Although robust 
replacement of structural cells has been discovered in mammalian tissues, such as the liver, 
blood and skin, most tissues do not share this remarkable ability, like the heart. In animal as 
salamander, hydra and flatworm, it has been described a huge regenerative capacities indeed, 
flatworms are able to generate an entirely new animal from a small piece of tissue (Salo and 
Baguna, 2002). The regeneration on limbs after amputation has been analyzed in detail in 
these organisms. This process is commonly divided in three sequential steps: (1) wound 
healing, in which the amputation site is covered by epithelial cells; (2) formation of a mass of 
undifferentiated progenitor cells, or blastema, by dedifferentiation of cells in the surrounding 
tissue; and (3) limb redevelopment, in which the correct pattern is generated in the blastema 
resulting in the regeneration of the amputated portions of the limb (trans-differentiation). The 
regeneration of limbs and lens in newts, as well as that of fins in zebrafish, relies on the 
formation, growth and patterning of a blastema. It is well established that, during limb 
regeneration in newts, multinucleated muscle cells dedifferentiate to adopt muscle or cartilage 
fates. In addition to limbs, tail, jaw and lens, newts also display the ability to regenerate large 
portions of their hearts after amputation. Although new heart regeneration does occur to some 
extent after partial resection of ventricular myocardium, there is only a modest level of tissue 
replacement that accompanies scarring. Despite the evident significance of understanding this 
process for the development of potential therapeutic target, heart regeneration in newts has not 
been addressed from molecular approaches, probably owing to the relative lack of genetic 
tools in this experimental model. While genetic approaches have been successfully applied to 
dissect many developmental, physiological and behavioral processes, and could conceivably 
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be applied to reveal factors required for regeneration, newts and other highly regenerative 
amphibians are not suitable for this analysis. This is because of their long generation times, 
enormous genomes, and the difficulty of maintaining large numbers of animals. Nonetheless, 
selected non-mammalian vertebrates, including Urodele amphibians and Teleost fish, display 
an elevated regenerative spectrum, with many more tissues capable of impressive 
regeneration. In particular, because of their amenability to genetic manipulation, zebrafish 
have proved to be a valuable laboratory model for understanding many aspects of vertebrate 
embryogenesis (Haffter and Nüsslein-Volhard, 1996). The robust capacity of zebrafish to 
regenerate a variety of tissues as fins, spinal cord, and retina, position it as an ideal genetic 
model system for understanding the molecular and cellular events governing regeneration 
(Wagner and Misof, 1992; Curado et al., 2007).  
 
UTILITY OF USE OF ZEBRAFISH AS MODEL ORGANISM FOR BIOLOGICAL 
STUDIES AND CARDIAC REGENERATION 
Several characteristics have made to use zebrafish as a model organism (Warren et al., 
2000), as for instance, the relatively short generation time (3 months), the small size at 
maturation (3 to 4 cm long as an adult), the simple husbandry requirements, the ease of 
manipulation and maintenance, and the high fecundity (100-200 eggs per clutch) (Gerhard, 
2003). Additionally, external fertilization coupled with optical clarity throughout 
embryogenesis allow the direct monitoring of developmental processes, and their 
manipulation using mechanical, chemical, or genetic technique (Nasevicius and Ekker, 2000; 
Bopp et al., 2006). Moreover, using zebrafish is further supported and facilitated by the 
sequencing of the zebrafish 1.7-Gb genome (Sanger Institute’s Danio rerio sequencing 
project), which has facilitated the generation of microarrays for large scale expression 
profiling (Ton et al., 2002; Lo et al., 2003; Mathavan et al., 2005; Quian et al., 2005). Again, 
zebrafish can be used as model for pathogenesis study (Neely et al., 2002; Prouty et al., 2003), 
for hematopoietic and cardiovascular diseases (North and Zon, 2003; Zheng et al., 2008) and 
for discovering new therapeutic target (Peterson, 2004). Also, zebrafish mutations faithfully 
phenocopy many human disorders (Goldsmith and Harris, 2003; Meeker and Trede, 2008). 
Each mutation, once cloned, provides candidate genes and pathways for evaluation in the 
human (Anderson and Ingham, 2003). The collection of mutations in their entirely potentially 
provides a medical taxonomy, one based in developmental biology and genetics (Eisen, 1996). 
18 
 
Large-scale genetic screens have been performed in zebrafish after use of ethyl-nitrosourea 
(ENU) to generate point mutations. More than 7000 mutations in 600 genes have been so 
generated. Zebrafish orthologos exists for most human genes, and in fact, there are large 
regions of conserved synteny between chromosomes of fish and mammal (Barbazuk et al., 
2000). There is believed to have been a genome duplication at the base of the Teleost 
radiation 450 million years ago (mya), as well as a second duplication 100 mya, with as many 
as 20% of genes having been duplicated in the fish as compared to the human. Although such 
defects are transient and not heritable, morpholinos can be used to assess the effects of 
diminishing function of orthologs of genes, including those known to be involved in disease, 
such as dystrophin, presenilin, and apolipoprotein E (For a review see Lieschke and Currie, 
2007).  
Zebrafish heart share common structures with mammalian hearts, serving as a model 
for vertebrate animal studies (Wang et al., 1998; Scott and Stainier, 2002; Sehnert and 
Stainier, 2002). The zebrafish is an ideal organism for the study of heart development because 
is capable to produce definitive hematopoietic cells and form a simple circulation two-
chambered heart (Stainier et al., 1996). Furthermore the detection of perturbations in 
cardiogenesis and for regeneration because heart formation and function can be assessed 
visually in the embryo and because the fish is not dependent on blood circulation for survival 
during embryogenesis (Pelster and Burggren, 1996). Additionally, because the fish is not 
dependent on blood circulation for survival during embryogenesis (Pelster and Burggren, 
1996), and the defects in heart development and/or function are more likely to be detected and 
recovered. Many zebrafish mutants with defects in cardiac development and function were 
identified in the large-scale mutagenesis screens and are described in detail elsewhere (Chen 
et al., 1996). Blood circulation in zebrafish begins by 24hpf and is clearly visible under the 
microscope. The process of blood development and the morphology of zebrafish blood closely 
parallels that of mammals (Wingert and Zon, 2003). There are both primitive and definitive 
waves of differentiation in the zebrafish, which produce primitive erythrocytes and 
macrophages, followed by definitive erythrocytes, B cells, T cells, monocytes, granulocytes, 
and thombocytes, respectively (Willet et al., 1999; Bennett et al., 2001; Lawson and 
Weinstein, 2002; Schoenebeck and Yelon, 2007). Many zebrafish orthologos of blood-
specific genes demonstrated to be important in mouse and human development have been 
isolated, including cmyb, gata1, gata2, globin, hhex, scl, and vegf (Hansen et al., 1997; Gering 
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 et al., 1998; Brownlie et al., 2003). Recently, Holtzinger and Evans (2007) have 
discovered that gata5 and gata6 in the zebrafish are functionally redundant for specification 
of cardiomyocytes. In the same year Jia et al., (2007) showed that vertebrate growth is 
regulated by functional antagonism between Gridlock and Gata5. Gata5 is also required for 
the development of the heart and the endoderm (Reiter et al., 1999). Although the genetic 
program appears to be highly conserved during hematopoietic development in the vertebrate 
embryo, the site of hematopoietic is not as consistent. Whereas primitive hematopoiesis in 
mice and humans takes place in the yolk sac, in the zebrafish, the primitive wave initiates in a 
region termed the intermediate cell mass (ICM) (Langeland and Kimmel, 1997; Orkin and 
Zon, 1997). Definitive hematopoiesis appears to initiate in the dorsal aorta of the zebrafish as 
it does in all the vertebrate studies to date; however, the site of adult hematopoiesis in the fish 
is the kidney, not the bone marrow as in mammals (Willet et al., 1997).  
In vertebrates, the linear heart tube forms from the migration and fusion of bilateral 
cardiac progenitors fields at the midline, followed by cardiac looping to form an s-shaped 
heart. Distinct atrial and ventricular chambers with unique physiological and electrical 
properties arise, separated by a discrete domain known as the atrio-ventricular canal (AVC) 
(Stainier, 2001; Beis et al., 2005). The AVC give rise to the valves that ensure unidirectional 
flow of blood. In mammals, each chamber and valve-forming region becomes septated, 
resulting in a four-chambered heart. The embryonic heart of the zebrafish has a close 
anatomic resemblance to that of a human heart at 3 weeks of gestation (Hu et al., 2000; 
Auman and Yelon, 2004). The zebrafish heart manifests the same pattern of electrical 
excitation as does the human heart, with impulses generated in the sino-atrial node, 
propagated through the atrium, pausing in the atrio-ventricular (A-V) node, and thence to the 
ventricular (Hu et al., 2001; Ho et al, 2002; Beis et al., 2005). Our understanding of heart 
development has benefited greatly from zebrafish mutants that specifically disrupt 
cardiovascular form and function (Berdougo et al., 2003; Kinna et al., 2006). Mutations that 
mimic the most common arrhythmias, including pacemaker problems (slow mo and reggae) 
(Warren et al., 2001), A-V block (hiphop and breakdance), and atrial fibrillation (island beat, 
isl) have been described (Baker et al., 1997; Kopp et al., 2005). Indeed, it remains the only 
laboratory model system that is both amenable to genetic manipulation and capable of 
carrying out a robust regenerative response after the loss of complex tissue (Ho et al., 2007). 
Zebrafish have a population of haemangioblasts, which is absent in chick and 
mammalian embryos, raising the possibility that these cells represent the evolutionary 
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ancestror of the second heart field. The genetic programs of these anterior haemangioblasts 
and the adjacent heart field are co-regulated, by transcriptional factors previously associated 
with heart but not blood or endothelial development (Chen and Fishman, 2000). The anterior 
lateral plate mesoderm (ALM) in zebrafish is a source of hematopoietic, endothelial and 
cardiogenic cells, with the blood and endothelium coming from the most rostral region and 
cardiac tissue deriving from the adjacent more posterior population. Differences between 
zebrafish and mouse/chick may in part reflect the different origins of the endoderm: whereas 
in chick and mouse, yolk sac haematopoiesis and vasculogenesis occur adjacent to the visceral 
endoderm, in zebrafish the ALM is adjacent to the definitive endoderm. 
 
DEVELOPMENT AND STRUCTURE OF THE ZEBRAFISH HEART 
The majority of biological research concerning the zebrafish has focused on its 
developmental stages because of its transparency of the embryo. The heart is enclosed in the 
pericardial cavity with paired pericardial muscles running in caudo-cranial direction and is 
covered by an epicardial membrane. Zebrafish heart develops from a simple tube, which 
bends and twists (loops) rightward to create the basic plan of the mature heart that consists of 
only one atrium and one ventricle (1 mm3) composed of two concentric layers: an inner 
endothelial layer called the endocardium and an outer muscular layer termed the myocardium 
(Stainier and Fishman, 1992; Stainier et al., 1993; Glickman and Yelon, 2002). Two 
additional smaller compartments are the sinus venosus (SV) and the bulbus arteriosus (BA) 
(Forouhar et al., 2006). The embryonic zebrafish heart at 24 hpf is nearly identical to the two-
chambered human heart at three weeks of gestation (Fishman and Chien, 1997). It is 
spontaneously contractile, emptying atrium and then ventricle sequentially to generate 
unidirectional blood flow (Bendig et al., 2006).  
Heart formation involves the specification and differentiation of cardiac precursors, the 
integration of precursors into a tube, and the remodeling of the embryonic tube to create a 
fully functional organ (Glickman and Yelon, 2002). Cardiac progenitors can be identified at 
approximately 11 hours post fertilization (hpf) as marked by nkx2.5 expression, termed the 
cardiac field (Stainier et al., 1993; Lee et al., 1994; Griffin et al., 2000). Angioblasts in 
zebrafish are first evident around 14 hpf and the formation of the zebrafish heart begins at 
approximately 16 hpf when zebrafish cardiac precursors begin to migrate to the midline from 
bilateral regions of the anterior lateral plate. Each bilateral cardiac sheet contains lateral atrial 
precursors that express Cardiac myosin light chain 2 (Cmlc2), and medial ventricle precursors 
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that express both Cmlc2 and Ventricular myosin heavy chain (Vmhc) (Yelon et al., 1999; 
Yelon, 2001; Huang et al., 2003; Rottbauer et al., 2006). For the embryonic heart 
development, it is also important the expression of NXT2, member of NXT proteins, involved 
in exporting nuclear RNA in eukaryotes, as demonstrated by Huang et al., (2005b). The 
timing of zebrafish myogenesis is regulated by smacd3 (Ochi et al., 2008). For normal 
myocyte proliferation during early cardiac development is necessary the expression of ndrg4 
(Qu et al., 2008). Early cardiac connexin, cx36,7/Ecx, regulates myofibril orientation and heart 
morphogenesis by establishing Nkx 2.5 expression (Sultana et al., 2008). Hrt is required for 
cardiovascular development in zebrafish (Szeto et al., 2002). The aorta begins to form in the 
posterior trunk at 17.5 hpf and complete its formation after the blood circulation starts (Thisse 
and Zon, 2002). The cone tilts and extends to produce the heart tube, which begins to beat as a 
peristaltic wave at 22 to 24 hpf (Stainier et al., 1993). Heart formation is completed through a 
series of remodeling steps that properly position the ventricle and atrium, and produce cardiac 
valves to ensure unidirectional blood flow through the heart (Stainier et al., 1992; Glickman 
and Yelon, 2002). By 36 hpf cardiac looping is completed and coordinated contractions of 
atrium and ventricle provide circulation to the head and trunk (Glickman and Yelon, 2002; 
Cha and Weinstein, 2007). Growth of a muscular septum late in human embryonic 
development, which divides the primitive atrium and ventricle into left and right parts, 
differentiates the adult human from the adult zebrafish heart, the latter retaining a single 
atrium and single ventricle. By 5 dpf, the larvae heart is essentially formed as noted in the 
adult Teleost configuration. The four compartments are now separated from another by three 
sets of fully functional valves (Weinstein and Fishman, 1996). In each compartment, the 
myocardium is about one cell layer thick except for the ventricle, which consists of two to 
three cell layers.  
More than 35 mutations in the zebrafish prevent the normal acquisition of contractile 
function, without disturbing the generation of normal chamber cell fate or formation, and 
therefore functionally mimic dilated cardiomyopathies (Sehnert and Stainier, 2002; Basset and 
Currie, 2003; Huang et al., 2005a). Pickwick, a mutation in titin, the myofibrillar element 
around wich the actin-myosin arrays assemble and contributor of most of the elastic force to 
the muscle, has been cloned. It is interesting to note that a human dilated cardiomyopaty 
family has also recently been documented to have a titin mutation (Xu et al., 2002). These 
“heart failure” mutations in zebrafish will reveal not only candidate genes for disease 
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propensity in humans, but also potential factors and pathways that could be pharmacologically 
manipulated to improve contractile function (Chun and Chen, 2007).  
Concern the contractile function, it is well known that vertebrates have evolved a 
nerve system to modulate cardiac activity in a sophisticated fashion (Incardona et al., 2004). 
These activities include heart rates, contractile force, action potential and conduction velocity 
that can be exposed to several anomalies (Ernest et al., 2000). Congenital anomalies of the 
heart affect 8 of 1000 live births. Three percent of these are due to inadequate chamber 
growth. Although there is a high sibling recurrence, suggesting a genetic component, these 
diseases in general are not transmitted in a Mendelian fashion. Several mutations in zebrafish 
disrupt generation of early heart form. For example, heart and soul causes the ventricle to 
form inside of the atrium and is due to a mutation in PKCλ. Handsoff and Pandora have 
diminutive ventricles. The former due to mutation in the bHLH transcription factor dHAND. 
Jekyll is due to a defect in the enzyme UDP-glucose dehydrogenase and lacks an A-V valve. 
Casanova is a sox-related gene that lacks endoderm and causes cardia bifida. The zebrafish 
homologue of caldesmon (CaD, an actin-binding protein implicated in the cytoskeletral 
organization and various signaling pathways) is similar to the mammalian low molecular 
weight caldesmon (l-CaD, associated with the development of tumor vasculature). It is 
essential for normal vertebrate cardiac looping, chamber formation, muscularization and 
proper cardiac function. The obvious contribution of CaD to cardiac muscularization offers 
clues for future therapeutic strategies in regeneration of cardiomyocytes. 
Despite a two-chambered heart and lack of pulmonary vasculature the zebrafish heart 
parallels that of humans in terms of QT interval and heart rate (Arnaout et al., 2007). The 
atrium is medially dorsal and posterior to the ventricle. Similar to humans, the zebrafish heart 
is enchased by a pericardial sac in the thoracic cavity, and is situated below the pectoral bone 
of the pectoral fins. The bulbous arteriosus is analogous to the human aortic arch with thick 
contractile smooth muscle. Blood returns into the sinus venosus, which is analogous to the 
vena cava. The fundamental electrical properties are remarkably similar to those of humans, 
and the critical pathways in cardiovascular development parallel higher vertebrates (Kopp et 
al., 2007). In 2004, Forouhard at al., reported an electrocardiogram (ECG) of an embryonic 
zebrafish, revealing similar atrial and ventricular electrical signals as found in a human ECG. 
It has been demonstrated that zebrafish embryos are sensitive toward a range of QT-
prolonging drugs inducing severe arrhythmia (Langheinrich et al., 2003). Ventricular 
trabeculae are more prominent in the zebrafish heart than in those of humans (Grimes et al., 
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2006). Histological studies show that the ventricle of an adult zebrafish is composed of 
trabecular and compact myocardium, and surrounded by epicardium and endocardium. Using 
zebrafish mutant tr265/tr265, whose Band 3 mutation disrupts erythrocyte formation and 
result in anemia, Sun and colleagues (2009a) showed that cardiac hypertrophy involves both 
myocyte hypertrophy and hyperplasia in anemic zebrafish.  
 
ZEBRAFISH HEART REGENERATION  
The zebrafish has emerged as an excellent model for cardiovascular research (Curado 
and Stainier, 2006). Recently, it has been shown that adult zebrafish possess a unique yet 
poorly understood capacity for cardiac regeneration, restoring in 1-2 months, the ventricular 
muscle removed by surgical resection, offering new possibilities for experimentally 
approaching this fascinating biological phenomenon (Lepilina et al., 2006) (Figure 5). The 
regenerative ability of an adult zebrafish heart was uncovered by surgical resection of a large 
portion (20-30%) of the ventricular chamber including the apex (Poss et al, 2002). This was 
easily accomplished in anesthetized adult fish, whose hearts were readily accessible after 
incision of the skin, muscle, and pericardial sac. The ventricle was then gently pulled at the 
apex and cut at the desired position with iridectomy scissors. This surgical procedure was 
highly reproducible and relatively safe, with greater than 80% survival.  
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Figure 5. Model for Zebrafish Heart Regeneration Resection of the ventricular apex 
stimulates rapid expansion of the entire epicardium by 3 dpa (black dots), at which time 
myocardial progenitor cells first originate in the wound, express pre-cardiac markers, and 
associate with existing muscle. By 7 dpa, raldh2/tbx18-positive epicardial cells begin to 
surround and invade the wound. Meanwhile, there is continued seeding, maturation, and 
proliferation of myocardial progenitor cells, contributing the first layers of new muscle (stage 
1). To coordinate these epicardial and myocardial events, regenerating myocardium 
synthesizes Fgf17b and possibly other factors with the potential to recruit Fgfr2/Fgfr4-
presenting epicardial cells. Epicardial-derived cells undergo EMT in response and vascularize 
the regenerate (green dots). Presence of new coronary vasculature by 14 dpa extends 
progenitor cell activity and facilitates restoration and expansion of the ventricular wall (stage 
2). From Lepilina et al., (2006). 
 
In response to amputation, thrombosis immediately develops to achieve homeostasis in 
the ventricle. After a short initial phase of intense bleeding that stops within 1 minute, a blood 
clot formed that sealed the ventricle and kept fish from exsanguinations. The formation of the 
blood clot in the low-pressure fish circulatory system is remarkably efficient. Probably 
because of this, amputated fish did not, in contrast to newts, exhibit intense myocardium 
contraction at the site of resection, or circulatory stasis. First, the clot that seals the apex 
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matures within several days (1-4 day post-amputation -dpa), into fibrin, a complex milieu 
containing serum factors and degenerated erythrocytes. Functional cardiomyocytes and new 
contractile muscle infiltrated the injured area and sealed off the wound. Interestingly, the 
regenerated myocardium displayed a transiently hypertrophied compact zone, from 21-30 dpa, 
most likely reflecting a compensatory reaction to the hemodynamic overload subsequent to 
myocardial loss. Scarring and collagen deposition, characteristic of damaged mammalian 
hearts, did not occur. Remarkably, 60 days after surgery, the zebrafish heart appeared roughly 
normal both histologically and based on examination of heartbeat. In contrast, mouse hearts 
subjected to similar damage induced by freezing do not regenerate, but instead form scar 
tissue (Wills et al., 2008). In the infarcted mammalian ventricle, fibrin deposition attracts 
fibroblasts and inflammatory cells, and is a precursor to scarring. The normal response of 
mammalian hearts to injury or hypoxia is hypertrophy, the growth of cardiomyocytes without 
cell division. Cardiac hypertrophy refers to the cardiac remodeling process in response to a 
variety of intrinsic and extrinsic stimuli that stress the heart (Baohua et al., 2006). Initially, the 
heart compensates for the stress though increasing cardiac mass to normalize wall tension. 
However, if the underlying stress is untreated, cardiac hypertrophy can lead to sudden death or 
heart failure. The hallmarks of pathological hypertrophy include enlargement of individual 
cardiomyocytes, disarray or myofibrils, fibrosis in the extracellular matrix, reactivation of 
fetal transcriptional programs, and decreased cardiac function (Kitzmann et al., 2006). 
The ventricular myocardium displays histological characteristics of hypertrophy at 21 
and 31 dpa, most likely reflecting compensatory reaction to the hemodynamic overload 
subsequent to myocardial loss. Milan et al., (2006) obtained zebrafish ECG by inserting two 
needle electrodes through the ventral epidermis. They saw that the mean rate of the adult male 
zebrafish is 151±30 beats/min. Sun and colleagues (2009b) applied a minimally invasive 
methodology to monitor zebrafish heart function, electrical activities, and regeneration in real-
time. They performed a micro-electrocardiograms to study post-ventricular amputation of the 
zebrafish heart and, unlike the human counterpart, they didn’t observed ventricular 
tachycardia or fibrillation in response to ventricular amputation 2 and 4 dpa. Atrial arrhythmia 
was recorder after prolonged sedation. Ventricular amputation led to a shortened QTc interval 
without affecting the PR and QRS intervals from non-anesthetized and non-paralyzed adult 
zebrafish. It has been demonstrated that agents known to induce QT prolongation in humans 
led to QT prolongation in zebrafish embryos and drugs that induce repolarization abnomalies 
cause bradicardia in zebrafish (Milan et al., 2003). Understanding the cellular and molecular 
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mechanisms of this regenerative process can have exciting implications for human cardiac 
biology and diseases. 
 
CELLULAR BASIS OF ZEBRAFISH HEART REGENERATION 
Regeneration of the zebrafish heart appears to differ from that described in other 
tissues, including the newt limb and zebrafish fin, where differentiate cells (muscle, cartilage, 
and skin) adjacent to the wound site, first dedifferentiate to form a blastema or mass of 
pluripotent cells, which then give rise to a fully formed and patterned limb or fin (Biga and 
Goetz, 2006). The formation of the blastema that regenerates these tissues requires successive 
process of dedifferentiation, transdifferentiation, and pattern formation. The zebrafish 
myocardium is a relatively simple structure, composed of one major cell type, so the initial 
step of dedifferentiation observed during limb regeneration may not be required for cardiac 
regeneration. Using double transgenic animals with both nuclear-localized DsRed2 
fluorescent reporter for cmlc2 (cmlc2:nRFP, where RFP is red fluorescent protein) and 
enhanced green fluorescent protein (EGFP), that can reveal temporal and spatial 
characteristics of promoter activation and inactivation, Lepilina and colleagues (2006) 
demonstrated that new myocardium arises from undifferentiated progenitors cells and 
maintained by a dynamic epicardial injury response (Figure 6).  
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Figure 6. New Myocardium Arises from Undifferentiated Progenitor Cells. (A) Sections 
through uninjured and injured cmlc2:nRFP ventricles. A subpopulation of RFPlo nuclei 
manifests by 14 dpa (arrowheads), representing ostensibly the entire regenerate by 22 dpa. 
Magenta line in high-magnification insets delineates RFPhi CMs (above line) from RFPlo 
CMs. (B) cmlc2:nRFP; cmlc2:EGFP ventricles. EGFP and RFP expression from the cmlc2 
promoter is reported at the same basoapical level at 3 dpa. By 7 dpa, an RFPneg front of 
newly differentiated muscle reporting the faster-fluorescing EGFP (brackets) appears apical to 
the EGFPposRFPpos portion. Arrowhead indicates an EGFPpos cell process extending into 
the clot. (C) cmlc2:nRFP; cmlc2:EGFP ventricles stained for DsRed immunoreactivity with 
an anti-DsRed antibody. At 3 dpa, there is no difference in appearance from the unstained 3 
dpa ventricle in (B). By 7 dpa, a front of RFPcyto muscle (arrowheads), representing the most 
recently differentiated CMs, colabels EGFPpos tissue apical to natural RFPnuc fluorescence. 
Scale bar = 100 mm. From Lepilina et al., (2006). 
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To directly investigate the nature of cells that contribute to the regenerating tissue in 
the zebrafish heart, Poss and colleagues (2002) undertook an exhaustive series of 
bromodeoxyuridine (BrdU) pulse-chase analyses. Bromodeuxiridine (BrdU), a chemical that 
is only incorporated into cells undergoing de novo DNA synthesis (S phase), was injected into 
fish at various time point following the surgery. Cardiomyocytes from uninjured hearts rarely 
incorporate BrdU, even after prolonged exposure. However, there was a marked increase in 
BrdU incorporation following injury, which peaked at 14 days after surgery and was primarily 
localized to the outermost layer of the myocardium adjacent to the wound area. The 
regeneration resulted from proliferation of cardiomyocytes adjacent to the area of injury. 
Surprisingly, uninjured zebrafish hearts displayed a significant number of cardiomyocytes 
labeled with BrdU (Raya et al., 2003), indicating that normal cardiac cell turnover in this 
animal is much higher than in other organisms. Remarkably, a ten-fold increase in BrdU-
labeled cardiomyocytes was detected in the area surrounding the lesion 2 weeks after 
amputation. These results were further confirmed by staining with anti-phosphorylated histone 
3, a marker of condensed chromatin (Poss et al., 2002). The Authors then analyzed the source 
and fate of regenerating cardiomyocytes by administering BrdU at 7–14 dpa and analyzing 
labeled cells at 14, 30, and 60 dpa. These studies identified a leading edge of proliferation in 
the new layer of epicardial cardiomyocytes, which were continuously displaced inward to 
replenish the amputated region (Poss et al., 2002). The identification of a population of 
differentiated cardiomyocytes that re-enter the cell cycle and proliferate in response to heart 
amputation (Poss et al., 2002), together with the absence of molecular markers of de novo 
cardiomyocyte differentiation in the injured area (Raya et al., 2003), provide strong support 
for a scenario in which heart regeneration in zebrafish is carried out by resident 
cardiomyocytes. It has been recently reported that resident stem cells exist in the adult 
mammalian heart, which can participate in a regenerative response (Beltrami et al., 2003). 
Whether such cells exist in the zebrafish heart, and indeed whether they contribute to its 
regeneration after amputation, was not directly addressed in the studies by Poss and 
colleagues (2002) or by Raya and colleagues (2003). The ventricular resection induces 
developmental gene expression and proliferation within the epicardial layer, activated 
epicardial cells soon surround the wound with a portion of them penetrating several cell layers 
deep into the wound and regenerating muscle. Concomitantly, the new myocardium is 
substantially vascularized. Thus, it is assumed that the epicardial cells have similar roles as in 
the embryonic heart; that is, as a progenitor tissue that contributes smooth muscle and/or 
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endothelial cells during neovascularization. It will be very interesting to investigate the 
existence of resident stem cells and to analyze their behavior after heart amputation in the 
zebrafish, a vertebrate with regenerating capacity far exceeding that of mammals. 
 
MOLECULAR BASES OF HEART REGENERATION IN ZEBRAFISH  
The fact that adult zebrafish show a remarkable heart regenerating ability provides 
new and promising entry-points for advancing our knowledge of this complex phenomenon 
(Akimenko et al., 2003). Raya and colleagues (2003) analyzed the expression of nkx2.5, tbx5, 
and CARP in sections of regenerating hearts at different time points after amputation. Nkx2.5 
is the earliest known marker of cardiac lineage, and its expression, although at low levels, 
persists in the myocardium during adult life (Targoff et al., 2008). In zebrafish, comparable 
low levels of nkx2.5 expression were detected in the myocardium of both control and 
regenerating hearts by in situ hybridization and RT-PCR. Similarly, tbx5 expression did not 
change significantly during regeneration. To address the possibility that a transient expression 
of either nkx2.5 or tbx5 was missed by the in situ hybridization analyses, the authors made use 
of transgenic line expressing eGFP under the regulatory sequences of the CARP gene. CARP 
is a direct target of Nkx2.5, whose expression is limited to heart structures during cardiac 
development. Indeed, adult fish carrying this transgene do not display detectable eGFP 
fluorescence in their hearts. Consistent with the results of nkx2.5 and tbx5 expression, no 
upregulation of CARP-driven eGFP fluorescence was detected in regenerating transgenic 
hearts from this line.  
Raya and colleagues (2003) demonstrated that adult zebrafish have a remarkable 
capacity to regenerate the heart in a process that involves up-regulation of msxB and msxC 
genes. Heart regeneration in zebrafish is accompanied by up-regulation of components of the 
Notch pathway, followed by members of the Msx family. These genes are not expressed 
during zebrafish heart development, indicating that regeneration involves the execution of a 
specific genetic program, rather than redeployment of a developmental program. Also, Raya 
and colleagues (2003) demonstrated that components of the Notch pathway are also up-
regulated during zebrafish fin regeneration, suggesting that this pathway may play a general 
role in the activation of the regenerative process. 
Some molecular mechanisms are likely to be shared by embryonic cardiogenesis and 
adult cardiac regeneration (e.g., myocardial differentiation programs) (Raya et al., 2004). 
However, heart regeneration invokes multiple distinct and definitive events, including (1) 
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iniziation by injury, (2) activation of quiescent tissue, (3) ostensibly local development as 
opposed to organ-and organism wide development, (4) simultaneously healing and growth, (5) 
morphogenesis on large scale to form adult tissue, and (6) possible long-term maintenance or 
de novo creation of progenitor cells. Not only is genome-wide information already available 
for sequence comparison or gene expression profiling analyses in this organism, but zebrafish 
also offer the possibility of conducting large-scale mutagenesis screens to identify genes 
required for heart regeneration (Wood and Schier, 2008). Proof-of-principle experiments have 
yielded successful results for both expectations. On the one hand, a temperature-sensitive 
mutation in msp1, a mitotic checkpoint kinase upregulated during cell proliferation and 
necessary for fin regeneration (Poss et al., 2002), was shown to result in scarring, rather than 
regeneration of the amputated heart (Poss et al., 2002). On the other hand, analysis of the 
expression pattern of msxB and msxC, encoding homeodomain-containing transcription 
factors upregulated in the regenerating fin blastema (Raya et al., 2003), revealed a strong 
expression of these transcripts in regenerating zebrafish hearts, starting as early as 3 dpa, in 
the myocardial areas surrounding the lesion area. Interestingly, neither gene is expressed in 
uninjured adult zebrafish heart, or during heart development in zebrafish embryos. Also, they 
saw that some of the pre-cardiac and early differentiation markers, as hand2, nkx2.5, tbx20 
and tbx5 are expressed during heart regeneration. Retinaldehyde deydrogenase 2 gene (raldh2; 
also known as aldh1a2-Zfin) controls a rate-limiting enzyme for retinoic acid (RA) synthesis. 
it has been demonstrated that the reduction of RA signaling causes formation of an excess of 
cardiomyocytes. Raldh2 is expressed throughout early zebrafish embryogenesis: in the 
blastula, raldh2 is found at the embryonic margin; during gastrulation, raldh2 is in involuting 
mesoderm and, after gastrulation, raldh2 is in both lateral and paraxial mesoderm. Moreover, 
adult zebrafish submitted to rapid growth conditions show dramatic, hyperplastic cardiac 
growth and epicardial expression of raldh2. As early as 24 hr after partial ventricular 
amputation (hpa), raldh2 was strongly induced in epicardium surrounding the ventricle, 
atrium, and outflow tract (Figure 7). Induced expression of raldh2 appeared sequentially, first 
in the outflow tract and atrial epicardium by 6–12 hpa and then joined by the ventricular 
epicardium (Lepilina et al., 2006). Ventricular and atrial epicardial cells also expressed tbx18 
by 1–2 dpa and consequently, began to proliferate. Thus, nkx2.5, hand2 and tbx20, the earliest 
markers of the embryonic zebrafish heart field, were also the earliest detectable precardiac 
markers during heart regeneration (Yelon et al., 2000). Another factor, tbx5, is expressed very 
early during heart development and continues to be expressed at low levels in the adult 
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myocardium (Garrity et al., 2002). Recent studies illustrate that a proper balance of Wnt/-
catenin signaling is also critical for the formation and proliferation of blastemal cells 
(Kawakami et al., 2006; Stoic-Cooper et al., 2007). This is consistent with result observed in 
the larval model by Mathew et al., (2009): when canonical Wnt signaling is blocked, the 
formation of wound epithelium and blastema are blocked. Normally is necessary to program 
the anterior limb formation since tbx5 expression is related in embryogenesis to torax 
formation, in the adult zebrafish myocardium is not altered during heart regeneration. Recent 
results have shed light on the role of the outer non muscle layer of the heart, the epicardium, 
in zebrafish cardiac regeneration. During embryogenesis, the epicardium migrates out as a 
sheet from the proepicardium, a cluster or mesodermderived cells near the liver primordium 
and the septum transversum, to envelop the developing myocardial tube. Following this 
encasement, some epicardial-derived cells undergo an EMT into the subepicardial space and 
invade the myocardium to contribute endothelial and smooth muscle tissue of the coronary 
vasculature. Its developmental activation can be assayed by raldh2 and tbx18 expression, two 
genes known to be expressed within the embryonic epicardium. As early as 6 h post-
ventricular resection, raldh2 expression initiates within the epicardium of the outflow tract 
and atrium and then follows within the ventricle by 24 h. In addition, tbx18 expression is 
observed within the atrial and ventricular epicardium by 1–2 days. Later on, cells positive for 
tbx18 and/or raldh2 appear at the wound site. This organ-wide response is intriguing for 
multiple reasons. First, the response is extremely rapid. The molecular details that connect the 
injury to this early response are unknown but are of interest, as their understanding will shed 
light on how heart regeneration is initiated. Second, the response is seen first distant from the 
wound site, within the atrium. 
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Figure 7 Organ-Wide Activation of Epicardial Cells and Invasion of the Regenerate (A and 
B) Whole-mount (top) and section (bottom) ISH of uninjured and 3 and 14 dpa hearts for 
raldh2 (A) and tbx18 (B). Expression of each marker is low or undetectable in the uninjured 
hearts but induced at 3 dpa in epicardial tissue surrounding the atrium (a) and ventricle (v) for 
tbx18 and these tissues plus the outflow tract (o) for raldh2. The endocardium surrounding 
wounded myofibers also expresses raldh2. By 14 dpa, expression of both markers is localized 
to the apical wound (arrowhead). (C) Colocalization of BrdU (green) with raldh2 (top) and 
tbx18 (bottom) in the ventricular epicardium at 3 and 7 dpa. The left images display a lateral 
edge of the 3 dpa ventricle away from the wound, while the right images display a lateral and 
apical portion of the 7 dpa ventricle including some of the wound. By 7 dpa, 
raldh2/tbx18/BrdU-positive cells begin to localize to the injury site. The majority of 
nonepicardial BrdU-positive cells are erythrocytes within the ventricular lumen. (D) 
Epicardial-derived cells positive for tbx18 invade the regenerate by 7 dpa and remain by 30 
dpa. Scale bar = 100 mm. From Lepilina et al., (2006). 
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Recent work has tried to address these questions through in-vivo developmental timing 
assays that employed double transgenic zebrafish strains carrying reporter constructs for the 
cmlc2 (cardiac myosin light chain 2) promoter. In these experiments, transgenes for EGFP and 
nuclear-DsRed2, both simultaneously driven by separate cmlc2 promoters, reported the 
contractile state of cardiac cells (Baird et al., 2000; Bevis and Glick, 2002). Because GFP 
folds and fluoresces more rapidly than DsRed2, any cardiac progenitors that begin to turn on 
the cmlc2 promoter, and thus change their contractile status, will be transiently marked as 
GFP-positive/DsRed2- negative in nascent myocardium. Indeed, this was the case in the 
double-transgenic embryo, as GFP fluorescence is observed up to a day before DsRed2 
fluorescence within developing cardiomyocytes. Within five days of ventricular resection, a 
front of GFP-positive/DsRed2-negative cardiomyocytes was found at the apical edge. This 
suggests that regenerating myocardium matures from undifferentiated, Cmlc2-negative, 
progenitor cells at the leading edge. In support of this mechanism, this leading edge was found 
to express a variety of molecular markers for the embryonic heart field, such as hand2, tbx20 
and nkx2.5, suggesting that these cells acquire cardiac fate reminiscent of cardiac progenitors 
that provide the first cardiomyocytes of the developing embryo. It is not known from what 
source(s) these apparent progenitor cells are derived. One possibility is that dedifferentiation 
of mature cardiac cells supply the regenerate with new progenitors. 
A series of similarities between both regenerative and developmental processes argued 
for common mechanisms to some extent (Gardiner et al., 2002), although specific differences 
have also been reported (Carlson et al., 1998). In this respect, it is important to note that none 
of the genes members of the Notch signaling pathway, described to be up-regulated during 
heart regeneration in zebrafish (msxB, msxC, notch1b, and deltaC) appear to be expressed in 
the developing myocardium. Similarly, none of the heart development genes analyzed 
(nkx2.5, tbx5, and CARP) were up-regulated in the context of heart regeneration. These results 
indicate that heart regeneration in zebrafish involves the execution of a specific genetic 
program, rather than re-deployment of a developmental program. To address this issue further, 
Raya and colleagues (2003) attempted to induce regeneration in the developing heart of 
zebrafish embryos, by amputating a large portion of the prospective atrium of 24-h post-
fertilization embryos. Notably, a strong upregulation of msxB and msxC transcripts was 
evident in the remnants of the cardiac tube from as early as 3 h post-amputation, until 24 h 
later (Raya et al., 2003). These results clearly indicate that regeneration and embryonic 
development do not rely on mutually exclusive genetic programs and that the expression of 
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molecular markers of regeneration is not an exclusive property of adult cells, but that 
embryonic cardiac cells are also competent to activate the genetic program of regeneration. In 
addition to the biological significance of this observation, it also raises the possibility that 
zebrafish embryos be used to investigate the molecular mechanisms underlying the heart 
regeneration ability displayed by adult individuals of this model organism. Taken together, 
these results indicate that de novo produced cardiomyocytes during heart regeneration in 
zebrafish are unlikely to be derived from undifferentiated stem cells or from dedifferentiated 
blastemal cells. Rather, the absence of upregulation of early cardiomyocytes differentiation 
markers after heart amputation suggests that the source of the regenerating tissue are 
differentiated cardiomyocytes that re-enter the cell cycle in response to heart injury. 
Comparative gene expression analysis revealed significant common gene expression changes 
in larval fin, adult caudal fin, and heart regenerating tissues, suggesting common molecular 
pathways choreographing the regeneration process. The physiological progression of fin 
regeneration in larvae and adults is similar, as both initiate with the formation of a wound 
epithelium, blastema formation, and the distal to proximal propagation of cell proliferation. 
 
FGF SIGNALING IN CARDIAC REGENERATION 
Fibroblast Growth Factors (FGFs) represent a large family of over 23 secreted 
glycosylated proteins that elicit a variety of important processes, like proper development and 
physiological homeostasis, and that are conserved throughout evolution. Mutations in mouse 
and zebrafish FGFs result in defect in ontogenic development and lethality (Ewton and 
Florini, 1990; Poss et al., 2000; Goishi et al., 2003; Molina et al., 2007). FGFs initiate 
signaling cascades through the extracellular interactions of ligands with a receptor tyrosine 
kinases (RTK) that, through intracellular cascade transduction, results in the activation of the 
RAS/MAPK, phopholipase-C-gamma (PLCγ) and phosphatidylinositol-3-kinase (PI3K) 
pathways that ultimately regulate gene transcription (Maciag and Friesel, 1995; Powers et al., 
2000). During embryogenesis, FGFs are crucial in the specification of several tissues and for a 
multitude of developmental processes, tight regulation of its signal intensity and duration is 
crucial (Kardami and Fandrich, 1989; Marques et al, 2008) and further have a role in cell 
proliferation and survival (Itoh, 2007), Several modulators of the FGFs pathways have been 
identified, including the cytosolic protein sprouties and map kinase phosphatases. The 
generation of in-vivo reporters for FGF activity will provide a valuable tool to screen for 
genes or chemicals that modulate FGF signaling. For example, chemical screens with FGF-
35 
 
reporter transgenic embryos have been used to identify specific compounds that can block 
FGFR signaling in the zebrafish. These compounds were counter screened against an indirect 
transgenic reporter for Vascular Endothelial Growth Factor (VEGF) signaling that plays an 
important role in formation of the aorta FGF proteins may act in a redundant manner so that 
the simultaneous inactivation of multiple FGF proteins has revealed overlapping functions for 
these secreted ligands in several vertebrate species. More in particular Lepilina et al. (2006) 
has demonstrated that zebrafish heart regeneration initiated predominantly by undifferentiated 
progenitors cells proceeds through two coordinated and FGF-dependent stages (Figure 8). 
First the formation of a blastema, comprised of progenitors cells that express pre-cardiac 
markers, undergo differentiation, and proliferate. Second, the induction of developmental 
markers that creates a new epithelial cover for the exposed myocardium. A subpopulation of 
these epicardial cells undergoes epithelial-to-mesenchymal transition (EMT), invades the 
wound, and provides new vasculature to regenerating muscle (Lepilina et al. 2006). During 
regeneration, the ligand fgf17b is induced in myocardium, while receptors fgfr2 and fgfr4 are 
induced in adjacent epicardial-derived cells. Lepilina and colleagues (2006) also demonstrated 
that when FGFs signaling is experimentally blocked by expression of dominant-negative FGF 
receptor, epicardial EMT and coronary neovascularization fail, prematurely arresting 
regeneration. FGFs are appealing candidates for signals that regulate the establishment of 
cardiomyocyte number. FGFs comprise a large family of secreted polypeptides thought to 
signal in a dose-dependent manner through receptor tyrosine kinases (Böttcher and Niehrs, 
2005). In-vitro studies have even shown that FGFs promote epicardial EMT into collagen gels 
(Morabito et al., 2001). Lastly, the role of FGFs in the recruitment of epicardial cells into 
cardiac wounds and into the muscle regeneration, has been studied and expression of multiple 
FGF ligands and all 4 FGFr receptors (FGFrs) during regeneration has been evaluated (Cao et 
al., 2004): FGF17b, a member of the FGF8/17/18 subclass of FGF ligands, was the only 
ligand gene that showed detectable expression during the regeneration process (Reifers et al., 
2000; Draper et al., 2001; Lepilina et al. 2006). Among zebrafish FGF ligands, FGF17b shows 
the highest homology to mammalian FGF17, which binds receptors FGFr1-3 (the ‘‘c’’ spliced 
forms) and FGFr4 (Olsen et al., 2006). In the uninjured adult zebrafish heart, smooth muscle 
cells in the outflow tract expressed FGFr1 and FGFr2, and valve mesenchyme expressed 
FGFr1, FGFr2, and FGFr4 (Lepilina et al., 2006).  
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Figure 8 Heart Regeneration in Zebrafish. Following partial surgical removal of the ventricle, 
replacement cells appear to arise from undifferentiated progenitor cells that progressively 
differentiate into more mature cardiomyocytes (EGFP+RFP−, and then EGFP+RFP+). In 
addition, epicardial cells turn on expression of a number of genes, including fgfr2/4 (activated 
epicardium, dark blue), and then subsequently appear to migrate toward the newly 
differentiated cardiomyocytes expressing fgf17b, leading to the establishment of new blood 
vessels in the regenerating tissue (steps 1–6). In the absence of Fgf signaling, the activated 
epicardial cells fail to invade the regenerating region, new blood vessels do not form, and a 
scar appears. From Curado and Stainier (2006). 
 
Studies in a number of model organisms have implicated FGF signaling in cardiac 
specification (Zaffran and Frasch, 2002). FGF signaling has reiterative roles in regulating 
heart size and chamber proportionality: early in development, FGF signaling helps to establish 
properly sized and proportioned cardiac progenitor pools, and, at later stages, FGF signaling 
continues to contribute to the regulation of ventricular cell number, potentially by controlling 
population maintenance or growth. Various growth factors (e.g. FGF1, Neuregulin), small 
molecules (e.g. BIO, SB203580), viral oncoproteins (e.g. E1A, SV40 T antigen), an 
extracellular matrix protein (Periostin), and cell cycle activators (e.g. Cyclin A2, Cyclin D2, 
E2F1, E2F2, c-myc) were studied to induce mammalian cardiomyocyte proliferation in the 
hope that these molecules can be utilized for cardiac regeneration (Kühn et al., 2007). 
Recently, it has been demonstrated that a p38 inhibitor induced cardiomyocyte proliferation 
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(Brette et al., 2008). Treatment with a p38 inhibitor induced cell division in cultured adult 
cardiomyocytes demonstrated by transient dedifferentiation combined with cleavage furrow 
formation and separation of the cytoplasm studies to date have shown that cyclin D2, cyclin 
A2, FGF5, VEGF165, Periostin, and p38 inhibitor treatment promote cardiac regeneration due 
to induction of cardiomyocyte proliferation (van Amerongen and Engel, 2008). Unfortunately, 
improved cardiac function after treatment did not directly indicate that cardiomyocytes have 
proliferated; for example, growth factors could improve cardiac function by other mechanisms 
as they display pleiotropic actions. Inhibition of FGF signaling, a partway necessary for 
normal heart regeneration, disrupts epicardial cell supplementation and causes spontaneous 
ventricular scarring in uninjured adult fish. The significance of this distal activation and how 
this signal is transferred over these distances are unknown, but are of interest to the field. In 
the regenerating zebrafish heart, FGF receptors 2 and 4 are expressed in epicardial or 
epicardial-derived cells at or near the injury site, which was shown to express at least one FGF 
ligand. Furthermore, signaling by Fibroblast Growth Factors (FGFs) is necessary for 
epicardial cell activity during regeneration, as ectopic expression of a dominant negative 
transgene that inhibits signaling through FGF receptors disrupts this invasion of epicardial-
derived cells, arresting regeneration. This stimulatory role for FGF signaling in adult zebrafish 
epicardial cells in-vivo appears to mirror its effects on cultured epicardial cells in in-vitro 
EMT assays. Together, these data indicate a specific role for FGF signaling indirecting the 
EMT of epicardial derived cells that ultimately vascularize the regenerate. Interestingly, 
treatment of injured rodent hearts by FGF supplementation along with p38 MAP kinase 
inhibition stimulated neovascularization, decreasing infarct size and the level of scarring 
These results suggest that both mammalian and non-mammalian vertebrates are responsive to 
FGFs after injury as a means to increase neovascularization, but only selected species like 
zebrafish naturally utilize FGFs to support myocardial regeneration. It is likely that additional 
factors will emerge that affects the production of coronary vessels in both zebrafish and 
mammalian models. Other recent studies support the idea that zebrafish have naturally 
optimized regenerative machinery that can function in both non-mammalian and mammalian 
injured hearts. The G-actin sequestering protein, Thymosin-b4, induces outgrowths from 
mammalian epicardial explants in-vitro (Bock-Marquette et al., 2004). Treatment of epicardial 
explants with Thymosin-b4 induces the differentiation of fibroblasts, endothelial and smooth 
muscle cells as assessed by gene expression and cellular morphology. In addition, in-vivo 
Thymosin-b4 treatment can partially restore cardiac survival and function following coronary 
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ligation in the mouse heart. Notably, during zebrafish heart regeneration, Thymosin-b4 
expression is induced in the wound and compact myocardium, indicating that fish naturally 
release this epicardial stimulant upon injury. Using microarray technique Lien et al., (2006) 
demonstrated that both platelet-derived growth factor-a and -b (pdgf-a and pdgf-b) are 
upregulated during the heart regeneration in zebrafish. Also, it has been shown that PDGF-B 
homodimers induce DNA synthesis in adult zebrafish cardiomyocytes and that a chemichal 
inhibitor of PDGF receptor decreases DNA synthesis of cardiomyocytes both in-vitro and in-
vivo during regeneration. 
MicroRNAs: CHARACTERISTICS, FUNCTIONS AND THEIR INVOLVEMENT IN THE 
HEART REGENERATION PROCESS  
MicroRNAs (miRNAs) are genomically encoded small RNAs used by organisms to 
regulate the expression of proteins generated from messenger RNA transcripts (Carrington 
and Ambros, 2003; Bartel, 2004) (Figure 9). miRNAs are non coding RNAs, highly 
conserved, abundant and predicted to regulate a large number of transcripts (Mishima et al., 
2006). It has become clear that miRNAs are involved in many biological processes, including 
development, differentiation, proliferation and apoptosis (Reviewed by Callis and Wang, 
2008). MicroRNA negatively regulate gene expression by binding to complementary target 
sequences at the 3’-untraslated regions (UTRs), trough translational repression and target 
mRNA degradation. (Pasquinelli et al., 2005; Ason et al., 2006; Flynt et al., 2007; Zhao and 
Srivastava, 2007). Nearly 500 mammalian miRNAs are transcribed in the nucleus and 
undergo successive processing events by the enzymes Drosha and Dicer to ultimately yield 
mature miRNAs of ~20–22 nucleotides (Berezikov et al., 2006). Mature miRNAs typically 
bind to target mRNAs by partial sequence matching after becoming incorporated into the 
RNA-induced silencing complex (RISC), resulting in degradation of the mRNA transcript 
and/or translational inhibition (Bagasra and Prilliman, 2004).  
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Figure 9 miRNA biogenesis and function. The primary transcripts of miRNAs, called pri-
miRNAs, are transcribed as individual miRNA genes, from introns of protein-coding genes, or 
from polycistronic transcripts. The RNase Drosha further processes the pri-miRNA into 70–
100 nucleotide, hairpin-shaped precursors, called pre-miRNA, which are exported from the 
nucleus by exportin 5. In the cytoplasm, the pre-miRNA is cleaved by Dicer into an 
miRNA:miRNA* duplex. Assembled into the RISC, the mature miRNA negatively regulates 
gene expression by either translational repression or mRNA degradation, which is dependent 
on sequence complementarity between the miRNA and the target mRNA. ORF, open reading 
frame. From van Rooij and Olson (2007). 
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The mechanism of action, in fact, appears to depend on the degree of complementarity 
between the miRNA and the target (McCarthy and Esser, 2007). Disruption of miRNAs in 
Caenorhabditis elegans and Drosophila suggest several ways by which miRNAs may control 
cellular events (Stark et al., 2003). In some cases, they function to “fine-tune” physiologic 
events, but in others they function as molecular “switches” (Brennecke et al., 2003; Johnston 
and Hobert, 2003; Sokol and Ambros, 2005). miRNAs can also function in a “fail-safe” 
mechanism to silence mRNAs that are unwanted in specific cell lineages (Cohen et al., 2006; 
Hornstein et al., 2005). In mice, interference with miRNA biogenesis by tissue-specific 
deletion of Dicer revealed a requirement of miRNA function during limb outgrowth 
(Bernstein et al., 2003) and in development of skin progenitors (Yi et al., 2006). However, the 
in-vivo requirement of specific miRNAs in mammals through targeted deletion remains 
unknown, and reliable prediction of mRNA targets is still problematic (Ason, 2006). 
Confronting the expression of some microRNAs between medaka, chicken, mouse and 
zebrafish, Ason et al., (2006) saw that the timing and location of miRNA expression is not 
strictly conserved in vertebrates and the variation of miRNA expression being more 
pronounced the greater the differences in physiology. Importantly, dysregulation of miRNAs 
has been linked to muscle-related diseases, such as cardiac hypertrophy (Rao et al., 2006; 
Chien, 2007). miRNAs therefore are a new class of regulators of muscle biology and they 
might become novel therapeutic targets in muscle-related human diseases (Callis et al., 2007). 
Also, the expression of microRNAs is dynamically regulated during cardiomyocytes 
hypertrophy (Tatsuguchi et al., 2007). Using microarray analysis Tsonis et al., (2007) 
discovered that miRNAs are involved in regeneration process; more in particular, they saw 
that Let-7 members are potential regulators of dedifferentiation in lens and inner ear hair cell 
regeneration of the adult newt. Recent studies have revealed key roles of microRNAs as 
regulators of the growth, development, function, and stress responsiveness of the heart, 
providing glimpses of undiscovered regulatory mechanisms and potential therapeutic targets 
for the treatment of the heart disease. (van Rooij & Olson, 2007). In several recent studies, 
microarray analyses were performed to determine whether miRNAs are dysregulated in 
hypertrophic and failing hearts. These studies point to a collection of miRNAs that are up- and 
downregulated during pathological cardiac remodeling in rodents and humans (Latronico et 
al., 2008; Wang et al., 2009). In-vitro experiments using either over-expression or knockdown 
of miRNAs in cultured cardiomyocytes indicate that a subset of these miRNAs are indeed 
actively involved in cardiomyocyte hypertrophy (Tatsuguchi et al., 2007). 
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Many miRNAs are expressed in a tissue-specific manner and several miRNAs are 
specifically expressed in cardiac and skeletal muscle and play an important role in the 
regulation of muscle proliferation and differentiation processes (Callis and Wang, 2008). It 
has been demonstrated that miRNA biogenesis in the mouse heart is essential for 
cardiogenesis (Plasterk, 2006). A signature pattern of stress-responsive microRNA that can 
evoke cardiac hypertrophy and heart failure. van Rooij et al., (2006) described >12 miRNAs 
that are up- or down-regulated in cardiac tissue from mice in response to transverse aortic 
constriction or expression of activated calcineurin, stimuli that induce pathological cardiac 
remodeling. Many of these miRNAs were similarly regulated in failing human hearts. 
Similarly, cardiac over-expression of miR-195, which was up-regulated during cardiac 
hypertrophy, resulted in pathological cardiac growth and heart failure in transgenic mice. 
Northern blot analysis of the hypertrophy-regulated miRNAs in idiopathic end-stage failing 
human hearts showed increased expression of miR-24, miR-125b, miR-195, miR-199a, and 
miR-214, whereas the expression for miR-23 appeared to be variable within the non failing 
and failing groups. Thus, the altered pattern of miRNA expression in the failing human heart 
overlapped that of the hypertrophic mouse heart, suggesting that these miRNAs represent a 
molecular signature of adverse cardiac remodeling Over-expression of miRNAs evokes 
morphological changes in cardiomyocytes. miR-1 is among the most widely conserved 
miRNAs during evolution, and is found in the genomes of organisms as diverse as C. elegans, 
Drosophyla, zebrafish, chicken, mouse, and human. An ancient genomic duplication likely 
resulted in two distinct loci for the miR-1/miR-133 cluster in vertebrates, with identical 
mature sequences derived from the duplicated loci. In Drosophila, deletion of the single miR-
1 gene (dmiR-1), expressed specifically in cardiac and somatic muscle, results in a defect in 
muscle differentiation or maintenance (Kwon et al., 2005; Carè et al., 2007). dmiR-1 targets 
the Notch ligand, Delta, a known regulator of cardiogenesis and myogenesis in flies (Kwon et 
al., 2005). In contrast, over-expression of miR-1 in mouse cardiac progenitors has a negative 
effect on proliferation, where it targets the transcription factor Hand2, which is involved in 
myocyte expansion (Zhao et al., 2005). More in particular it has been demonstrated that, miR-
1-1 and miR-1-2 are specifically expressed in cardiac and skeletal muscle precursor cells. 
Similar to the heart, miR-1 over-expression in cultured skeletal myoblasts promotes skeletal 
muscle differentiation, as does the related but skeletal muscle-specific miR-206 (Chen et al., 
2006; Kim et al., 2006). miR-133 over-expression curiously prevents skeletal muscle 
differentiation, suggesting that differential processing from the dicistronic transcript may 
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regulate cellular decisions of differentiation or proliferation (Chen and Lodish, 2005; Chen et 
al., 2006). Although significant dysregulation of miRNA expression has been reported in 
cardiac disease (Cheng et al., 2007; Sayed et al., 2007),it remains unknown if the heart 
requires miRNA function for normal development or maintenance. Furthermore, targeted 
deletion of the muscle-specific miRNA, miR-1-2, revealed numerous functions in the heart, 
including regulation of cardiac morphogenesis, electrical conduction, and cell-cycle control. 
(Kusenda et al., 2006; Zhao et al., 2007; Yang et al., 2007). The muscle specific microRNA 
miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. It was 
shown that miR-1 is overexpressed in individuals with coronary artery disease, and that when 
overexpressed in normal or infarcted rat hearts, it exacerbates arrhythmogenesis. Elimination 
of miR-1 by an antisense inhibitor in infarcted rat hearts relieved arrhythmogenesis. miR-1 
overexpression slowed conduction and depolarized the cytoplasmic membrane by post-
transcriptionally repressing KCNJ2 (which encodes the K+ channel subunit Kir2.1) and GJA1 
(which encodes connexin 43), and this likely accounts at least in part for its arrhythmogenic 
potential. Thus, miR-1 may have important pathophysiological functions in the heart, and is a 
potential antiarrhythmic target. Neonatal hearts show increasing expression of miR-1 with 
age, and substantially higher levels are maintained in adult hearts as compared to neonatal 
hearts4–6, indicating that it might have cellular or pathophysiological functions other than 
myogenesis. It was found that miR-1 expression was elevated (B2.8-fold) in RNA samples 
from individuals with coronary artery disease (CAD; Supplementary Table 1 online) 
compared with those from humans with healthy hearts (HH). Some Authors have described 
muscle-specific miRNAs, such as the bicistronic miR-1 and miR-133 cluster and miR-206 
(Callis et al., 2007). miR-1 and -133 are expressed in cardiac and skeletal muscle and are 
transcriptionally regulated by the myogenic differentiation factors MyoD, Mef2, and serum 
response factor (SRF) (Lagos-Quintana et al., 2001; Lagos-Quintana et al., 2003; Kwon et al., 
2005; Zhao et al., 2005; Chen et al., 2006; Adams et al., 2007). miR1 and miR-206 belong to 
the same miRNA gene family and share an identical seed sequence, which is defined by the 2-
8 nucleic acids of the mature miRNA, whereas miR-133 is dissimilar to both miR-1 and miR-
206. While miR-1 and miR-206 enhanced myogenesis, over-expression of miR-133 repressed 
myoblast differentiation and promoted myoblast proliferation. miR-1 and miR-133 play an 
important role in modulating muscle proliferation and differentiation (Callis et al., 2007). Carè 
et al., (2007) demonstrated that in mice and human miR-133 has a critical role in determining 
cardiomyocyte hypertrophy. In hypertrophyc hearts they observed a decreased expression of 
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both miR-133 and miR-1, which belong to the same transcriptional unit. In-vitro over-
expression of miR-133 or miR-1 inhibited cardiac hypertrophy. In contrast, suppression of 
miR-133 by “decos” sequences induced hypertrophy. In mice miR-1 and miR-133 expressions 
are decreased during skeletal muscle hypertrophy in mice (McCarthy and Esser, 2007). Over-
expression of miR-1 in the developing mouse heart resulted in reduced ventricular myocyte 
expansion and decreased the number of proliferating myocytes (Zhao et al., 2005). Using a 
sensitive and quantitative high-throughput technology, they profiled global miRNA 
expression in phenilephrine (PE)-treated mice neonatal cardiomyocytes Also they saw that 
specific inhibition of endogenous miR-21 or miR-18b with locked nucleic acid (LNA)-
modified antisense oligonucleotides, augments hypertrophyc growth. It is interestling to note 
that miR-1/-206 and miR-133 have opposing effects although miR-1 and miR-133 derive from 
the same miRNA polycistron and are transcribed together (Callis et al., 2007). Inhibition of 
miR-133 was sufficient to induce cardiomegaly in-vivo (Carè et al., 2007); similarly, targeted 
deletion of miR-1-2 revealed numerous functions in the heart, including regulation of cardiac 
morphogenesis, electric conduction, and cell cycle control (Zhao et al., 2007). More recently, 
miR-1 and miR-133 were shown to produce opposing effects on oxidative stress-induced 
apoptosis in H9c2 cells, with miR-1 being proapoptotic and miR-133 being antiapoptotic. (Xu 
et al., 2007a; Yin et al., 2008). FGF-dependent depletion of microRNA-133 promotes 
appendage regeneration in zebrafish, defined by rapid changes in gene expression that achieve 
dramatic developmental effects. During zebrafish fin regeneration there is a dynamic 
regulation of many miRNAs from FGFs. In particular, miR-133 levels are high in uninjured 
fins but low during regeneration. When regeneration was blocked by FGF receptor inhibition, 
high miR-133 levels were quickly restored. Experimentally increasing amounts of miR-133 
attenuated fin regeneration. Conversely, miR-133 antagonism during FGF receptor inhibition 
accelerated regeneration through increased proliferation within the regeneration blastema. The 
Mps1 kinase, an established positive regulator of blastemal proliferation, is an in-vivo target of 
miR-133. In this way, miRNA depletion can be identified as a new regulatory mechanism for 
complex tissue regeneration. miR-133, has relatively high levels in the uninjured fin, but these 
levels drop sharply during regeneration. By a combination of gain of- function and loss-of-
function experiments, our data indicate that miR-133 acts as a regenerative brake within a 
regulatory circuit for regeneration. Following amputation, FGF signaling reduces miR-133 
expression as part of the regeneration program, facilitating normal expression of targets like 
the mps1 kinase that direct blastemal proliferation and tissue renewal. miR-133 is depleted by 
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FGF signaling during fin regeneration and attenuates growth mechanisms. The expression of 
several miRNAs was identified as being regulated in response to cardiac muscle hypertrophy 
using a miRNA microarray screen (van Rooij et al., 2006). Further analysis of those miRNAs 
revealed that miR-195, whose expression is up-regulated during cardiac hypertrophy, is 
sufficient to induce hypertrophic growth in cultured cardiomyocytes as well as in transgenic 
mice. Dysregulation of miRNA expression was also found in patients with heart failure (van 
Rooij et al., 2006). These findings point out that miRNAs are likely associated with muscle-
related diseases and are potential therapeutic targets. Cardiac overexpression of miR-195 is 
sufficient to drive cardiac hypertrophy (Figure 10).  
 
 
 
Figure 10 Induction of cardiac hypertrophy and heart failure by miR-195. H&E sections of 2-
week-old wild-type and transgenic mice expressing miR-195 under control of the áMHC 
promoter. In transgenic as compared with wild-type mice, moderate levels of miR-195 
expression (26-fold) cause cardiac hypertrophy, and higher levels of expression (29-fold) 
cause dilated cardiomyopathy with ventricular dilatation and wall thinning. Scale bar: 2 mm. 
From van Rooij and Olson (2007). 
 
Authors overexpressed miR-24, miR-195, and miR-214 specifically in the heart under 
the control of the myosin heavy chain (MHC) promoter. Thus, down-regulation of miR-133 
during cardiac hypertrophy would be predicted to result in an increase in SRF expression, 
which could contribute to the adverse remodeling response. It is also notable that miR-133a is 
encoded by the same pre-miRNA as miR-1, an inhibitor of cardiac growth. It will be 
interesting to determine whether forced overexpression of miR-133 and other miRNAs that 
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are down-regulated during cardiac hypertrophy suppress cardiac growth in-vivo Recently it 
has been demonstrated that microRNA-320 is involved in the regulation of cardiac 
ischemia/reperfusion (I/R) injury in murine hearts in-vivo and ex-vivo, by targeting heat-shock 
protein 20 (Ren et al., 2009). Overexpression of miR-320 enhanced cardiomyocyte death and 
apoptosis and in-vivo treatment with antagomir-320 reduced infarction size. Thus, miR-320 
may constitute a new therapeutic target for ischemic heart diseases. van Rooij et al., (2007) 
demonstrated that mir-208 is an essential cardiac-specific regulator of βMHC expression and 
mediator of stress and T3 signaling in the mice heart. miR-208, encoded by an intron of the 
αMHC gene, is required for cardiomyocyte hypertrophy, fibrosis, and expression of βMHC in 
response to stress and hypothyroidism.  
Current analysis indicates the zebrafish genome encodes 415 miRNAs, which can be 
grouped into 44 families (Thatcher et al., 2008). The largest of these families is the miR-430 
family, containing 72 members largely clustered in two main locations along chromosome 4. 
Most zebrafish miRNAs exhibit tissue patterns of expression. By hight-throughput sequencing 
of small-RNA cDNA libraries from 5-day-old zebrafish larvae and adult zebrafish brain 
Kloosterman et al., (2006) found 139 known miRNAs and 66 new miRNAs. They analyzed 
the temporal and spatial expression patterns for35 new miRNAs and for 32 known miRNAs in 
the zebrafish by whole mount in situ hybridization and northen blotting, and they found that 
some of them were expressed ubiquitously, but many of the miRNAs were expressed in a 
tissue-specific manner. Wienholds et al., (2005) determined the temporal and spatial 
expression patterns of 115 conserved vertebrate miRNAs in zebrafish embryos using 
microarray and in situ hybridization, using locked-nucleic acid-modified oligonucleotide 
probes. They saw that most miRNAs are expressed in a highly tissue-specific manner during 
segmentation and later stages, but not early in development, which suggests that their role is 
not in tissue fate establishment but in differentiation or maintenance of tissue identity. 
Woltering and Durston, (2008) demonstrated that miR-10, conserved within the vertebrates, 
represses HoxB1a and HoxB3a and synergize with HoxB4 in the repression of these target 
genes in zebrafish, genes involved in patterning the anterior-posterior axis. Using a target-
selected inactivation of the dicer1 gene in zebrafish, Wienholds et al., (2003) discovered that 
the microRNA-producing enzyme Dicer1, which is conserved from fungi to vertebrates, is 
essential for zebrafish development. Morton et al., (2008) demonstrated that the highly 
conserved miR-138 is expressed in specific domains in the zebrafish heart and is required to 
establish appropriate chamber-specific gene expression patterns. Also, disruption of miR-138 
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function led to ventricular expansion of gene expression normally restricted to the atrio-
ventricular valve region and, ultimately, to disrupted ventricular cardiomyocyte morphology 
and cardiac function. They saw that miR-138 targets aldh1a2, encoding retinoic acid (RA) 
dehydrogenase (Raldh2). Raldh2 is involved in RA synthesis, which is required for early 
chamber specification and anterior-posterior cardiac patterning in mouse, chick, and zebrafish, 
and is important for myocardial maturation (Stainier and Fishman, 1992). 
Cardiac-specific overexpression of miR-195, which is consistently up-regulated in 
rodent and human hypertrophic hearts, for example, results in dilated cardiomyopathy and 
heart failure in mice as early as two weeks of age, implying that upregulation of miR-195 
during cardiac hypertrophy actively contributes to the disease process (van Rooij et al., 2006). 
Based on target predictions for miR-195, Authors speculate that the cardiac phenotype of 
these transgenic mice results from the downregulation of multiple pro-survival proteins by this 
miRNA. Since miR-195 belongs to a small family of related miRNAs, it will be interesting to 
investigate the potential involvement of the other family members in cardiac disease. 
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AIM OF THE THESIS 
Cardiac diseases are the major cause of death in developed countries, and heart failure 
is the most common cause of hospitalization in US citizens over 65. In particular, Myocardial 
Infarction (MI) is characterized by loss of functional cardiomyocytes that are not able to 
regenerate; for this reason, nowadays the only effective treatment is heart transplantation. 
Recent work demonstrates that the injection of adult bone marrow stem cells into infracted 
area can represent an effective alternative method for the treatment of MI. However, the 
routine application in the clinic requires further studies. Stem cells, which have the potential 
to form a wide variety of different cell types, are widely regarded as being essential to repair 
damaged organs. Another approach is the ability to manipulate the regeneration potential of 
the adult organ through the activation of adult stem cells in damaged tissue. Also, is not yet 
well clear the origin on new cardiomyocytes those repopulate the damaged area and which 
signals are involved. In this regard, it has been shown that the Teleost zebrafish (Danio rerio) 
efficiently regenerate the ventricle after a removal of about 20% of the ventricle apex in-vivo; 
for this reason and for all the vantages that this model organism offers for scientific studies, it 
can use as model to better understand the molecular differences with the human heart 
regeneration. 
The present thesis has the aim to study the molecular mechanisms of heart 
regeneration in zebrafish; it has been demonstrated that microRNAs (miRNAs) are involved 
in many biological processes and also in cardiac regeneration and in hypertrophic conditions, 
but it isn’t clear in which manner. In addition, the identification of the microRNA involved in 
heart regeneration is not complete and it is unknown if the same miRNAs are conserved in 
mammals. For this reason a purpose of the work is to understand the regulation of genetic 
translation by cardiac microRNAs, to identify with qRT-PCR, miRNAs naturally expressed in 
the adult zebrafish heart and those that are differentially expressed during the regeneration 
process in-vivo and in hypertrophic conditions induced ex-vivo with phenilephrine (PE) 
(Chapter II).  
Other aim of the thesis is to characterize the time and space expression of genes during the 
regeneration process in-vivo, by whole-mount In Situ Hybridization experiments (ISH). Also, 
it is unknown if the zebrafish heart is able to survive in ex-vivo conditions and if injured 
hearts are able to regenerate under these conditions. For this reason, another aim of the thesis 
is to obtain an ex-vivo model of cardiac regeneration, optimize the culturing conditions to 
reproduce the in-vivo process and to understand the role of different Fibroblast Growth 
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Factors (FGFs) involved in this process. It is important to understand if the regeneration can 
occur under ex-vivo conditions and if this is as efficient as in in-vivo conditions. Further, we 
will determine if heart regeneration in ex-vivo involves proliferation of cardiac resident cells, 
through BrdU incorporation assays (Chapter III). 
Despite the numerous genomic studies involving zebrafish, there are only a limited 
number of reports regarding the zebrafish proteome. Proteomic approaches are innovative and 
offer an understanding of all the proteins species within a tissue or embryo at a fixed stage. 
Little is known about which proteins are naturally present in the adult zebrafish heart and 
which are differentially synthesized (up or down regulated) during the in-vivo regeneration 
process. One aim of this study is to profile the proteome of zebrafish adult heart using two-
dimensional polyacrylamide-gel electrophoresis (2DE), protein fractionation, and in-gel 
proteolysis, followed by MALDI-TOF MS analysis of proteolytic digests extracted from 
individual spots (Chapter IV). It is important to identify the proteins that are differently 
expressed during the heart regeneration and this will be performed using the Differential Gel 
Electroforesis (DiGE), an innovative and sensitive proteomic technique that allows the 
simultaneous comparison of two samples in the same 2D gel (Chapter V). Understanding the 
cellular and molecular mechanisms by which lower vertebrate model systems, as zebrafish, 
are able to faithfully regenerate complex organs, as the heart, after injury will help illuminate 
potential therapies for diseases of organ damage in humans and can yield a tremendous 
impact in modern translational medicine. 
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ABSTRACT 
Despite being a well-recognized model to study cardiogenesis, zebrafish (Danio rerio) 
is an under utilized organism for studying cardiac remodeling, possibly since myocytes 
hypertrophy has not been reported in adult zebrafish. In this study, for the first time, the 
hypertrophy was induced in zebrafish hearts cultured ex-vivo, using phenilephrine. The effect 
of the treatment was dose and timing valued by histology and immunohistochemistry. 
Moreover, due to the similarities between fish and mammalian genomes, using qRT-PCR 
experiments, it was analyzed the expression of some microRNAs (miRNAs or miRs) (miR-1, 
miR-133a, miR-133b), already known to be involved in hypertrophic hearts in mammals. 
Vertebrates like Urodele amphibians and Teleost fish, as zebrafish, are able to effectively 
restore organs, including the heart, differently from mammals. In this study, 20% ventricle-
deprived hearts were left regenerate in-vivo and analyzed from 1 to 30 days for the expression 
of the above-mentioned miRNAs. Both experimental designs showed down-regulation of 
miRNAs, especially miR-133a and miR-133b, demonstrating the importance of miRs in the 
hyperthrophy conditions and during the regeneration process. This experimental system, using 
different and easier model of study, should provide clues to understand human 
pathophysiology and the new frontier of stem cell regeneration system.  
 
INTRODUCTION 
 Human heart disease can involve abnormalities in morphogenesis, cardiac rhythm, 
muscle maintenance, and function. Damage to the heart muscle is typically irreversible as 
cardiomyocytes terminally exit the cell cycle postnatally and have little or no regenerative 
capacity, despite the niches of cardiac progenitors that may contribute to basal turnover of 
myocytes (Soonpaa and Fiel, 1998; Torella et al., 2006). Networks of transcription factors 
regulate heart development and maintenance in a dose-dependent manner (Olson and 
Srivastava, 1996), but the effects of translational regulation on the titration of these pathways 
are still not completely understood. Among the factors involved in the heart development, 
maintenance, and regeneration, microRNAs (miRNAs or miRs) could play an important role. 
MiRNAs are genome encoded small RNAs that undergo successive processing events by the 
enzymes Drosha and Dicer to ultimately yield mature miRNAs of 20–22 nucleotides, used by 
organisms to regulate the expression of proteins generated from messenger RNA transcripts 
(Berezikov et al., 2006). This regulation is exerted by the down-regulation of protein 
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production, either by inhibiting the translation of protein from messenger RNA or by 
promoting the degradation of mRNA, primarily through base paring to the 3' untranslated 
region (UTR) of target mRNAs; this leads to mRNA cleavage and/or translation repression 
(Bartel, 2004). Growing evidence indicates that miRNAs are involved in basic cell functions 
and differentiation, including cardiac myocytes (Zhao et al., 2007). The complex cellular 
processes where myocytes undergo depend on precise spatiotemporal regulation of protein 
levels, some of which function as “rheostats” to execute programs in a quantitative fashion 
(Ambros, 2004; Kloosterman and Plasterk, 2006; Zhao and Srivastava, 2007). A few 
miRNAs, particularly miR-133 and miR-1, which are included in the same bicistronic unit, 
are specifically expressed in skeletal muscle and cardiac myocytes (Chen et al., 2006; Carè et 
al., 2007). Notably, miR-133 and miR-1 play key roles in skeletal myoblast proliferation and 
differentiation, respectively. For example, miR-133 overexpression prevents skeletal muscle 
differentiation, suggesting that differential processing from the dicistronic transcript may 
regulate cellular decisions of differentiation or proliferation (Chen et al., 2006; Carè et al., 
2007). Although significant dysregulation of miRNA expression has been reported in cardiac 
disease (van Rooij et al., 2006; Sayed et al., 2007), recently it was demonstrated the role of 
miR-1 and miR-133, are involved in cardiac hyperthrophy (Carè et al., 2007; Elia et al., 
2009).  
Mammalian species have little or no ability to replace lost cardiac muscle. This poor 
regenerative capacity is due in part to the failure of adult cardiomyocytes, the beating cells in 
the heart, to undergo proliferation (Quaini et al., 2004). In fact, the normal response of 
mammalian hearts to injury or hypoxia is hypertrophy—the growth of cardiomyocytes 
without cell division. Being the heart one of the most conserved organs at the molecular level 
in vertebrates (Poss et al., 2002; Buckingham et al., 2005; Lepilina et al., 2006; Olson, 2006; 
Srivastava, 2006), and, considering that different vertebrate species have different cardiac 
regeneration rates -high in teleost fish, moderate in urodele amphibians, and almost negligible 
in mammals (Scaddind, 1977)-, it is possible to study some differentiation, regeneration and 
pathology processes using vertebrates models evolved before mammals such as the fish. 
Despite being a well-recognized model to study cardiogenesis, the zebrafish is an under 
utilized organism for studying cardiac remodeling, possibly since myocytes hypertrophy has 
not been reported in adult zebrafish. Thus, the aim of this research is to characterize the miRs 
involved in cardiac hypertrophy induced with phenilephrine (PE) in ex-vivo culture. 
Moreover, since the role of miRs during the cardiac regeneration process in zebrafish is 
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largely unknown, in this research, it was evaluated the gene expression timing in adult 
regenerating hearts in-vivo operated by 20% of ventricle. Regenerating the human heart has 
thus become a major goal in experimental medicine, discovering the molecular mechanisms 
of cardiac regeneration and hypertrophy in zebrafish can suggest new strategies to control 
heart pathologies and activate genes able to repair cardiac damages.  
 
MATHERIALS AND METHODS 
Ex-vivo hearts culture and induction of hypertrophy with phenilephrine (PE) 
Hearts were removed from adult zebrafish, letally anesthetized with Tricaine (MS222, 
Sigma), see below. After one wash in osmolar L15 media (Leibovitz’s L15 media, Sigma) 
added with 5% FCS, 5% glutammin, 5% penicillin/streptomicin), hearts were transferred in 
12 wells dish petri with 1 ml of L15 media and incubated at 28°C for 8 hours. Hearts were 
than transferred in L15 media without FCS, and in the presence of 100 (n=10), 200 (n=10), 
500 (n=40) µM of phenilephrine (PE, Sigma) for 48, or 72 hours to study the hypertrophy 
induction. At the end of treatment, some hearts were fixed in Bouin or 4% PFA in PBS and 
then embedded in paraffin or included in OCT for cryostat sections. Others hearts were used 
for RNA extraction. 
 
Resection of 20% of ventricular apex of zebrafish heart 
The animal experiments were performed according to protocol approved by the 
Institutional Animal Care and Use Committee (IACUC) at the University of Pittsburgh. Adult 
zebrafish (6-18 months old, n=60) were anesthetized for 3 minutes in 0.168 mg/l Tricaine 
(MS222, Sigma) and placed dorsally in a humid sterile sponge, with ventral side up. The 
surgery was done following the protocol developed by Poss et al., (2002). Brefly, a small 
incision (scalpel 0.15mm, Fine Science Tools Inc. US.) was made just under the gills, in 
correspondence to where the heart is located. The pericardial sac was isolated and punctured 
to expose the ventricle by gentle abdominal pressure. Approximately 20% of the ventricle 
apex was removed by iridectomy scissors (Fine Science Tools Inc. US.). With this protocol, 
90% of fish was survived. After surgery, fish were returned to water and stimulated to breathe 
with air bubbles from an air pump. After 1, 2, 3, 7 and 30 days post amputation of ventricular 
apex (dpa), fish (n=9 for each timing point considered) were lethally anesthetized with 
Tricaine and the whole hearts were used for histology (n=3 for each timing point) or for RNA 
extraction for qRT-PCR analysis (n=6 for each timing point). 
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Histology and immunohistochemistry 
i. Sections and histology 
Hearts collected from adult zebrafish were fixed in Bouin’s fluid for 8 hours at 4°C or 
fixed in 4% PFA for 24 hours at 4°C. an overnight incubation in PBS containing 10% sucrose 
was performed to prevent cryo-damage before immersion in liquid nitrogen or the consequent 
dehydration process (for paraffin embedding). Cryostat sections (7 µm thick) were prepared 
(Bright-GB), mounted onto poly-L-lysine-coated slides (Sigma) or APES treated slides and 
used for immunohistochemistry or normal staining. Dehydration (only for paraffin 
embendding) was performed in degreeded alchool series, transferred into in 100% toluen and 
finally included in paraffin. Hearts section of 7 µm obtained using a Reichert-OME 
microtome were placed in slides treated with APES. Dewaxed sections were rehydrated and 
stained by Mallory's trichrome or Masson' s trichrome staining methods. Sections were 
observed with an Axioskope microscope (Zeiss) supplied with image-analysis programs. 
 
ii. Fluorescence  
Cryosections were let hawed at R.T. for 20 minutes (under sterile flow) and 
permeabilization was performed with 0.5% TRITON in PBS for 15 minutes. Blocking of 
specific sites was performed with 2% BSA in PBS for 20 minutes at 37°C. 1:500 phalloidin in 
2% BSA in PBS and 1:100 DAPI were added for 1 hour at 37°C in the dark. After one wash 
in PBS, slides were mounted with glicerol: phosphate tampon 9:1 and kept at 4°C in the dark 
until observation at the confocal microscope (Elipse 90-Nicon C eclipse, Nikon). 
 
iii. Statistical analysis 
Two-five specimens per group were used and, in each specimen, 5-8 consecutive 
sections of the heart were examined. The stained myocytes of heart (ventricle portion) were 
calculated on 1 mm1 area by a computer-assisted image analysis system by an observer 
unaware of treatments. The marked area occupied by myocytes was calculated as mean ± 
standard deviation from the mean. Numerical results were analyzed by means of a two-tailed 
Student’s t-test. For qRT-PCR, significant differences (probability values) between the 
experimental groups and controls/non treated animals were calculated using 1-way, unpaired 
Student’s t test. All experiments were repeated 3 times and presented as average standard 
error of the mean. 
 
54 
 
Total RNA extraction and qRT-PCR 
Total RNA from various samples was extracted from fresh tissues homogenized with 
1 ml/50 mg Trizol (Invitrogen)/tissue. After, 0,2 ml of chloroform were added for ml of Trizol 
used; samples were vigorously vortexed for 15 sec., left on ice and centrifuged at 13.000 rpm 
for 20 minutes at 4°C. The supernatant, containing the RNA, has been transferred in a new 
eppendorf tube. Precipitation was performer adding 0,5 ml of isopropanol (2-isopropanol, 
Sigma) every ml of Trizol used. Samples were incubated over night at -20°C and centrifuged 
at 13.000 rpm for 20 minutes at 4°C; upper phase was discarded and pellet has resuspended in 
1 ml of 75% ethanol, centrifuged and the pellet has been dried at R.T., before resuspending in 
dietil-pirocarbonate (DEPEC) water and stored at -80°C. Total RNA has been checked by 
Pico-drop (Perkin Elmer) and in electrophoretic gel, and used to perform RT-PCR and qRT-
PCR. Total RNA has been extracted from one adult zebrafish (body weight: 400 mg), from an 
adult zebrafish without heart (528 mg), from a pool of 13 hearts (23,6 mg). For the 
experimental design of hypertrophy, total RNA was extracted from hearts (n=6), cultured (48 
or 72 hours) in L15 (Sigma) media without serum and from hearts (n=6), cultured with 500 
µM phenilephrine (48 or 72 hours). Total RNA has been analyzed with qRT-PCR to evaluate 
the expression of miR1, miR133a, miR133b and miR208. For the in-vivo heart regeneration 
experiments, total RNA was extracted from 7 hearts of control (not operated), 1 dpa (n=6), 2 
dpa (n=8), 3 dpa (n=6) and 7 dpa (n=6). miRNAs levels have been measured with mirVana 
qRT-PCR miRNA Detection Kit (Ambion, Inc.), conjugated with fluorescent dye SYBR 
Green I (Molecular Probes, Carlsbad, CA). Amplification and visualization of specific 
products has been performed with sequence detection system ABI Prism 7700. As internal 
control, have been used U6 primers for themplate normalizzazion. Fluorescence signals have 
been normalized respect to an internal reference and the Cycle of threshold (Ct) has been set 
in inside the exponential phase of PCR. Relative gene expression has been calculated 
comparing the cycle times for every PCR target. Ct values of every PCR target have been 
normalized subtracting the Ct value of the U6 that is represented from ΔCt value. The relative 
expression level has been calculated using the following equation: relative gene expression=2- 
(ΔCt sample- ΔC control). 
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RESULTS 
The histology analysis of the zebrafish adult heart (Figure 1 a) evidenced the presence 
of four chamber in series disposed: sinus venosus, atrium, ventricle and bulbus arteriosus. 
The heart is localized in ventral position, just next and caudally the gill chamber and 
enveloped by serous pericardium. The hearts cultured in ex-vivo with L15 w/o fetal serum, 
fixed after 48 h or 72 h evidenced similar histology as compare with the fixed hearts left in 
the body (Figure 1 a,b). These latter specimens were used as controls for the ex-
vivo/hypertrophy experiments. The first experiment evaluated the dose-action of the PE in the 
48 h of culture. These experiments revealed that the optimal concentration to obtain the 
enlargement of the muscle fibers was 500 µM (Figure 1). Figure 2 (c-f) displays adult 
zebrafish hearts cultured ex-vivo with 500 µM phenilephrine (PE) for 48 or 72 h. The 
treatment with 500 µM PE for 48 h caused a slight increase of the muscles fibers (Figure 2 c-
d) and the permanence of PE for 72 h had significantly increased the size of the myocytes (P< 
0.01), as revealed by image analysis done per muscles area (1 mm2) (Figure 2 e,f). Moreover, 
in the latter experimental group, the wall of ventricle resulted thickest as compare to control 
group (Figure 2 f). To better evaluate the contractile apparatus and thus the hypertrophy, was 
performed a staining with phallodine rodamate, and the specimens were analyzed by confocal 
microscopy (Figure 3). The phalloidine had marked the actin filament of the muscle fibers, 
evidencing also in this case, an increase of muscle fibers in experimental hearts, especially in 
72 h cultured hearts (P< 0,05). 
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Figure 1. a) Control cultured ex-vivo 48 h; (A=atrium; V=ventricle) for 48 hours; bar: 250 
µm. b-d) experimental hearts (ventricle part) treated with 100 µM PE (b), 200 µM PE (d) and 
for 500 µM PE (c) for 48 hours; bar: 200 µm. 
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Figure 2. Zebrafish heart cultured with PE. a) Heart in the adult whole zebrafish is placed 
in ventral position and shows the four chambers in series: sinus venosus (SN), atrium (A), 
ventricle (V) and conus arteriosus (AC) (Mallory's, trichrome staining); bar: 0,25 mm. b) 
Control zebrafish heart cultured in ex-vivo for 48 hours shows similar muscle fibers pattern as 
compare whit in-vivo heart, (Masson's trichrome staining) bar: 40 µm. c-d) Experimental 
hearts cultured with PE. c) 48 h cultured heart shows a slight enlargement of muscle fibers 
(Mallory's trichrome staining), evidenced in d) with Masson's trichrome staining (MF= 
muscles fibers). e) Mallory's trichrome staining and the f) Masson's trichrome staining 
evidenced the enhancement of hyperthrophy of the muscle fibers (MF) and of the muscle wall 
of the heart ventricle (arrows) in 72 h PE cultured organ. (bar: 40 µm). 
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Figure 3. Phallodine rodamate/DAPI staining of non treated (a) and PE treated hearts for 48 h 
(b) and 72 h (c). The heart treated with PE for 72 h evidenced an enhancement of the 
phalloidin staining-actin fibers (red color). Bar 40 µm. 
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Cardiac miRNAs expression in zebrafish 
A multiple alignment of miRNAs sequences between human, zebrafish and mouse 
was performed before starting the qRT-PCR experiments in order to detect the miRNAs 
expression levels in zebrafish hearts as compared with mammals. The multiple alignments 
showed a high level of homology among the sequences (Table 1). The qRT-PCR of the adult 
no treated hearts evidenced the miR-1, miR-133a, miR-133b expression was also in zebrafish 
hearts, whereas the miR-208 was unexpressed in whole animal as compare to mouse and 
human hearts (Graphic 1). In zebrafish, miR-1 has a similar expression to miR-133a and 
miR-133b, it was expressed in the hearth and in other parts of the body (in whole Zf, in Zf 
without heart and in heart specifically) but with less expression levels as compare with other 
probes. 
 
CLUSTAL W (1.83) multiple sequence alignment 
 
hsa-mir-1-2      UGGAAUGUAAAGAAGUAUGUA- 21 
hsa-mir-1-1      UGGAAUGUAAAGAAGUAUGUA- 21 
mmu-mir-1-1      UGGAAUGUAAAGAAGUAUGUA- 21 
mmu-mir-1-2      UGGAAUGUAAAGAAGUAUGUA- 21 
dre-mir-1-1      UGGAAUGUAAAGAAGUAUGUAU 22 
dre-mir-1-2      UGGAAUGUAAAGAAGUAUGUAU 22 
                 *********************  
 
dre-mir-133b*        -UUUGGUCCCCUUCAACCAGCUA- 22 
dre-mir-133c         -UUUGGUCCCUUUCAACCAGCUA- 22 
hsa-mir-133b         --UUGGUCCCCUUCAACCAGCUA- 21 
mmu-mir-133b         --UUGGUCCCCUUCAACCAGCUA- 21 
hsa-mir-133a-1       --UUGGUCCCCUUCAACCAGCUGU 22 
mmu-mir-133a-1*      --UUGGUCCCCUUCAACCAGCUGU 22 
hsa-mir-133a-2       --UUGGUCCCCUUCAACCAGCUGU 22 
mmu-mir-133a-2*      --UUGGUCCCCUUCAACCAGCUGU 22 
dre-mir-133a-2       -UUUGGUCCCCUUCAACCAGCUG- 22 
dre-mir-133a-1*      -UUUGGUCCCCUUCAACCAGCUG- 22 
mmu-mir-133a-1       -GCUGGUAAAAUGGAACCAAAU-- 21 
dre-mir-133a-1       AGCUGGUAAAAUGGAACCAAAU-- 22 
mmu-mir-133a-2       -GCUGGUAAAAUGGAACCAAAU-- 21 
dre-mir-133b         -GCUGGUCAAAUGGAACCAAGUC- 22 
                        ****    *  *****  *   
 
 
Table 1. Zebrafish (dre), mouse (mmu), human (hsa) miR1-1, miR1-2, miR133a-1, miR133a-
2, miR133b and miR133c. No sequences were found for miR-208 in zebrafish. Clustal W 
multiple alignments. 
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Graphic 1. Relative RNA expression of cardiac miRNAs (miR-1, miR-133a, miR-133b and 
miR-208) in adult zebrafish (ZF tot), in zebrafish heart (zfH), in zebrafish without the heart 
(ZF w/o H) and in human heart (hH), used as positive control, in qRT-PCR experiments.  
 
i) PE treatments 
Different concentration of PE (100, 200 and 500 µM) was added in ex-vivo cultured 
zebrafish hearts and left for 48 h to assess if the miRs (miR-1, miR-133a and miR-133b) were 
expressed differently as compared with controls (not treated) hearts. The qRT-PCR results 
evidenced that only the concentration of 500µM was able to provoked a different expression 
(not shown). The treatment with 500 µM-phenylephrine for 48h (that is, when the increase in 
cell size start to be evident, see the previous section) displayed by qRT-PCR analysis a sub-
expression trend of miR-1 (0,953 ± 0,001), miR-133a (0,729 ± 0,140) and miR-133b (0,864 ± 
0,420) but the difference from controls was not statistically significantly (Graphic 2). After 
72h the PE treatment provoked a marked decrease of miRs. The major decrease was observed 
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for miR-133b where the expression was detected about the 75% less (0,235 ± 0,001) as 
respect to controls (P< 0,001) and 75% and 50% less the miR-1 and miR-133a (P<0,001, 
miR-133b versus miR-133a and versus miR-1). 
 
 
 
Graphic 2. Relative expression of cardiac miRNAs (miR-1, miR-133a and miR-133b,) 
detected by qRT-PCR experiments in adult zebrafish heart non treated (C or NT, black 
columns) or treated with phenil-ephrine 500 µM (PE, white columns) for 48 and 72 h. The 
analyses done in the 72 h PE treatment revealed a significative decrease as compare with the 
controls/non treated hearts (versus control, * P<0,05; **P<0,001, two-tail student T test). U6 
snRNA was used as normalizer sample. 
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ii) Surgery and regeneration experiments 
The histological and qRT-PCR analysis of the heart in regeneration were done 
considering different time-points (1, 2, 3, 7 and 30 days) after the surgical removal of 
ventricular apex. After 1 day, the histological examination of the specimens evidenced a large 
connective-clot next to the operated area (Figure 4 a). After 2-3 days the clot started to be 
infiltrated by myocytes (Figure 4 b,c), but, at 7 days the operated hearts already shown a 
marked recovery with a reduction of the clot. Finally, at 30 days post-operation, the heart is 
completely recovered and comparable with control (Figure 4 e). 
 
 
 
Figure 4. Adult heart of zebrafish in regeneration (Masson' trichrome staining) subsequently 
the ventricular apex amputation. (a) After 24h, the histological section displays a large clot of 
connective tissue (arrows). (b) After 2 days the clot is still large and evidences some 
infiltrated myocytes (red portion of whole heart, indicated by arrow). (c) after 3 days the clot 
is reduces and new tissue is produced (arrow). (d) After 7 days, numerous new-differentiated 
myocytes are in the operated area (red parts indicated by arrows in the whole-stained heart). 
(e) After 30 days the heart is similar to non operated controls (whole heart). V: ventricle; AC 
Conus Arteriosus; A: atrial chamber. Bar: 100 µm. 
 
In qRT-PCR analysis it was assumed that the non-treated heart (control) has N=1 a 
expression of miR-1, miR-133a and miR-133b. Generally, the analysis of relative expression 
of miRs in regenerating hearts evidenced a marked decrease as compare with the controls 
(Graphic 3). Particularly, miR-1 (Graphic 3 a) was at least 50% less express in the first 2 
days (0,566 ± 0,008 and 0,526 ± 0,004, respectively). Interestingly, at 72h (3 days) the 
quantitative expression of miR-1 was the 75 % less than in control (0,240 ± 0,003) whereas at 
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7 days the expression return to be the 50% less than the control (0,564 ± 0,010). At 30 days 
the miR-1 expression is comparable with the control (not shown). As regard the miR-133a 
(Graphic 3 b) in the first 24 h the expression decreased about the 30% (0,707 ± 0,065), 
whereas in the day 2, 3, and 7 the trend was similar to that in miR-1 (0,519 ± 0,079; 0,255 ± 
0,016; 0,560 ± 0,145, respectively). The miR-133b decreased about the 42% in the first day 
post-operation (0,657 ± 0,00). At 2 days the expression was the 50% less and at 3 days was 
around the 75 % less as compare with control (0,513 ± 0,0246 and 0266 ± 0,026) (Graphic 3 
c). At 7 days the expression of miR-133b was around the 50 % less as respect to control 
(0,574 ± 0,068) and at 30 days was almost comparable (not shown). 
 
 
 
Graphic 3. Relative expression of miRs, by qRT-PCR analysis, in regenerating adult heart 
after the ventricular apex amputation (at 24h-1 day, 48h-2 days, 72h-3 days and 7 days). (a) 
expression of miR-1. (b) expression of miR-133a. (c) expression of miR-133b. (*) 
significantly different from control (P<0,001). One-tail Student T test. 
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DISCUSSION 
 Different vertebrate species have different cardiac regeneration process and in last 
analysis similar but not identical mechanisms of activation of genes responsible to the 
proliferation and differentiation of cardiomyocytes (Srivastava and Ivey, 2006; Ausoni and 
Sartore, 2009). Understanding how complex physiological processes are coordinately 
controlled at the molecular level in-vivo is one of the corner stones of research in modern 
translational medicine. MicroRNAs are involved in negative regulation of post-transcriptional 
gene expression (Carrington and Ambros, 2003; Lim et al., 2005; van Rooij and Olson, 2007) 
and are involved in the regulation of mammal heart functions, in development and disease 
(Lagos-Quintana et al., 2002; Chien, 2007). Thus, they are differently expressed in 
hypertrophic conditions and during heart regeneration (Chien, 2007). Comparing the 
expression of some miRNAs between medaka, chicken, mouse and zebrafish, it was ascertain 
that the timing and location of miRNAs expression was not strictly conserved in vertebrates 
and the variation of miRNAs expression being more pronounced the greater the differences in 
physiology (Ason et al., 2006). However, in the present research, the cardiac miRNAs 
sequence alignments among zebrafish, mouse and human revealed a high homology 
permitting the use of the same probe in the qRT-PCR analyses. The expression levels of miR-
1, miR-133a, miR-133b in adult zebrafish detected in this research, revealed in the whole 
body, in body without hearts and in the heart of zebrafish were comparable, less the miR-1 
that had minor expression levels. Moreover, the higher expression levels of miRs were 
observed in the whole zebrafish body, confirming that miR-1, miR-133a and miR-133b 
expression is specific for the muscles and not restricted to the heart (Chien, 2007). MiR-1 is 
among the most widely conserved miRNAs during evolution: it was found in the genomes of 
organisms as diverse as C. elegans, Drosophyla, zebrafish, chicken, mouse, and human (Zhao 
et al., 2007). An ancient genomic duplication likely resulted in two distinct loci for the miR-
1/miR-133 cluster in vertebrates, with identical mature sequences derived from the duplicated 
loci. Targeted deletion of the muscle-specific miRNAs, miR-1-2, revealed numerous 
functions in the heart, including regulation of cardiac morphogenesis, electrical conduction, 
and cell-cycle control (Zhao et al., 2007). miR-1 and miR-133 play an important different 
roles in modulating muscle proliferation and differentiation (Callis et al., 2007). While miR-1 
enhanced myogenesis, over-expression of miR-133 repressed myoblast differentiation and 
promoted myoblast proliferation (Chien, 2007; Takaya et al., 2009). Since the alignment of 
miR-208 sequence was failed it was concluded that this miRNA is not expressed in zebrafish, 
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contrary as reported in mammals heart (van Rooij et al., 2007). MiR-208, encoded by an 
intron of the αMHC gene and seems to be an essential cardiac-specific regulator of βMHC 
expression and mediator of stress and T3, is required for cardiomyocytes hypertrophy and 
fibrosis in the mice heart (van Rooij et al., 2007). However, lacking this miRNA in zebrafish 
it was concluded that the myocytes physiology and morphology must be controlled in this 
species by the know miRNAs or, possibly by other still unknown miRNAs. It has been 
already demonstrated that various forms of injury and stress evoke a hypertrophic growth 
response in adult cardiac myocytes, which is characterized by an increase in cell size, 
enhanced protein synthesis, assembly of sarcomeres, and reactivation of fetal genes, often 
culminating in heart failure and sudden death (van Rooij et al., 2006). Aiming to study the 
possible role of the miR-1, miR-133a, miR-133b in the morphology of myocardial cells, for 
the first time it was treated in ex-vivo organ-culture. Interestingly, in the present research the 
qRT-PCR analysis of the heart treated for 72h with 500 µM of PE revealed a significant 
decrease of miRNAs, whereas 48 h of treatment was not sufficient for provoked a decrease 
statistically significant. The major decrease was observed for miR-133b where the expression 
was detected about the 75% less as respect to controls, whereas the other miRNAs, miR-1 and 
miR-133a had a decrease as compare with controls. In mouse mode was reported that 
induced-hypertrophy (by aortic constriction) provoked, the expression of different miRNAs 
regulated temporally, among these miRs, the muscle-specific miR-1 was singularly 
downregulated as early as day 1 (0,56 ± 0,036), persisting through day 7 (0,29 ± 0,14) (Sayed 
et al., 2007). In the present study, miR-1 was down regulated already after 2 days, but only 
after 3 days appeared significant. Moreover, its downregulation seems to be less important as 
compare with the miR-133b. Sayed et al. (2007) suggested that the downregulation of miR-1 
could be necessary for the relief of growth-related target genes from its repressive influence 
and induction of hypertrophy. Unfortunately, the authors did not test the miR-133 (not of type 
a nor b). However, other Authors as Carè et al., (2007), demonstrated that in mice and human 
the down-regulation of miR-133 had a critical role in determining cardiomyocytes 
hypertrophy after in-vitro treatment with PE of neonatal cardiomyocytes. Contrary, the over-
expression induced in-vitro of miR-1 and miR-133 inhibited the hyperthrophy in cardiac 
myocytes (Carè et al., 2007; Tatsuguchi et al., 2007) and also in skeletal muscles (McCarthy 
and Esser, 2007). It will be interesting to determine whether forced overexpression of miR-
133 and other miRNAs that are downregulated during cardiac hypertrophy suppress cardiac 
growth in-vivo. In the present research, with the aim to analyze the morphological 
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hyperthrophy of the PE-treated zebrafish hearts was analyzed the specimens by histology (by 
specific staining of muscle fibers) and by confocal microscopy (by using the phalloidin-actin-
binding as a marker). Due to the auto-fluorescence of the muscle fibers (for the emission from 
green fluorescent protein as reported by Jackson et al, 2004) the analysis resulted anyway 
with the enhancement of the fluorescence of the fibers. Thus, the observations done in 
histology and in immunohistochemistry in PE-treated groups were coincident with 
hyperthrophy status of myocytes (Care’ et al., 2007; Espinoza-Derout et al., 2007). It can be 
concluded that the miRNAs analyzed are probably involved also in zebrafish in the control of 
myocytes gene expressions. Further studies are required to better understand if the way of 
action are the same of this reported in mammals, as well as anti-miR-1 and anti-miR-133 use 
to verify the hyperthrophy induced by these specific miRNAs (Carè et al., 2007). While the 
adult mammalian heart shows little or not natural regeneration (cell division in this organ is 
rare) other non-mammalian species as well as fish possess elevate capacity for cardiac 
regeneration (Poss et al., 2002). Zebrafish, from larvae to adult, possesses an unclear capacity 
of restoring the ventricular muscle removed for the 20% by surgical resection, offering new 
possibilities for experimentally approaching this fascinating biological phenomenon (Lepilina 
et al., 2006). The discovery of adult cardiac stem cells and the finding that cardiomyocytes 
have certain capacities to proliferate challenged that concept and raised significant interest in 
investigating the molecular mechanisms of myocytes differentiation and hypertrophy. In the 
present research, the experimental approach was similar to that of Poss et al., (2003) and 
similarly it was observed a recovery of the heart in the same timing point. Moreover, in 
original approach of study, the Masson's trichrome staining evidenced the clot infiltrating 
myocytes, already at 48h post ventricular-amputation. For the first time it was investigated the 
miRNAs expression during the regeneration trial. The data exerted by qRT-PCR revealed a 
clear down-regulation of miR-1, miR-133a and miR-133b. The lowest expression was 
reached for all the miRNAs at 3 dpa (72h). Thus, the data exerted by this research seems to 
indicate that the activation of genes responsible of the regeneration program are linked with 
the down regulation of the most important miRNAs of the vertebrate heart. Similarly in 
mammals, the role of these miRNAs in the myocytes proliferation and differentiation seems 
to be of negative regulation (Callis and Wang, 2008). Over-expression of miR-1 in the 
developing mouse heart resulted in reduced ventricular myocytes expansion and decreased the 
number of proliferating myocytes (Zhao et al., 2005). In particular, miR-133 levels were 
reported to be high in uninjured fins but low during their regeneration (Yin et al., 2008). 
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Which is the possible role of the Fibroblast Growth Factors (FGFs) during the 
development/regeneration program and which is the link with the miRs expression in 
zebrafish is still unexplored field. In mammals, it was suggested that FGFs, in one-hand, are 
responsible of activation of developmental genes and, in other hand, are involved in the 
control of miRNAs expression. For instance, it was observed an increase of the miR-133 and 
consequently a block of fin regeneration when used a specific inhibitor of the FGF receptor 
(Yin et al., 2008). Conversely, miR-133 antagonism during FGF receptor inhibition 
accelerated regeneration through increased proliferation within the regeneration blastema (Yin 
et al., 2008). miR-133 over-expression prevents skeletal muscle differentiation, suggesting 
that differential processing from the dicistronic transcript may regulate cellular decisions of 
differentiation or proliferation (Chen and Lodish, 2005; Chen et al., 2006). FGF-dependent 
depletion of miR-133 promotes appendage regeneration in zebrafish, as like rapid changes in 
gene expression that achieve dramatic developmental effects (Yin et al., 2008). Among these 
developmental effects the apoptosis of myocytes can be also related with miRs expression. 
Both miR-1 and miR-133 produced opposing effects on oxidative stress-induced apoptosis in 
H9c2 cells, with miR-1 being pro-apoptotic and miR-133 being anti-apoptotic. (Xu et al., 
2007a; Yin et al., 2008). The Mps1 kinase, an established positive regulator of blastemal 
proliferation, consists of an in-vivo target of miR-133 (Yin et al., 2008). A large body of 
indication evidenced that dyregulation of miRNAs is linked to muscle-related diseases, such 
as cardiac hypertrophy (Latronico et al., 2008). As such, there has been intense interest in 
deciphering the underlying molecular mechanisms and in discovering novel therapeutic 
targets for suppressing adverse cardiac growth (Wang et al., 2009). In this work, it has been 
demonstrated that zebrafish can also be used as hypertrophic and heart regeneration model. 
These findings point out that miRNAs are potentially associated with muscle-related diseases 
in fish as well as mammals. Converting the observations reported in this paper into biological 
targeted cardiovascular therapy is a central tenet in translational medicine. The titration of 
miRs and the study of their expression and targets could be a key act to control the cardiac 
hypertrophy and overall, the cardiac regeneration. 
68 
 
 
 
 
CHAPTER III 
 
 
 
 
Genes expression during zebrafish heart regeneration in-vivo and ex-vivo 
 
 
Maria Azzurra Missinato1,2, Michael Tsang2 and Nicla Romano1 
 
(1) Department of Environmental Science, University of Tuscia, Viterbo, Italy; (2) MMG, 
University of Pittsburgh, Pittsburgh, USA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Manuscript on preparation  
 
 
 
 
69 
 
ABSTRACT 
Zebrafish (Danio rerio) have the remarkable ability to regenerate the heart, by a 
process referred to as epimorphic regeneration, the regrowth of amputated structures from an 
anatomical complex stump. Networks of transcription factors regulate heart development, 
maintenance, and regeneration in a dose-dependent manner, but the effects of translational 
regulation on the titration of these pathways are largely unknown. Here, with In Situ 
Hybridization (ISH) experiments, it was tested in regenerating hearts the presence and the 
timing expression of genes involved in FGF regulation pathway. In-vivo experiments showed 
that the response to the injury started already at 3 hours post amputation (hpa), just around the 
surgered site, by the reactivation of developmental genes such as dusp6 (mkp3), erm, pea3, 
raldh2, and sef. Between 6 and 12 hpa all the amputated hearts evidenced the expression of 
other genes such as etv5 and sprouty4, showing the reactivation of development genes. With 
the aim to optimize the media to reproduce the regeneration process, it was also tested the 
ability of zebrafish heart to survive in ex-vivo cultures after the amputation of ventricular 
apex. Injured hearts cultured with BCI, FGF-2, Thrombin, and with a cocktail of FGFs were 
able to maintain expression of raldh2 between 7 and 14 days post amputation (dpa), whereas 
PDGF and Basement Membrane Extract (BME) supplemented with FGFs cocktail allowed 
the raldh2 expression until 30 dpa. Regenerating hearts in ex-vivo conditions were able to 
survive and make contractions, and surprisingly showed different degree of cell replication in 
dependence to the culture media. The highest level of duplication, detected by BrdU 
incorporation, was observed at 14 dpa in hearts cultured with addiction of BCI. However 
operated hearts in-vivo showed a complete regeneration after 30 dpa whereas ex-vivo cultured 
the hearts displayed only a partial regeneration. Moreover, in ex-vivo, a big diminution of the 
clot site was observed in hearts cultured with BCI, suggesting that this compound could 
interact with FGF pathway, stimulating and supporting the heart regeneration process. 
 
INTRODUCTION 
Although considerable progress has been made in pharmacological management, the 
possibly to stimulate the heart regeneration processes in mammals and overall in humans, 
seems to be a long-standing goal in cardiovascular medicine. The striking genetic and 
anatomic similarity between zebrafish and humans has also propelled the increasing 
characterization and analysis of zebrafish models of human diseases, and in all process 
correlated to a perturbation of normal developmental programs, including hematopoietic and 
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cardiovascular disorders (Wang et al., 1998; Ernest et al., 2000; Basset and Currie, 2003. For 
a review see Lieschke and Currie, 2007). The zebrafish heart evidenced a remarkable ability 
to regenerate large portions of myocardium after amputation of approximately 20% of the 
ventricular apex (Poss et al., 2002), although the mechanisms underlying this process have not 
been well characterized. Good candidates to drive the development and the regeneration 
programs could be the Fibroblast Growth Factors (FGFs). FGFs comprise of a large family of 
secreted polypeptides thought to signal in a dose-dependent manner through receptor tyrosine 
kinases (Böttcher and Niehrs, 2005). It was demonstrated their role in regulation of 
atrial/ventricular proportionality and the establishment of cardiomyocyte number and their 
differentiation (Tjwa et al., 2003). Furthemore, Roehl and Nüsslein-Volhard (2001) suggested 
that pea3 (Etv4) and erm (Etv5), PEA3/Ets transcription factors family, as targets of FGF8 
signaling, because both genes are expressed or downregulated by ectopic expression of fgf8. 
Moreover, among the studied developmental markers, the Dual Specificity Phosphatase 6 
(Dusp6) also known as Map kinase phosphatase 3 (Mkp3, Zebrafish Information Network), 
had the important function to dephosphorylate activated signaling factors as p44 and p42 
ERKs (Tsang et al., 2004). “Similar Expression to fgf genes” (Sef-il17rd-Zebrafish 
Information Network) has been identified as an antagonist of FGF signaling in zebrafish and 
subsequently in mouse and human, but not in invertebrates (Fürthauer et al., 2002; Darby et 
al., 2009). Sef encodes a putative type I transmembrane protein that antagonizes the 
Ras/mitogen-activated protein kinase pathway in all three species (Rong et al., 2007). 
Zebrafish Sef (zfSef) antagonizes FGF activity during embryogenesis by acting as a feedback-
induced antagonist of the Ras/MAPK-mediated FGF signaling. Sef expression is positively 
regulated by FGF and ectopic expression of Sef in zebrafish embryos specifically inhibits 
FGF signaling (Tsang et al., 2002). Overexpression of sef in zebrafish results in a ventralized 
phenotype (Tsang et al., 2002), similarly to what occurred after dusp6 and spry4 
overexpression (Fürthauer et al., 2001; Tsang et al., 2004), and contrary to the occurred after 
fgf8 overexpression (Fürthauer et al., 1997). Comparative analysis revealed raldh2, a rate-
limiting enzyme for the synthesis of retinoic acid, as one of the most highly induced genes 
across the three regeneration platforms. In situ localization and functional studies indicate that 
raldh2 expression is critical for the formation of wound epithelium and blastema (Mathew et 
al., 2009). Genes that are expressed during zebrafish heart development could be reactivated 
during the regeneration process (Lepilina et al., 2006). Studying the regenerative process in 
zebrafish at genomic and molecular level can help to understand how cardiac regeneration is 
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naturally optimized and why this characteristics has been lost during the evolution. 
Furthermore, study the FGFs role in differentiation of myocytes during the regenerative 
process in-vivo, could improve the culture conditions to try to reproduce the heart 
regeneration process in ex-vivo, and can help the formulation of new drugs.  
 
MATHERIALS AND METHODS 
 
Resection of 20% of ventricular apex of zebrafish heart and ex-vivo organ culture 
The animal experiments were performed according to protocol approved by the 
Institutional Animal Care and Use Committee (IACUC) at the University of Pittsburgh. The 
surgery was performed according to the methodology developed by Poss et al., (2002). 
Briefely, adult zebrafish (6-18 months old) were anesthetized for 3 minutes in 0.168 mg/l 
Tricaine (MS222, Sigma) and placed dorsally in a humid sterile sponge, with ventral side up. 
A small incision (scalpel 0.15mm, Fine Science Tools Inc. US.) was made just under the gills, 
in correspondence to where the heart is located. The pericardial sac was isolated and 
punctured to expose the ventricle by gentle abdominal pressure. Approximately 20% of the 
ventricle apex was removed by iridectomy scissors (Fine Science Tools Inc. US.). A kimwipe 
was used to blot the incision, because the wounds bleed profusely for few seconds until 
beginning to clot. Body wall incision was not sutured and in few days the injured part was 
recovered. With this protocol, 90% of fish was survived. After surgery, fish were returned to 
water and stimulated to breathe with air bubbles from an air pump. Animals usually begin to 
swim within few minutes. After 24 hours, or after 7 days, fish were lethally anesthetized with 
Tricaine and the whole hearts were removed and placed in Hank’s solution (supplemented of 
penicillin/streptomycin 2:100) for the ex-vivo cultures. Samples were then transferred in 24-
well plates with Leibovitz’s L15 medium (GIBCO-BRL) supplemented by 
penicillin/streptomycin (1ml/100ml Gibco, 20.000 US, 100X), L-glutamin 0.3 mg/ml 
(Invitrogen), Insulin 20 US/ml (Sigma), CaCl2 0.8mM, Hepes 25 mM (Sigma). Plates were 
maintained in incubator at 28°C and medium was changed every 4 days. Hearts were 
maintained in culture ex-vivo for 48 and 72 hours post amputation (hpa) and 7, 14 and 30 days 
post amputation (dpa). For each time, 5 hearts were used for proteomic studies and 3 hearts 
were fixed over night in 4% PFA for ISH studies. and 3 hearts were treated for 7 days with 
BrdU (see BrdU labeling) and then used for cryosections. 
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Whole-mount in situ hybridization (ISH) 
The in situ labeling was performed as previously described (Poss et al., 2000), with 
few modifications, using the markers: dusp6, erm, etv5, pea3, raldh2, sef, sprouty4. Probes 
were synthesized using T3, T7 or SP6 RNA polymerase (Promega). Briefly, zebrafish hearts 
of control, and hearts at different time points after the amputation of around 20% of the 
ventricle area, in-vivo and ex-vivo, were fixed in 4% paraformaldehyde overnight at 4°C, 
rinsed two times in 1X phosphate buffered saline (PBS) buffer and in methanol, and stored at 
-20°C in methanol until used. After hydratation stepwise through graduate ethanol in 1X PBS 
and in PBS-0.1% Tween (PBT), samples were treated with 20 µg/ml proteinase K in PBT for 
30 min and hybridized at 65°C with 50% formamide. The reaction was developed with BM 
purple (BMannheim) and stopped with PBS and fixed with 4% PFA at room temperature. 
Hearts processed for whole-mount in situ hybridization were mounted in 100% glycerol and 
photographed using a Leica MZ16 microscope and Q Imaging Retiga 1300 digital camera. 
Experiments were performed in triplicate.  
 
Organ culture supplemented with growth factors and chemical compounds 
To optimizing the heart organ culture ex-vivo, to the Leibovitz’s L15 medium were 
added different compounds as described: (1) a cocktail of FGFs, composed of 5 ng/ml of 
Recombinant Human Cardiotrophin-1 (Peprotech Inc.), 2 nM Thrombin (Sigma), 40 ng/ml 
Recombinant Human Fibroblast Growth Factor-basic (FGFb, FGF-2) (Invitrogen, Biosource), 
10ng/ml Fibroblast Growth Factor-4 (Sigma) and 10 ng/ml Platelet-Derived Growth Factor-
BB (Sigma); (2) 10 µM BCI, a chemical compound, dissolved in 0,5% DMSO. Medium with 
only DMSO was used as control; (3) 200 ng/ml Platelet-Derived Growth Factor-BB (PDGF); 
(4) 100 ng/ml Recombinant Human Cardiotrophin-1 (CT); (5) 100 ng/ml Recombinant 
Human Fibroblast Growth Factor-basic (FGF-2); (6) 10 mM Thrombin (TR); (7) 150 µl/cm2 
Cultrex Basement Membrane Extract (BME), Trevigen, according to the manufactures 
directions, and added with L15; (8) BME added with FGFs cocktail. Plates were maintained 
in incubator at 28°C and medium was changed every 4 days.  
 
Histology 
Hearts were fixed in 4% PFA overnight at 4°C, washed two times in 1% PBS and 
cryopreserved for several hours in a sucrose gradient (10-20-30%). Samples were included in 
cryogen embedding medium (Instrumedics Inc), frozen at -80°C for 30 minutes before 
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cryosectioning. Longitudinal sections of 10 µm were stained with Hematoxylin and eosin 
(H.E.) and with Masson’s trichrome procedure (Sigma Diagnostic Procedure), for fibrin, 
collagen and nuclei. 
 
BrdU labeling 
Bromodeoxyuridine (BrdU), a chemical that is only incorporated into cells undergoing 
de novo DNA synthesis, was added to the fresh media at the concentration of 3.0 mg/ml. 
BrdU was added during the last 7 days of ex-vivo culture. The determination of BrdU was 
made with a primary antibody Mouse Anti-BrdU BD Bioscience (Fischer) diluited 1:100 in 
PBST (PBS, 0,1% Tween) and with a secondary antibody Cy3 diluited 1:500 in PBST, over 
night at 4°C in the dark. Fluorescence was checked with red filter in a Leica MZ16FA 
microscope and pictures made with a Q Imaging retiga EXI digital camera. Quantification of 
BrdU incorporation was performed counting BrdU positive cells in the cut site in 5 sections of 
three hearts for each condition and were calculate averages and standard deviations. 
 
RESULTS 
Whole mount ISH 
In-vivo experiments 
From the analysis of the localization of considered genes, it is possible generalize the 
timing of events observed. 1) After the surgery of the 20% of ventricular apex, all the genes 
were at least detected from 1 day post amputation (dpa). 2) The localization of the probes 
were firstly detected in the area near the amputation site and consequently in the whole heart. 
3) After some days (time dependent from the gene considered) the expression in the heart turn 
confined in the area where the amputation was done. Particularly, at 3 hours post amputation 
(hpa) expression of dusp6, erm, pea3, raldh2, and sef, were visible in the clot site of hearts 
maintained in-vivo (Figure 1). The maximum expression of those genes, peacked in two 
times: at 6 and 12 hpa. At 6 hpa were detected a slight expression of etv5 and sprouty4 
reaching an intense expression level at 12 hpa (Graphic 1). Their localization seemed to be 
exclusively in the cut site. The regeneration process in-vivo was very efficient (Figure 2); at 
48 hpa a large clot was visible in the cut site that was completely replaced with muscular 
tissue by 30 dpa, and 15-20 days later the non operated and operated hearts were 
hystologically totally comparable (data not shown). 
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Figure 1. Localization of different genes in zebrafish hearts in-vivo, at different time point 
after the surgery, detected with ISH experiments. (hpa)= hours post amputation; (dpa)= days 
post amputation. 
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Graphic 1. Genes time expression in in-vivo heart regeneration detected with ISH. Value 0 
corrisponds to no expression, value 10 corresponds to maximum expression levels. (hpa)= 
hours post amputation; (dpa)= days post amputation. 
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Figure 2. Masson staining of zebrafish heart (a) control not amputated, (b) 48 hpa in-vivo, 
and (c) 30 dpa in-vivo. (d-h) Hearts at 30 dpa ex-vivo, put in plate after 1 dpa in-vivo, in 
presence of (d) Leibovitz’s L15 medium (L15) supplemented with FGFs cocktail (5 ng/ml 
Recombinant Human Cardiotrophin-1, 2 nM Thrombin, 40 ng/ml Recombinant Human 
Fibroblast Growth Factor-basic (FGFb, FGF-2), 10ng/ml Fibroblast Growth Factor-4 and 10 
ng/ml Platelet-Derived Growth Factor-BB), (e) 10 µM BCI, (f) 5 ng/ml Cardiotrophin (CT), 
(g) 10 ng/ml Platelet-Derived Growth Factor-BB (PDGF) (h) BME+L15=150 µl/cm2 Cultrex 
Basement Membrane Extract supplemented with Leibovitz’s L15; (i) Amputated heart left 
regenerate 7 days in in-vivo conditions and 14 days in ex-vivo culture with BME+ L15. (hpa)= 
hours post amputation; (dpa)= days post amputation. 
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Ex-vivo experiments 
In ex-vivo cultures, the expression of raldh2 in hearts was monitored after the 
treatment with different culture media (Figure 3). The higher levels of expression was 
detected at 7 dpa for all the media, except for the hearts cultured with Thrombin and with 
FGFs cocktail, that reached the maximum expression level later, at 14 dpa. At 30 dpa raldh2 
was not expressed in the hearts in-vivo (data not shown), but it was expressed in hearts ex-vivo 
cultured with: i) BME+FGFs cocktail, ii) FGF-2, and iii) PDGF. However, at 30 days after 
the surgery, in the heart ex-vivo was still visible a big in the area where the amputation was 
made, and no complete regeneration was observed as in in-vivo experiments.  
 
78 
 
 
79 
 
Figure 3. Localization of raldh2 in zebrafish hearts ex-vivo, cultured with different media, at 
different time point after the surgery. All the hearts were maintained in-vivo until 1 dpa and 
then cultured ex-vivo. (d)= days in ex-vivo conditions. L15= Leibovitz’s L15 medium; 
BCI=10 µM BCI, dissolved in 0,5% DMSO; CT= 100 ng/ml Recombinant Human 
Cardiotrophin-1; FGF2= 100 ng/ml Recombinant Human Fibroblast Growth Factor-basic 
(FGF-2); PDGF= 200 ng/ml Platelet-Derived Growth Factor-BB; Thr= 10 mM Thrombin; 
FGFs cocktail= 5 ng/ml Recombinant Human Cardiotrophin-1, 2 nM Thrombin, 40 ng/ml 
Recombinant Human Fibroblast Growth Factor-basic (FGFb, FGF-2), 10ng/ml Fibroblast 
Growth Factor-4 and 10 ng/ml Platelet-Derived Growth Factor-BB; BME=150 µl/cm2 Cultrex 
Basement Membrane Extract; BME+ FGFs cocktail= BME added with FGFs cocktail. 
 
Organ culture ex-vivo in L15 medium and in FGF supplemented media 
Zebrafish hearts (operated or not) in ex-vivo conditions cultured with in L15 were able 
to contract for several months.  In culture, several cells, with apparently myocytes and 
fibroblast typology, were released from the hearts from 5-6 hpa. The latter type, around the 
fifth day of culture, helped the organ to attach at the bottom of the plate. However, the 
regeneration process in operated hearts were apparently delayed for several days and even not 
comparable with in-vivo condition. For example, a visible diminution of the clot size and/or a 
regeneration of the ventricle apex were not observed after 30 days of culture, nor in 15 days 
later (not shown). The same culture supplemented with different growth factors as 1) 
cardiotrophin, and 2) PDGF, 3) the chemical BCI, 4) BME, and 5) a cocktail of FGFs did not 
show the complete absorption of the clot area and the final regeneration of the amputated 
ventricle area. However, in presence of BME and L15, a remarkable decrease of clot size was 
seen in operated hearts leaved in-vivo for 7 days and then cultured ex-vivo for a total of 30 
days.  
 
BrdU labeling 
Figures 4 shows the cell duplication occurred in the hearts in the presence of different 
media, during the last 7 days of ex-vivo culture. The hearts of control not submitted to 
surgery, cultured with L15, evidenced a few activity of cell duplication, especially at 14 days, 
in all the heart surface. An increase of BrdU incorporation from 14 days untill 30 days were 
observed adding BME. In both culture conditions, the higher activity of cell replication was 
visible at 14 days of culture (Graphic 2). Similarly, the hearts submitted to the surgery and 
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cultured with L15, Thrombin, Cardiotropin, BCI and FGFs cocktail, showed the maximum 
level of cell duplication at 14 dpa. At this time point, the higher number of BrdU+ cells was 
detected in the hearts treated with BCI. In culture media supplemented by PDGF, FGFs 
cocktail and BME+L15 BrdU+ cells were observed already at 7 dpa. Very low cell duplication 
activity was visible in hearts cultured with FGF2 and with Thrombin. At 30 dpa, few cells 
positive to the BrdU were observed in the hearts cultured with BCI, FGFs-cocktail, 
BME+L15 and BME+FGFs cocktail not only near the cut site, but in the total surface of the 
heart.  
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Figure 4. BrdU reactions in zebrafish hearts cryosections.; (d)= days in ex-vivo conditions. 
Hearts were treated with BrdU during the last 7 days of culture. L15= Leibovitz’s L15 
medium; BME+L15= 150 µl/cm2 Cultrex Basement Membrane Extract supplemented with 
L15; BCI= 10 µM BCI, dissolved in 0,5% DMSO; CT= 100 ng/ml Recombinant Human 
Cardiotrophin-1; FGF2= 100 ng/ml Recombinant Human Fibroblast Growth Factor-basic 
(FGF-2); PDGF= 200 ng/ml Platelet-Derived Growth Factor-BB; Thr= 10 mM Thrombin; 
FGFs cocktail= 5 ng/ml Recombinant Human Cardiotrophin-1, 2 nM Thrombin, 40 ng/ml 
Recombinant Human Fibroblast Growth Factor-basic (FGFb, FGF-2), 10ng/ml Fibroblast 
Growth Factor-4 and 10 ng/ml Platelet-Derived Growth Factor-BB; BME+ FGFs cocktail= 
BME added with FGFs cocktail. 
 
Graphic 2. Numbers of BrdU+ cells in cryosections of zebrafish hearts cultured in ex-vivo, 
with relative standar deviations. All the hearts were maintained in-vivo until 1 dpa, then 
cultured ex-vivo, and treated with BrdU during the last 7 days of culture (d)= days in ex-vivo 
conditions. L15= Leibovitz’s L15 medium; BME+L15= 150 µl/cm2 Cultrex Basement 
Membrane Extract supplemented with Leibovitz’s L15 medium; Thr= 10 mM Thrombin; 
FGF2= 100 ng/ml Recombinant Human Fibroblast Growth Factor-basic (FGF-2); CT= 100 
ng/ml Recombinant Human Cardiotrophin; PDGF= 200 ng/ml Platelet-Derived Growth 
Factor-BB; BCI=10 µM BCI, dissolved in 0,5% DMSO; FGFs cocktail= 5 ng/ml 
Recombinant Human Cardiotrophin-1, 2 nM Thrombin, 40 ng/ml Recombinant Human 
Fibroblast Growth Factor-basic (FGFb, FGF-2), 10ng/ml Fibroblast Growth Factor-4 and 10 
ng/ml Platelet-Derived Growth Factor-BB; BME+ FGFs cocktail= 150 µl/cm2 Cultrex 
Basement Membrane Extract added with FGFs cocktail. 
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DISCUSSION 
Teleost fish have a remarkable ability to regenerate organs and tissues, capacity that is 
limited in mammals. For this reason, zebrafish results a useful biological model to understand 
the cardiac regeneration process and these knowledge could be useful for translational 
medicine; in fact after a surgical amputation of around 20% of the ventricle apex, there is a 
complete restoration of muscular tissue, in a process that involves FGFs and takes between 30 
and 60 days (Poss et al., 2002; Lepilina et al., 2006). During the heart regeneration the 
formation of a blastema and the induction of developmental markers were also dependent by 
FGF factors (Lepilina et al., 2006). The clot that seals the apex matures within several days 
(1-4 day post-amputation -dpa), into fibrin, a complex milieu containing serum factors and 
degenerated erythrocytes. Functional cardiomyocytes and new contractile muscle infiltrated 
the injured area and sealed off the wound. Interestingly, the regenerated myocardium 
displayed a transiently hypertrophied compact zone, from 21-30 dpa, most likely reflecting a 
compensatory reaction to the hemodynamic overload subsequent to myocardial loss (Lepilina 
et al., 2006). Scarring and collagen deposition, characteristic of damaged mammalian hearts, 
did not occur. Remarkably, 60 days after surgery, the zebrafish heart appeared roughly normal 
both histologically and based on examination of heartbeat. In contrast, mouse hearts subjected 
to similar damage induced by freezing do not regenerate, but instead form scar tissue (Wills et 
al., 2008). In the infarcted mammalian ventricle, fibrin deposition attracts fibroblasts and 
inflammatory cells, and is a precursor to scarring.  
Using a comparative microarray analysis in zebrafish Mathew et al., (2009) 
demonstrated that various tissues, including the heart, respond to amputation/injury with 
strikingly similar genomic response. However, regeneration of the zebrafish heart appears to 
differ from that described in other tissues, including the newt limb and zebrafish fin, where 
differentiate cells (muscle, cartilage, and skin) adjacent to the wound site, first dedifferentiate 
to form a blastema or mass of pluripotent cells, which then give rise to a fully formed and 
patterned limb or fin (Biga and Goetz, 2006). The formation of the blastema that regenerates 
these tissues requires successive process of dedifferentiation, transdifferentiation, and pattern 
formation. The zebrafish myocardium is a relatively simple structure, composed of one major 
cell type, so the initial step of dedifferentiation observed during limb regeneration may not be 
required for cardiac regeneration. Using double transgenic animals with both nuclear-
localized DsRed2 fluorescent reporter for cmlc2 (cmlc2:nRFP, where RFP is red fluorescent 
protein) and enhanced green fluorescent protein (EGFP), that can reveal temporal and spatial 
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characteristics of promoter activation and inactivation, Lepilina and colleagues (2006) 
demonstrated that new myocardium arises from undifferentiated progenitors cells and 
maintained by a dynamic epicardial injury response. 
 
In-vivo experiments 
In the present research it was shown that the in-vivo regeneration process involved 
many genes that were correlated with the FGFs pathways. The group of FGF activity 
modulators includes transmembrane proteins that interact with the FGFR, as Sef, and 
cytoplasmatic proteins such as dusp6 and Sprouty. In the first 3 hours after the surgery the 
activation was restricted around the clot area. Between 6 and 12 hpa there is a gene activation 
of all heart surface suggesting that the surgery causes a response of all the organ and enforced 
the idea that FGFs are implied in the regeneration process. The genes implied in the activation 
of the regeneration and correlated to FGFs were dusp6, erm, pea3, raldh2, and sef. These 
genes were normally involved in the zebrafish embryogenesis and silent in the adult (Major 
and Poss, 2007). It is known that dusp6 expression is controlled by FGF ligands and receptors, 
however it has been controversial as to which signaling pathway downstream of the receptor 
is required for dusp6 gene transcription. Functional studies in zebrafish revealed that FGF 
signaling is necessary and sufficient for dusp6 expression (Tsang et al., 2004). Dusp6 and sef 
are two genes that exhibit almost identical expression to fgf8 and fgf3 during development the 
Ets transcription factors erm and pea3, and the FGF inhibitors sef and spry. (Li et al., 2007a; 
Tsang et al., 2004). Also, it was determined that dusp6 is a negative feedback regulator of 
FGF signaling in the zebrafish embryos as it is in mammalian cells, and that dusp6 expression 
is initiated by maternal β-catenin activity prior to any detectable FGF/RAS/MAPK signaling. 
It is known that dusp6 expression is controlled by FGF ligands and receptors. Pea3 subfamily 
members are FGF-dependent. In zebrafish, the only Pea3 identified members, pea3 and erm 
are regulated by fgf8 and fgf3 (Raible and Brand, 2001; Roehl and Nüsslein-Volhard, 2001). 
Overexpression of sef in zebrafish results in a ventralized phenotype (Tsang et al., 2002), 
similarly to what occurred after mkp3 and spry4 overexpression (Fürthauer et al., 2001; Tsang 
et al., 2004), and contrary to the occurred after fgf8 overexpression (Fürthauer et al., 1997). In 
this study was evidenced that at 1 dpa, the expression of the genes studied, was localized not 
only in the cut site as was observed during the first hours after the surgery: this observation, 
suggests that the genetic response to the injury is very rapid and probably the clot site 
stimulates all the epicardium to react. Thus, the area near the cut site starts the activation of 
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the whole heart and then is the last part to switch off. Moreover, the injury site is also 
responsible of silencing the re-activated genes when the regeneration process is concluded. In 
fact this part was here demonstrated to be the last to actuate the switch off of regeneration 
process. At 2 dpa is visible only the expression of etv5 and sprouty4 (Spry4), evidencing that 
these genes were activated later respect to the other genes and that they remain on for longer 
time. Similar to Sef, Sprouty4 encodes an FGF signaling antagonist (Fürthauer et al., 2002). 
Also, Sprouty proteins are activated both transcriptionally and postranslationally through the 
Ras-ERK1/2 pathway upon FGFR activation. Raya and colleagues (2003) demonstrated that 
adult zebrafish have a remarkable capacity to regenerate the heart in a process that involves 
up-regulation of msxB and msxC genes. Heart regeneration in zebrafish is accompanied by up-
regulation of components of the Notch pathway, followed by members of the Msx family. 
These genes are not expressed during zebrafish heart development, indicating that 
regeneration involves the execution of a specific genetic program, rather than redeployment of 
a developmental program. Also, the same Authors demonstrated that components of the Notch 
pathway are also up-regulated during zebrafish fin regeneration, suggesting that this pathway 
may play a general role in the activation of the regenerative process.  
 
Ex-vivo experiments 
In ex-vivo culture it has seen that zebrafish hearts cultured with L15 are able to 
contract for several months, even if the regeneration process apparently delayed and was not 
as efficient as in-vivo. Several reasons can cause the failure of regeneration in ex-vivo. Firstly, 
the lack of stem cells capable to reactivate the silent development/regeneration genes. In fact, 
the operated hearts culture ex-vivo, evidenced just a few hours after, numerous cells leaving 
the organ. These cells resembled similar to those observed in mammals models (Messina et 
al., 2004). It was demonstrated in mouse and in human that these cells had adult stem cells 
identity and were capable, at occurrence, to differentiate in cardiomyocytes (Barile et al., 
2007). Sometimes, after 5 days around the hearts were also observed fibroblast that allowed 
the organ attachment to the plate. These elements were also observed in mammals models, 
confirming the similarity of regeneration process in vertebrates (Luo et al., 2009). Secondly, 
the gene re-activation seemed to be more complicated and not exclusively driven by FGFs. In 
fact with the aim to understand the role of FGFs in the regeneration process and to improve 
this process in ex-vivo, the medium was also supplemented with different growth factors and 
with a cocktail of FGFs. However, similarly with the first experiment with L15 medium, the 
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treatment of ex-vivo operated hearts using FGFs cocktail revealed not efficient as well as in-
vivo process: at 30 dpa, the clot was still present in all the hearts cultured with different 
media. These findings suggest that the presence of FGFs were not sufficient in se to activate 
the efficient regeneration process. Since FGFs display pleiotropic actions and are appealing 
candidates for signals, it is difficult to exactly determine their time of action and the 
combination of these factors with others (Watanabe et al., 2001). The question if the process 
is simply delayed in culture or if is blocked by the absence of necessary key factors could take 
an answer by the analysis of gene expression in operated hearts cultured. In ex-vivo cultures 
the presence of raldh2 was detected at 7 dpa, thus, several days later the in-vivo experiments. 
In mammals, raldh2 expression is regulated by Wnt signal and FGFs/ERK signaling 
(Halilagic et al., 2007). It is possible hypothesize that Wnt signal is delayed or blocked in ex-
vivo conditions, whereas is active in in-vivo experiments. Interestingly, a significant 
diminution of the clot size, and a quite complete regeneration, occurred in the hearts removed 
from the fish at 7 dpa- instead of at 1 dpa- and then cultured with L15 supplemented with 
BME. These results suggests that the first days after the surgery were critical for the 
regeneration process and that until 7 days several growth factors were involved and not 
exclusively FGFs. Thirdly, the factors expressed during the first days after the amputation in 
in-vivo regeneration were necessary not only for the differentiation but also for improve the 
myocytes proliferation. In fact, by incorporation of BrdU, it was demonstrated in this study 
that the operated hearts were able to duplicate the myocytes in ex-vivo. However, the amount 
of cells was not sufficient to allow the regeneration. Only the culture medium composed by 
L15 supplemented with PDGF, FGFs cocktail and BME were able to efficiently stimulate the 
cell proliferation, confirmed by the large incorporation of BrdU in cells that starting from 7 
dpa. It has been demonstrated by Lien et al., (2006), that PDGF was up-regulated in 
regenerating zebrafish hearts and that a chemical inhibitor of PDGF receptor decreased DNA 
synthesis in adult zebrafish cardiomyocytes both in-vitro and in-vivo during regeneration. The 
BME could improve the cell replication because it is a gelatinous membrane that can embody 
the heart and restrict the release of the cells important for the regeneration in the culture 
media. Interesting, the BrdU+ cells were localized not only near the cut site, but in the total 
surface of the heart, enforcing the idea that the activation from the injured site is capable to 
stimulate the whole organ. An increase of BrdU+ cells was seen between 14 and 30 dpa, 
adding the BME in the culture media, showing that this particular media is improving the 
culture conditions. In this study, it was studied the activation of some genes related to FGFs 
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induction during the in-vivo and ex-vivo heart regeneration process. Moreover, it was 
developed an ex-vivo system to reproduce the cardiac regeneration, to understand the role of 
different growth factors and chemicals involved in this process. Raldh2 that is expressed 
during the in-vivo heart regeneration is also expressed in ex-vivo process too, even if in retard. 
These results will help to understand the distribution and cell type-specific expression of FGF 
during the heart regeneration process and can give important insight into the action of FGF 
signaling on adult zebrafish, and in last analysis vertebrate heart. In fact various growth 
factors, and small molecules could be used to induce mammalian cardiomyocyte proliferation 
in the hope that these molecules can be utilized for cardiac regeneration.  
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ABSTRACT 
The use of zebrafish (Danio rerio) as a model to study human hematopoietic and 
cardiovascular disease could contributes valuable leads toward the current understanding 
human pathophysiology in these organ systems. Aimed to know the protein pattern expressed 
in adult zebrafish heart, a proteomic approach has been employed in this study. One hundred 
and fifteen proteins were identified using MALDI/TOF-MS analysis. Identified proteins 
belong to different families, including metabolic enzymes (glyceraldehydes-3-phosphate 
dehydrogenase, mitochondrial malate dehydrogenase, ATP synthase), proteins of signal 
transduction pathways (transcription factor Lmx1b, Mcm10 protein), growth factors (vascular 
endothelial growth factor, insulin-like growth factor), cytoskeletal components, globin family 
proteins (myoglobin, ba1 globin), and structural proteins (four and a half LIM domains, actin, 
desmin). For the first time, an overall study of proteins that are naturally expressed in the 
adult zebrafish heart has been done. This study can give a basic contribute in understanding 
the biological knowledge of the vertebrate heart. 
 
INTRODUCTION 
During last decade zebrafish has become a widely used and powerful vertebrate model 
system for studies of the molecular mechanisms of ontogeny (Quian et al., 2005), pathology 
(Eisen, 1996), and pharmacology (Drummond et al., 1998). The adult zebrafish heart is 
composed of two main chambers, the atrium and the ventricle, and of two additional 
chambers, constituted by sinus venous and bulbus arteriosus, all chambers derived during the 
ontogeny by a transformed arterial vase (Thisse and Zon, 2002). In mammals, the heart is 
composed by four main chambers (2 atrial chambers and 2 ventricles), and the additional 
bulbus arteriosus, one for each ventricle. Generally, vertebrate heart possesses autoregulatory 
mechanisms that enable it to adapt its force of contraction to continually changing demands 
(Bending et al., 2006). The molecular components of the cardiac mechanical stretch sensor 
are mostly unknown but of immense medical importance, since dysfunction of this sensing 
machinery is suspected to be responsible for a significant proportion of human heart failure 
(Kim et al., 2002). Although the zebrafish genome is only half the size of the human genome, 
the genetic structure is remarkably similar. Also, the utility of the genome sequence increases 
with the quality of annotation of protein-encoding genes and the creation of transgenic 
zebrafish has been used to monitor protein expression patterns during development (Udvadia 
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and Linney, 2003). It has been proposed that proteomics should complement the genome-
wide expression profiling (Love et al., 2004). In fact, with proteomics, that allows the 
separation of thousand of proteins in a single analysis, it is possible confirm and revise 
existing genome annotations, and also discover completely new genes (Findlay et al., 2009). 
Since there are just few proteomic studies in zebrafish, and not one focused on the heart, here, 
for the first time, it is reported a proteomic analysis of the adult zebrafish heart. The peptide 
fragments obtained from the digestion of proteins separated by two-dimensional gel 
electrophoresis (2DE), were analyzed using mass spectrometry (MS); the peak lists generated 
from the MS data were analyzed using software and used to search existing Danio rerio 
protein databases to identify the protein. Understanding the type of proteins that are naturally 
expressed in the adult zebrafish heart is not only important as basic biological knowledge, but 
also, because it constitute a reference point to compare proteins expression in various cardiac 
diseases. 
 
MATHERIALS AND METHODS 
Proteomics of the zebrafish heart 
i) Samples preparation 
2DE gel system was used to detect the protein expression of adult zebrafish hearts 
(n=8) followed by MALDI-TOF/MS protein identification. Protein identification was carried 
out using matrix assisted laser desorption ionization-time of flight (MALDI-TOF) mass 
spectrometry and the Mascot and ProFound search engines. The zebrafish hearts were 
removed and homogenized (Teflon pestle) in 20 µl of labeling buffer (30 mM Tris, 7 M urea, 
2 M thiourea, 4% (w/v) CHAPS (3-[(3-cholamidopropyl) dimethylammonio]-2-hydroxy-1-
propanesulfonate), pH 8.5 adjusted with 1N HCl, clarified by ultracentrifugation (100,000 x 
g, 23oC, 1.0 hr) and stored at −80 °C.  
 
ii) 2-D Electrophoresis 
Sample was subjected to isoelectric focusing (IEF) using an Ettan IPGphor (GE 
Healthcare/Amersham Biosciences) and 13 cm linear, pH 3–10 Immobiline DryStrips (GE 
Healthcare/ Amersham Biosciences). The IPGphor system was programmed to perform IEF 
with the following settings: (i) 12 hour rehydration, (ii) 500 V, 1.0 h, “Step-n-hold”; (iii) 1000 
V, 1.0 h, “Step-n-hold”; (iv) 1500 V, 1 h, “Step-n-hold”; (v) 4000 V, 1 h, “Step-n-hold”; and 
(vi) 8000 V, 60,000 Vh, “Step-nhold”. The IPG strip was subjected to two 15-min 
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equilibration steps with 1% DTT in SDS buffer (3 M urea, 50mM Tris-HCl pH 8.8, 30% 
glycerol, 2% SDS and trace bromophenol blue). The 2DE was carried out on a 8-16% SDS-
polyacrylamide gradient gel with a constant current of 30 mA until the tracking dye was 1 cm 
above the bottom of the gel. Silver staining of the 2D gel was performed using Silver Stain 
Plus Kit (Bio-Rad) according to the manufacturer’s instructions. Gel was also stained with 
Comassie Blue (Bio-Rad) Gel images were created by acquiring digitized images (400-600 
dpi) using a Canon LiDE 30 flatbed scanner. Once scanned, gels were stored in 1.0% acetic 
acid (Fisher) at 4oC until spots of interest were excised for mass spectrometry. 
 
iii) In-gel trypsin digestion of proteins 
Protein spots of interest were manually picked (1.0 mm to 3.0 mm in diameter) and 
rinsed in distilled water. Silver ions were removed by adding fresh destaining solution (15 
mM potassium ferricyanide and 50 mM thiosufate in distilled water) (Invitrogen, Carlsbad, 
CA) to each spot and incubating for 20 min. Samples were then rinsed with distilled water, 
destained for blue comassie with 40% methanol 10% acetic acid, and equilibrated with 200 
mM ammonium bicarbonate (Fisher). Samples were rinsed in 50% acetonitrile (Fisher) in 20 
mM ammonium bicarbonate and dehydrated in 100% acetonitrile.  Samples were digested in-
situ with 200-300 ng trypsin (Sigma) (14 hours, 37oC) and peptides were extracted twice with 
50% acetonitrile, 2.5% TFA (Fisher) in distilled water and dried using a CentriVap Speed 
Vacuum. Extracted, dried peptides were mixed with α-cyano-4-hydroxycinnamic acid 
(CHCA) (ABI) and 0.5 µl was spotted onto the target for MALDI-TOF analysis. MALDI-
TOF was performed using the 4800 Proteomics Analyzer (ABI, Foster City, CA). Mass 
spectra were individually calibrated using internal trypsin peaks (842.51 and 1045.56 m/z) 
with Data Explorer software available from ABI. Proteins were identified using 
ProteinProspector (University of California, San Francisco; http://prospector.ucsf.edu/) set to 
a mass accuracy of +/- 50 ppm to compare unknown mass fingerprints to those of known 
proteins in the NCBI non-redundant database using a species-specific filter for Danio rerio. 
 
RESULTS 
Lysate from the adult zebrafish hearts proteins separated using a 2DE is shown in 
Figure 1. The protein separation in the first dimension was done according the Isoelectic 
Point (PI), the pH at which a particular protein carries no net electrical charge. The second 
dimension allows the separation of proteins according to molecular weights (MW). MALDI-
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TOF/MS/MS data analysis using ProteinProspector analyzed 115 proteins, a number of which 
had a unique NCBI annotation. It was possible to identify several metabolic enzymes 
(glyceraldehydes-3-phosphate dehydrogenase, mitochondrial malate dehydrogenase, ATP 
synthase), proteins of signal transduction pathways (transcription factor Lmx1b, Mcm10 
protein), growth factors (vascular endothelial growth factor, insulin-like growth factor), 
cytoskeletal components, globin family proteins (myoglobin, ba1 globin), and structural 
proteins (four and a half LIM domains, actin, desmin). Particularly, glyceraldehydes-3-
phosphate dehydrogense, revealing the same molecular weight (MW 35784 Da) in numerous 
different spots (Spots # 37, 38, 42, 44), were identificates as probable isoforms. Tha ATP 
synthase with MW of 59744 Da was identified in three spots (# 67, 68, 78) in the 2D gel 
(Figure 1). As regard the enzyme isocitrate dehydrogenase, two isoforms were founded: the 
isoform 3 (NAD+) alpha, with MW of 39984 Da (Spots # 56, 57), and the isoform 2 (NAD+) 
mitochondrial, with MW corresponding to 50397 Da (Spots # 62, 63, 64, 65). One isoform of 
the enzyme mitochondrial aconitase (MW 84860), was founded in two consecutive spots 
(Spots # 104, 105). Regarding the fructose bisphosphatase aldolase, were identified the 
isoform a (Spots # 41, 43), with MW of 39741 Da and the isoform c (Spot # 50), 
corresponding to 39260 Da.  
In the 2D gel of the zebrafish heart it was possible also identified proteins with 
structural function. More in particular, two isoform of actin were founded; the alpha 2, 
characteristic of smooth muscle of aorta (Spots # 59, 60, 75), with MW of 41995 Da, and the 
alpha 1b, characteristic of skeletal and cardiac muscle (Spots # 61, 73, 77), with MW of 
41887 Da. Also, several forms of myosin were founded: the light polypeptide 7, with 
regulatory function, (Spot # 13 - MW 19021), the myosin binding protein C, cardiac specific 
(Spot # 114 - MW 142312), and the ventriculat myosin heavy chain-like (Spots # 113, 115 - 
MW 223315).  
In this study were also identified several proteins of globin family, as myoglobin 
(Spots # 3, 4 – MW 15583), cytoglobin 2 (Spot # 11 – MW 20585), and microglobulin (Spot 
# 15 - MW 23835). As regard the Ba globin, two isoforms with similar MW were founded: 
the ba1 globin (Spots # 5, 6), corresponding to 16389 Da, and the Ba1 globin (Spot # 7), 
corresponding to 16403 Da.  
A complete list of all the proteins identified in this study, with the corrispondent 
values of MW (Da), the Isoelectic Point (PI), score, and accession number, is reported in 
Table 1. 
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Figure 1. Two-dimensional electrophoresis gels (2DE) of proteins expressed in 8 zebrafish 
hearts, and spots of 115 proteins used for identification in MALDI/TOF-MS. 
 
Spot 
# 
Protein name MW (Da) pI % Cov Accession # 
1 Rbp2b protein 15659 5.8 38.5 66267453 M 
2 transcription factor Lmx1b  13543 4.6 50.4 61287134 
3 myoglobin 15583 7 46.3 41053652 M 
4 myoglobin 15583 7 46.3 41053652 M 
5 myoglobin 15525 7.9 63.3 37695556 
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6 ba1 globin 16389 7.7 87.8 18858329 M 
7 Ba1 globin 16403 7.7 45.9 92096378 
8 PREDICTED: similar to Myosin-Id 20875 9.5 31.1 189526020 
9 PREDICTED: similar to Myosin-Id 20875 9.5 24 189526020 
10 nucleoside diphosphate kinase B 17124 6.8 51.6 41053595 M 
            
11 cytoglobin 2 20585 5 23.5 145279651 M 
12 
PREDICTED: similar to phosphoinositide-3-
kinase, regulatory subunit 6 
26669 6.9 27.2 189520820 
13 myosin, light polypeptide 7, regulatory 19021 4.7 23.5 29725603 M 
14 apolipoprotein A-1 30257 5.1 60.7 18858281 M 
15 
alpha-1-microglobulin/bikunin precursor, like 
precursor 
23835 5.2 50 41055365 M 
            
16 kinase 1 binding protein 1 28063 7.7 25.3 66472792 M 
17 Prdx3 protein 26866 8.9 31.2 60688276 M 
18 
PREDICTED: hypothetical protein 
LOC100006474 
26668 8.2 28.9 189534558 
19 PREDICTED: similar to Wnt4b protein 25168 9 36.4 125843849 
20 insulin-like growth factor binding protein 2b 29436 8 26.4 187608371 M 
            
21 regulator of microtubule dynamics 1 34131 8.2 24.1 157311701 M 
22 triosephosphate isomerase B 26828 6.4 37.5 82245450 M 
23 regulator of microtubule dynamics 1 34131 8.2 33.6 157311701 M 
24 Rho-class glutathione S-transferase  26409 6.8 27.9 113682261 M 
25 insulin-like growth factor binding protein 1a 28200 7.8 21.4 40254671 M 
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26 Four and a half LIM domains 32019 8.9 28.9 166797040 
27 calbindin 2, like 31125 5 31.7 41152295 M 
28 PREDICTED: hypotetical protein  31398 5.3 21.8 189515152 
29 Mcm10 protein 37690 5.5 25.9 62202893 
30 electrontransfer-flavoprotein, alpha polypeptide 35091 6.9 42.6 38707985 M 
            
31 3-hydroxyisobutyrate dehydrogenase b 34618 8.3 28.3 41055658 M 
32 coiled-coil domain containing 89 42157 5.6 32.8 167621496 M 
33 coiled-coil domain containing 89 42157 5.6 34.2 167621496 M 
34 four and half LIM domains protein 2 isoform a 32480 8.1 20.8 74013664 
35 
novel protein similar to vertebrate WNT1 
inducible signaling pathway protein 1 (WISP1) 
34937 8.7 25.6 148726365 
            
36 PREDICTED: similar to zinc finger protein 502 41796 9.2 29.2 189534640 
37 glyceraldehyde-3-phosphate dehydrogenase 35784 8.2 45.5 169403947 M 
38 glyceraldehyde-3-phosphate dehydrogenase 35784 8.2 61 169403947 M 
39 
wingless-type MMTV integration site family, 
member 8a 
43379 8.9 24.5 220678939 
40 
PREDICTED: similar to WNT1- inducible-
signaling pathway protein 3 precursor (WISP-3) 
41746 9.2 30.1 189532808 
      
41 fructose-bisphosphate aldolase A 39741 8.5 40.4 41282154 M 
42 glyceraldehyde-3-phosphate dehydrogenase 35784 8.2 55.3 169403947 M 
43 fructose-bisphosphate aldolase A 39741 8.5 40.4 41282154 M 
44 glyceraldehyde-3-phosphate dehydrogenase 35784 8.2 61 169403947 M 
45 mitochondrial malate dehydrogenase 35420 8.4 56.7 47085883 M 
            
46 mitochondrial malate dehydrogenase 35420 8.4 38.6 47085883 M 
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47 mitochondrial malate dehydrogenase 35420 8.4 47.2 47085883 M 
48 mitochondrial malate dehydrogenase 35420 8.4 49.3 47085883 M 
49 mitochondrial malate dehydrogenase 35420 8.4 35.3 47085883 M 
50 aldolase c, fructose-bisphosphate 39260 6.2 27.8 35902900 M 
            
51 
NADH dehydrogenase (ubiquinone) 1 alpha 
subcomplex, 10 
40337 6.7 20.8 48734808 
52 
PREDICTED: similar to Protein zyg-11 
homolog 
42480 5.8 30.9 189538821 
53 
PREDICTED: similar to Protein zyg-11 
homolog 
42480 5.8 13.8 189538821 
54 pyruvate dehydrogenase (lipoamide) beta 39309 5.8 52.6 47085923 M 
55 PREDICTED: similar to mKIAA0844 protein 38920 8.7 37.1 125842480 
            
56 isocitrate dehydrogenase 3 (NAD+) alpha 39984 7 35.9 46358344 M 
57 isocitrate dehydrogenase 3 (NAD+) alpha 39984 7 48.5 46358344 M 
58 vascular endothelial growth factor c 45288 8.1 32.1 45387875 M 
59 Actin, alpha 2, smooth muscle, aorta 41995 5.2 19.1 49901223 
60 actin, alpha 2, smooth muscle, aorta 41995 5.2 35.3 49901223 M 
            
61 actin, alpha 1b, skeletal muscle 41887 5.3 45.6 70778800 M 
62 
isocitrate dehydrogenase 3 (NAD+) 
mitochondrial 
50397 8.4 33.2 41054651 M 
63 
isocitrate dehydrogenase 3 (NAD+) 
mitochondrial 
50397 8.4 46.4 41054651 M 
64 
isocitrate dehydrogenase 3 (NAD+) 
mitochondrial 
50397 8.4 55.7 41054651 M 
65 
isocitrate dehdrogenase 2 (NADP+), 
mitochondrial 
50397 8.4 43.4 41054651 M 
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66 
wingless-type MMTV integration site family, 
member 10a 
50116 8.7 30.8 229577306 M 
67 
ATP synthase, H+ transporting, mitochondrial 
F1 complex, alpha subunit 1, cardiac muscle 
59744 9.1 59.9 116325975 M 
68 
ATP synthase, H+ transporting, mitochondrial 
F1 complex, alpha subunit 1, cardiac muscle 
59744 9.1 64.6 116325975 M 
69 dihydrolipoamide dehydrogenase 53561 7.6 41.6 41393167 M 
70 enolase 3, (beta, muscle) 47472 6.2 46.9 47551317 M 
            
71 PREDICTED: similar to zinc finger protein 721 72333 9.3 44.6 189517662 
72 
PREDICTED: similar to von Willebrand factor 
precursor (vWF) 
60614 5.1 35.4 189542644 
73 actin, alpha, cardiac muscle 41887 5.3 35 70778800 M 
74 Prmt1 protein 43567 5.7 28.3 27882547 
75 Actin, alpha 2, smooth muscle, aorta 41995 5.2 38.2 49901223 
            
76 
PREDICTED: similart to zinc finger protein 
568 
44108 9.5 23 189518306 
77 actin, alpha, cardiac muscle 41887 5.3 23.9 70778800 M 
78 
ATP synthase, H+ transporting, mitochondrial 
F1 complex, beta polypeptide 
55001 5.2 28.6 66773080 M 
79 myotubularin related protein 7a 75258 6.3 24.4 94536956 M 
80 PREDICTED: similar to zinc finger protein 40 53243 9.1 32.2 189534638 
            
81 P2rx4a protein 45045 6.5 29.4 27503429 M 
82 PREDICTED: similar to zinc finger protein 160 72858 9.3 25.7 189528537 
83 Desm protein 55616 5.6 25 62204269 M 
84 
novel protein similar to vertebrate dual-
specificity tyrosine-(Y)-phosphorylation 
regulated kinase 2 (DYRK2) 
64141 9.5 29.3 55962523 
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85 LOC553337 protein 68993 6.8 35.7 61403613 
            
86 PREDICTED: similar to zinc finger protein 160 65587 8.5 29.2 189534592 
87 PREDICTED: similar to zinc finger protein 160 72858 9.3 53.3 189528537 
88 PREDICTED: similar to zinc finger protein 721 72333 9.3 24.3 189517662 
89 PREDICTED: similar to zinc finger protein 721 72333 9.3 28.3 189517662 
90 
RecName: Full=Myotubularin-related protein 8; 
AltName: Full=Myotubularin-related protein 6 
72504 6.3 18.7 82187381 M 
            
91 LGN 72007 6.9 25 51944894 
92 PREDICTED: similar to zinc finger protein 721 72333 9.3 33.3 189517662 
93 TPA_exp: transferrin 73532 6.8 36.1 47264590 
94 PREDICTED: similar to zinc finger protein 208 79103 9.1 30.5 189528501 
95 PREDICTED: similar to mCG142610 91424 9.3 32.5 189528482 
            
96 PREDICTED: similar to zinc finger protein 160 72858 9.3 19.2 189528537 
97 myotubularin related protein 8 72324 6.3 22 41055311 M 
98 PREDICTED: similar to zinc finger protein 721 72333 9.3 29.9 189517662 
99 
PREDICTED: ras homolog gene family, 
member T1 isoform 2 
75344 6.4 23.2 189520622 M 
100 PREDICTED: similar to mCG142610 122393 9.1 36.4 189534703 
  PREDICTED: similar to mCG142610 91424 9.3 34.7 189528482 
            
101 PREDICTED: similar to dynamin 2 86596 6.4 25.8 189519626 
102 PREDICTED: similar to pol polyprotein 128147 8.7 29 189515367 
103 PREDICTED: similar to zinc finger 142 169377 8.7 25.1 189523652 
104 aconitase 2, mitochondrial 84860 7.6 59.1 38707983 M 
105 aconitase 2, mitochondrial 84860 7.6 58.4 38707983 M 
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106 similar to zinc finger protein 721 70257 9.3 25.9 189517658 
107 PREDICTED: similar to mCG142610 71778 9.5 23.4 189518369 
108 
PREDICTED: similar to protein tyrosine 
phosphatase, receptor type, T 
96885 7.1 22.7 189520775 
109 PREDICTED: similar to mCG142610 134532 9.3 46.6 189534972 
110 
PREDICTED: similar to Ca2+-dependent 
secretion activator 
1038986 5.8 15.3 189525131 
            
111 
PREDICTED: PTK2B protein tyrosine kinase 2 
beta 
115235 9.6 14.5 189526015 
112 
PREDICTED: PTK2B protein tyrosine kinase 2 
beta 
115235 9.6 21.2 189526015 
113 ventricular myosin heavy chain-like 223315 5.5 29.5 163644263 
114 myosin binding protein C, cardiac 142312 6.3 18 172072588 
115 ventricular myosin heavy chain-like 223315 5.5 30.2 163644263 
Table 1. Proteins identified in 8 adult zebrafish hearts, using MS, with relative MW (Da), PI, 
score and accession number. In yellow, the proteins identified with score <20. 
 
Table 2 reports the proteins identified with MS, classified according to their 
biological function. They include metabolic enzymes, structural proteins, motor proteins, 
signaling proteins, receptors, transcription factors, globin family proteins and novel/predicted 
proteins. 
Function Spot 
# 
Protein name MW 
(Da) 
pI % 
Cov 
Accession # 
Metabolic 
enzyme 
10 nucleoside diphosphate kinase B 17124 6.8 51.6 41053595 M 
 14 apolipoprotein A-1 30257 5.1 60.7 18858281 M 
 16 kinase 1 binding protein 1 28063 7.7 25.3 66472792 M 
 22 triosephosphate isomerase B 26828 6.4 37.5 82245450 M 
 24 Rho-class glutathione S-transferase  26409 6.8 27.9 113682261 M 
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30 electrontransfer-flavoprotein, alpha 
polypeptide 
35091 6.9 42.6 38707985 M 
 
31 3-hydroxyisobutyrate dehydrogenase 
b 
34618 8.3 28.3 41055658 M 
 
37 glyceraldehyde-3-phosphate 
dehydrogenase 
35784 8.2 45.5 169403947 M 
 
38 glyceraldehyde-3-phosphate 
dehydrogenase 
35784 8.2 61 169403947 M 
 41 fructose-bisphosphate aldolase A 39741 8.5 40.4 41282154 M 
 
42 glyceraldehyde-3-phosphate 
dehydrogenase 
35784 8.2 55.3 169403947 M 
 43 fructose-bisphosphate aldolase A 39741 8.5 40.4 41282154 M 
 
44 glyceraldehyde-3-phosphate 
dehydrogenase 
35784 8.2 61 169403947 M 
 45 mitochondrial malate dehydrogenase 35420 8.4 56.7 47085883 M 
 46 mitochondrial malate dehydrogenase 35420 8.4 38.6 47085883 M 
 47 mitochondrial malate dehydrogenase 35420 8.4 47.2 47085883 M 
 48 mitochondrial malate dehydrogenase 35420 8.4 49.3 47085883 M 
 49 mitochondrial malate dehydrogenase 35420 8.4 35.3 47085883 M 
 50 aldolase c, fructose-bisphosphate 39260 6.2 27.8 35902900 M 
 
51 NADH dehydrogenase (ubiquinone) 
1 alpha subcomplex, 10 
40337 6.7 20.8 48734808 
 
54 pyruvate dehydrogenase (lipoamide) 
beta 
39309 5.8 52.6 47085923 M 
 
56 isocitrate dehydrogenase 3 (NAD+) 
alpha 
39984 7 35.9 46358344 M 
 
57 isocitrate dehydrogenase 3 (NAD+) 
alpha 
39984 7 48.5 46358344 M 
 
62 isocitrate dehydrogenase 2 (NAD+) 
mitochondrial 
50397 8.4 33.2 41054651 M 
 
63 isocitrate dehydrogenase 2 (NAD+) 
mitochondrial 
50397 8.4 46.4 41054651 M 
 
64 isocitrate dehydrogenase 2 (NAD+) 
mitochondrial 
50397 8.4 55.7 41054651 M 
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65 isocitrate dehydrogenase 2 (NADP+), 
mitochondrial 
50397 8.4 43.4 41054651 M 
 
67 
ATP synthase, H+ transporting, 
mitochondrial F1 complex, alpha 
subunit 1, cardiac muscle 
59744 9.1 59.9 116325975 M 
 
68 
ATP synthase, H+ transporting, 
mitochondrial F1 complex, alpha 
subunit 1, cardiac muscle 
59744 9.1 64.6 116325975 M 
 69 dihydrolipoamide dehydrogenase 53561 7.6 41.6 41393167 M 
 70 enolase 3, (beta, muscle) 47472 6.2 46.9 47551317 M 
 74 Prmt1 protein 43567 5.7 28.3 27882547 
 
78 
ATP synthase, H+ transporting, 
mitochondrial F1 complex, beta 
polypeptide 
55001 5.2 28.6 66773080 M 
 79 myotubularin related protein 7a 75258 6.3 24.4 94536956 M 
 
90 
RecName: Full=Myotubularin-
related protein 8; AltName: 
Full=Myotubularin-related protein 6 
72504 6.3 18.7 82187381 M 
 93 TPA_exp: transferrin 73532 6.8 36.1 47264590 
 97 myotubularin related protein 8 72324 6.3 22 41055311 M 
 104 aconitase 2, mitochondrial 84860 7.6 59.1 38707983 M 
 105 aconitase 2, mitochondrial 84860 7.6 58.4 38707983 M 
       
Structural 
function 
26 Four and a half LIM domains 32019 8.9 28.9 166797040 
 32 coiled-coil domain containing 89 42157 5.6 32.8 167621496 M 
 33 coiled-coil domain containing 89 42157 5.6 34.2 167621496 M 
 
34 four and half LIM domains protein 2 
isoform a 
32480 8.1 20.8 74013664 
 59 Actin, alpha 2, smooth muscle, aorta 41995 5.2 19.1 49901223 M 
 60 Actin, alpha 2, smooth muscle, aorta 41995 5.2 35.3 49901223 M 
 61 actin, alpha 1b, skeletal muscle 41887 5.3 45.6 70778800 M 
 73 actin, alpha, cardiac muscle 41887 5.3 35 70778800 M 
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 75 Actin, alpha 2, smooth muscle, aorta 41995 5.2 38.2 49901223 
 77 actin, alpha, cardiac muscle 41887 5.3 23.9 70778800 M 
 83 Desm protein 55616 5.6 25 62204269 M 
       
Motor 
proteins 
13 myosin, light polypeptide 7, 
regulatory 
19021 4.7 23.5 29725603 M 
 114 myosin binding protein C, cardiac 142312 6.3 18 172072588 
 113 ventricular myosin heavy chain-like 223315 5.5 29.5 163644263 
 115 ventricular myosin heavy chain-like 223315 5.5 30.2 163644263 
       
Signaling 1 Rbp2b protein 15659 5.8 38.5 66267453 M 
 17 Prdx3 protein 26866 8.9 31.2 60688276 M 
 
20 insulin-like growth factor binding 
protein 2b 
29436 8 26.4 187608371 M 
 21 regulator of microtubule dynamics 1 34131 8.2 24.1 157311701 M 
 23 regulator of microtubule dynamics 1 34131 8.2 33.6 157311701 M 
 
25 insulin-like growth factor binding 
protein 1a 
28200 7.8 21.4 40254671 M 
 27 calbindin 2, like 31125 5 31.7 41152295 M 
 
39 wingless-type MMTV integration 
site family, member 8a 
43379 8.9 24.5 220678939 
 58 vascular endothelial growth factor c 45288 8.1 32.1 45387875 M 
 
66 wingless-type MMTV integration 
site family, member 10a 
50116 8.7 30.8 229577306 M 
 91 LGN 72007 6.9 25 51944894 
       
Receptors 81 P2rx4a protein 45045 6.5 29.4 27503429 M 
       
Transcription 
factors 
2 transcription factor Lmx1b  13543 4.6 50.4 61287134 
 29 Mcm10 protein 37690 5.5 25.9 62202893 
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Globin family 3 myoglobin 15583 7 46.3 41053652 M 
 4 myoglobin 15583 7 46.3 41053652 M 
 5 ba1 globin 16389 7.7 87.8 18858329 M 
 6 ba1 globin 16389 7.7 66.9 18858329 M 
 7 Ba1 globin 16403 7.7 45.9 92096378 
 11 cytoglobin 2 20585 5 23.5 145279651 M 
 
15 alpha-1-microglobulin/bikunin 
precursor, like precursor 
23835 5.2 50 41055365 M 
       
Novel/ 
predicted 
8 PREDICTED: similar to Myosin-Id 20875 9.5 31.1 189526020 
 9 PREDICTED: similar to Myosin-Id 20875 9.5 24 189526020 
 
12 
PREDICTED: similar to 
phosphoinositide-3-kinase, 
regulatory subunit 6 
26669 6.9 27.2 189520820 
 
18 PREDICTED: hypothetical protein 
LOC100006474 
26668 8.2 28.9 189534558 
 
19 PREDICTED: similar to Wnt4b 
protein 
25168 9 36.4 125843849 
 28 PREDICTED: hypothetical protein  31398 5.3 21.8 189515152 
 
35 
novel protein similar to vertebrate 
WNT1 inducible signaling pathway 
protein 1 (WISP1) 
34937 8.7 25.6 148726365 
 
36 PREDICTED: similar to zinc finger 
protein 502 
41796 9.2 29.2 189534640 
 
40 
PREDICTED: similar to WNT1- 
inducible-signaling pathway protein 
3 precursor (WISP-3) 
41746 9.2 30.1 189532808 
 
52 PREDICTED: similar to Protein zyg-
11 homolog 
42480 5.8 30.9 189538821 
 
53 PREDICTED: similar to Protein zyg-
11 homolog 
42480 5.8 13.8 189538821 
 
55 PREDICTED: similar to 
mKIAA0844 protein 
38920 8.7 37.1 125842480 
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71 PREDICTED: similar to zinc finger 
protein 721 
72333 9.3 44.6 189517662 
 
72 PREDICTED: similar to von 
Willebrand factor precursor (vWF) 
60614 5.1 35.4 189542644 
 
76 PREDICTED: similar to zinc finger 
protein 568 
44108 9.5 23 189518306 
 
80 PREDICTED: similar to zinc finger 
protein 40 
53243 9.1 32.2 189534638 
 
82 PREDICTED: similar to zinc finger 
protein 160 
72858 9.3 25.7 189528537 
 
84 
novel protein similar to vertebrate 
dual-specificity tyrosine-(Y)-
phosphorylation regulated kinase 2 
(DYRK2) 
64141 9.5 29.3 55962523 
 85 LOC553337 protein 68993 6.8 35.7 61403613 
 
86 PREDICTED: similar to zinc finger 
protein 160 
65587 8.5 29.2 189534592 
 
87 PREDICTED: similar to zinc finger 
protein 160 
72858 9.3 53.3 189528537 
 
88 PREDICTED: similar to zinc finger 
protein 721 
72333 9.3 24.3 189517662 
 
89 PREDICTED: similar to zinc finger 
protein 721 
72333 9.3 28.3 189517662 
 
92 PREDICTED: similar to zinc finger 
protein 721 
72333 9.3 33.3 189517662 
 
94 PREDICTED: similar to zinc finger 
protein 208 
79103 9.1 30.5 189528501 
 
95 PREDICTED: similar to 
mCG142610 
91424 9.3 32.5 189528482 
 
96 PREDICTED: similar to zinc finger 
protein 160 
72858 9.3 19.2 189528537 
 
98 PREDICTED: similar to zinc finger 
protein 721 
72333 9.3 29.9 189517662 
 
99 PREDICTED: ras homolog gene 
family, member T1 isoform 2 
75344 6.4 23.2 189520622 M 
 
100 PREDICTED: similar to 
mCG142610 
122393 9.1 36.4 189534703 
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 101 PREDICTED: similar to dynamin 2 86596 6.4 25.8 189519626 
 
102 PREDICTED: similar to pol 
polyprotein 
128147 8.7 29 189515367 
 
103 PREDICTED: similar to zinc finger 
142 
169377 8.7 25.1 189523652 
 106 similar to zinc finger protein 721 70257 9.3 25.9 189517658 
 
107 PREDICTED: similar to 
mCG142610 
71778 9.5 23.4 189518369 
 
108 
PREDICTED: similar to protein 
tyrosine phosphatase, receptor type, 
T 
96885 7.1 22.7 189520775 
 
109 PREDICTED: similar to 
mCG142610 
134532 9.3 46.6 189534972 
 
110 PREDICTED: similar to Ca2+-
dependent secretion activator 
1038986 5.8 15.3 189525131 
 
111 PREDICTED: PTK2B protein 
tyrosine kinase 2 beta 
115235 9.6 14.5 189526015 
 
112 PREDICTED: PTK2B protein 
tyrosine kinase 2 beta 
115235 9.6 21.2 189526015 
Table 2. Proteins identified in 8 adult zebrafish hearts, using MS, with relative MW (Da), PI, 
score and accession number, classified according to their biological functions. In yellow, the 
proteins identified with score <20. 
 
The number of the total proteins present in each biological function is reported in 
Graphic 1. Numerous proteins identified resulted to have a metabolic function. Few proteins 
had a structural and signaling function. Two proteins were identified as transcription factors 
and one as receptor. Since sometimes the same protein was found in different spots because of 
post-transcriptional modifications (e.g. phosphorilation, oxidation, and acetylation), that may 
change the separation characteristics of the proteins, it was also counted the exact number of 
different proteins identified in each biological function and these values are reported in 
Graphic 2. It was possible to identify 55 different proteins, 20 of which resulted to have a 
metabolic function. The total and exact numbers of proteins identified in each biological 
function class is reported in Graphic 3. Numerous proteins with metabolic, structural, and 
motility function resulted subjected to post-transcriptional modifications. 
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Graphic 1. Number of total proteins identified, present in each biological function 
(Total=115). 
 
 
Graphic 2. Exact number of different proteins identified in each biological function 
(Total=55). 
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Graphic 3. Total and exact numbers of proteins identified in each biological function class. 
The amount of total proteins identified is 115 and the amount of exact proteins is 55. 
 
DISCUSSION 
Using zebrafish to study genes and proteins is supported by the sequencing of his 1.7-
Gb genome (Sanger Institute’s Danio rerio sequencing project), which has facilitated the 
generation of microarrays for large scale expression profiling (Ton et al., 2002; Lo et al., 
2003; Mathavan et al., 2005; Quian et al., 2005). Moeover, this fish can be used as vertebrate 
model for pathogenesis study (Neely et al., 2002; Prouty et al., 2003) such as hematopoietic 
and cardiovascular diseases (North and Zon, 2003) or for discovering new therapeutic target 
(Peterson, 2004). Thus, aiming to contribute to the knowledge of the proteomic expression of 
the heart, it was reported for the first time a proteomic subset of the adult zebrafish heart 
using a 2DE. Proteome-based technologies are powerful tools for the analysis of protein 
expression in cells and organs. Such technology can be applied to the identification of 
potential diseases biomarkers. Among the proteome technologies, two-dimensional 
electrophoresis followed by mass spectrometric analysis is the most established method, 
resulting in the identification of thousands of expressed proteins.  
Here, we reported for the first time a proteomic subset of the adult zebrafish heart 
using a 2DE. This study revealed more than one hundred proteins of different function, 
metabolic enzymes (glyceraldehydes-3-phosphate dehydrogenase, mitochondrial malate 
dehydrogenase, ATP synthase), proteins of signal transduction pathways (transcription factor 
Metabolic  Structural  Motor  Signaling  Receptor  TF  Globin  Novel 0 
5 10 
15 20 
25 30 
35 40 
45 
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Lmx1b, Mcm10 protein), growth factors (vascular endothelial growth factor, insulin-like 
growth factor), cytoskeletal components, globin family proteins (myoglobin, ba1 globin), and 
structural proteins (four and a half LIM domains, actin, desmin). The highest numbers of 
proteins resulted to have a metabolic function or resulted novel/predicted. In both classes the 
exact number of proteins resulted almost the half respect to the total proteins identified, 
suggesting a high level of post-transcriptional modifications, as was described in other classes 
of vertebrates (Gooley and Packer, 1997; Mann and Jensen, 2003; Kane and Van Eyk, 2009). 
It was also characterized proteins that are included in the globin family. This finding could be 
correlated with the naturally presence of blood in the hearts, as already found in proteomic 
study of mouse heart by Chakravarti et al., (2008). Interestingly, the identification of proteins 
with functions of signaling, receptor and transcription factors, because if altered, could be 
correlated with pathology (Simkhovich et al., 2003). It must be take note that, not all the spots 
processed in this research, gave score >20 due to the low concentration or overlapping of 
multiple proteins in the same spot. Here it was described some features of the most important 
proteins identified and, for simplicity, they are separated according to their reported function. 
 
• Proteins involved in signal transduction pathway 
One calcium-binding protein, calbindin 2, like (Spot # 27) was identified in this study. 
This protein is a cytosolic intracellular Ca2+ regulator that restricts the Ca2+-mediated signals 
in the cytoplasm (Heizmann and Braun, 1995). In particular, there are several possible 
functions for the role of calbindin, in the cerebellum such as the protection of intracellular 
organelles or the regulator of intracellular signaling (Hong et al., 2009). The functional role of 
calbindin is the partial stabilization of intracellular calcium levels, which can confer 
protection against different proapoptotic stimuli. 
Another protein identified in the heart was the retinol-binding protein (Rbp b2) (Spot# 
1). In human and rodent genomes there are single copies of genes encoding the cellular 
retinol-binding protein type I and II (CRBPI and CRBPII) (De Baere et al., 1998). In the adult 
zebrafish have been identified duplicate genes for both CRBPI and CRBPII (Liu et al., 2004), 
with crucial roles in organogenesis, vision, reproduction, growth and immunity (Costaridis et 
al., 1996; Cameron et al., 2002). Rbp belong to the large family of low-molecular-mass (~15 
kDa) intracellular lipid-binding proteins (iLBP) that bind fatty acids, retinoids, and steroid 
(reviewed by Ong et al., 1994 and by Bernlohr et al., 1997).  
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• Proteins involved in cell and energy metabolism 
In the present research were identified glycraldehyde-3-phosphate dehydrogenase 
(Spots # 37, 38, 42, 44), and isocitrate dehydrogenase (Spots # 56, 57, 62, 63, 64, 65). A 
recent proteomic work concerning ventricular remodeling in rats affected by heart failure, 
shows that energy metabolism proteins as glycraldehyde-3-phosphate dehydrogenase, alphaB-
crystallin, peroxiredoxin 2, and isocitrate dehydrogenase are linked to echographic parameters 
according to heart failure severity (Cieniewski-Bernard et al., 2008). Interesting, 
glycraldehyde-3-phosphate dehydrogenase was also detected in the rat heart (Shi et al., 2008), 
and, comparing with this study, the spots in the 2DE resulted in the same position. Other 
matches in the positions of the spots in the gels were founded for triosephosphate isomerase, 
another protein involved in the energy metabolism, and for actin and myosin, proteins with 
structural and motor function, respectively (See below).  
ATP synthase, here identified in Spots # 67, 68, and 78, represent a critical enzyme in 
the energetic pathways of cells because it is the enzyme complex that produces the majority of 
cellular ATP (reviewed by Velours et al., 2009). It has been shown to be involved in several 
cardiac phenotypes including heart failure and preconditioning, a cellular protective 
mechanism. Also, in mammals hearts, ATP synthase is subjected to several post-translational 
modification, as reviewed by Kane and Van Eyk, (2009). 
Another protein involved in energetic metabolism identified in this study was the 
mitochondrial aconitase, 2 (Spots # 104, 105). Enzymatic isoforms of aconitase, which are 
integral to the TCA cycle, and the mitochondrial respiratory complexes (Complexes I, II, and 
III), seems to be involved in electron transport, incorporate iron-sulfur clusters and are 
responsible for mitochondrial respiration and energy production (Rouault and Tong, 2008).  
Fructose 1,6-bisphosphatase (FBPase) [EC 3.1.3.11] was also identified in the heart 
proteome (Spots # 41, 43, 50). This enzyme catalyzes the hydrolysis of fructose 1,6-
bisphosphate to fructose 6-phosphate and inorganic phosphate (Benkovic and deMaine, 
1982). Tejwani, (1983) investigated the colocalisation of aldolase and FBPase in 
cardiomyocytes. The results indicate in-vivo interaction of these two enzymes. Also, in the 
cardiomyocytes cytoplasm, these enzymes were found to co-localize at the Z-line and on 
intercalated discs. 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) [EC 1.2.1.12], here identified 
in Spots # 37, 38, 42, and 44, is an enzyme that catalyze the sixth step of glycolysis, but it is 
also implicated in non-metabolic processes, as transcription activation (Sirover, 1997). 
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Changes in the expression of a variety of proteins involved in energy metabolism have been 
detected in heart failure by performing proteome analysis (Arrell et al., 2001). 
In this study, Spot # 101 was identified as similar to dynamin 2. Dynamin (Dyn) is a 
96kDa enzyme and a member of a novel group of GTPases which was initially identified as a 
microtubule-binding protein with a role in vectorial movement. Dyn proteins exhibit a high 
degree of evolutionary conservation (Diatloff-Zito et al., 1995). A unique 3.6-kb transcript is 
found in all human tissues examined and it is more abundant in skeletal muscle and heart 
(Diatloff-Zito et al., 1995).  
 
• Proteins with structural function 
Cardiac and skeletal muscles have a similar sophisticated organization of contractile 
proteins into sarcomeres and are collectively referred to as striated muscles. Defects in a large 
set of sarcomeric proteins such as cardiac b myosin heavy chain, atropomyosin, and cardiac a-
actin have been demonstrated to induce cardiac hypertrophy (Berry et al., 2007). Here have 
been identified several isoform of actin (Spots # 59, 60, 61, 73, 75, 77), and of myosin (Spots 
# 13, 113, 114, 115). Cardiac myocytes are normally surrounded by a fine network of collagen 
fibers. Sarcomeres are the functional unit of contraction in cardiac muscles, which consist of 
thick and thin filament proteins. Several proteins that are post-translationally modified in the 
cardiac sarcomere have now been identified in mammals, including cardiac myosin binding 
protein-C (cMyBP-C), cardiac troponin I (cTnI), cardiac troponin T (cTnT), α-tropomyosin 
(α-TM) and the myosin light chain (MLC) (Jacques et al., 2008; Scruggs et al., 2009). 
Moreover, dephosphorylation of cMyBP-C, which accelerates its degradation, has been shown 
to associate with the development of heart failure in mouse models and in humans and its 
phosphorylation play in regulating cardiac function and heart failure (Hamdani et al., 2008). 
Elucidating the function of cMyBP-C is clinically important because mutations in this protein 
have been linked to cardiomyopathy in more than sixty million people worldwide (Lloyd-
Jones et al., 2009). Smooth muscle a-actin (42 kDa), b-actin (41 kDa), c-actin (41 kDa), 
myosin heavy chain (223 kDa) and the actin-binding protein filamin A (281 kDa) were 
identified as the major serotonylated proteins serotonylated because they are among the most 
abundant in a smooth muscle-rich tissue (Watts et al., 2009). 
Another structural protein identified in this study resulted Desm protein (Spot # 83), a 
52kD protein that is a subunit of intermediate filaments in skeletal muscle tissue, smooth 
muscle tissue, and cardiac muscle (Bär et al., 2004). Desmin provides structural and 
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functional integrity by coordinating mechanical stress transmission, organelle positioning, 
organization and assembly of sarcomeres, signal transduction, and apoptosis. Mutations in the 
gene encoding desmin (DES) are associated with a variable clinical phenotype referred to as 
desminrelated myopathy (OMIM #601419), a clinically heterogenous group of disorders 
encompassing myopathies, cardiomyopathies, conduction disease, and combinations of these 
disorders (Li and Dalakas, 2001; van Tintelen et al., 2009).  
 
• Proteins for lipid transport 
In this study it was identified apolipoprotein A-1 (Spot # 14). Apolipoproteins are 
proteins that bind to fats and can have different functions as enzyme cofactors, lipid transport, 
and ligands (Mahley et al., 1988). The major apolipoproteins include aopE, apoB, apoA-I, 
apoA-II, apoA-IV, apoC-I, apoC-II, and apoC-III (Tall and Small, 1978). Apolipoprotein E 
(apoE) has a prominent role in the transport and metabolism of plasma cholesterol and 
triglycerides resulting from its ability to interact with lipoprotein receptors (Mahley, 1988; 
Weisgraber, 1994). Besides its role in cardiovascular diseases, accumulating evidence has 
suggested that apoE polymorphism is an important determinant of risk for the development of 
neurodegenerative diseases, such as Alzheimer’s disease. It has been demonstrated that apoE 
gene can be found in a non-mammalian vertebrates and is highly expressed during zebrafish 
embryonic development (Babin et al., 1997). Whole-mount in situ hybridization was 
performed to analyze the pattern of apoE expression during development of the zebrafish 
paired and unpaired fins (Monnot et al., 1999). 
 
• Proteins of the globin family 
Several proteins of globin family were identified in this study, as myoglobin (Spots # 
3, 4), Ba globin (Spots # 5, 6, 7), cytoglobin 2 (Spot # 11), and microglobulin (Spot # 15). 
Globins are a family of heme-containing proteins that reversibly bind oxygen and they have 
been described in bacteria, fungi, protists, plants, and animals (reviewed by Hardison, 1996). 
Four mammalian globins have been identified so far (hemoglobin [Hb], myoglobin, 
neuroglobin [Ngb], and cytoglobin [Cygb]) (Burmester et al., 2002). The crystal structures of 
these globins have been characterized, and all are heme-containing respiratory proteins 
(Pertutz, 1962 for Hb; Kendrew, 1963 for Mb; Pesce et al., 2003 for Ngb; de Sanctis et al., 
2004, for Cygb). Hb is localized in erythrocytes and has a major role to facilitate the transport 
of oxygen in the blood. Myoglobin is localized in the cytoplasm of skeletal and cardiac 
113 
 
muscle, acts in intracellular oxygen storage, and enhances oxygen diffusion to the 
mitochondria for use in oxidative phosphorylation. In addition, Hb and myoglobin can act as 
scavengers of bioactive nitric oxide. Ngb and Cygb are two recently described members of the 
globin family; Ngb has a yet unidentified function in nerve cells. Cygb has been identified as 
a 20.9-kDa protein in virtually all human, mouse, and zebrafish tissues. It is expressed in 
apparently all types of human tissue and therefore has been called cytoglobin (CYGB). Cygb 
(but not Ngb) was also present in canine kidney, liver, lung, and heart tissue. Mouse and 
human CYGBs comprise 190 amino acids; the zebrafish CYGB, 174 amino acids. Among 
them, Cygb is the most recently discovered O2-binding globin in rat hepatic stellate cells as 
stellate cell activation associated protein. Recently, a fifth globin protein, globin X, was 
reported in fishes (Roesner et al., 2005). Phylogenetic analysis suggests that an ancient globin 
differentiated into a cellular globin that gave rise to Mb and Cygb, which share a common 
ancestor before the split of jawless and jawed vertebrates about 450 million years ago (Xi et 
al., 2007). 
In conclusion, this proteomic study allowed the identification of more than one 
hundred proteins naturally expressed in adult zebrafish heart, having different biological 
functions. This study can give a basic contribute in understanding the biological knowledge of 
the vertebrate heart and can constitute a reference point to compare proteins expression in 
various cardiac diseases. 
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ABSTRACT 
Many complex cellular, developmental, homeostatic and regenerative processes 
depend on precise spatiotemporal regulation of protein levels, some of which function as 
“rheostats” to execute programs in a quantitative fashion. The heart of vertebrate is one of the 
most conserved organs at the molecular level and is the organ most affected by disease in 
childhood and adult populations. Using the model organism zebrafish (Danio rerio), here it 
was tested the hypothesis that proteins are differently expressed during the heart regeneration. 
Numerous studies have considered the gene expression during the heart regeneration process, 
but so far, there is no study regarding the proteomic aspect. Applying two-dimensional 
differencial gel electrophoresis (DiGE) combined with MALDI-TOF/TOF tandem mass 
spectrometry, here were identified proteins differentially expressed at 3 days after amputation 
of around 20% of the ventricle apex, compared with hearts not injured. Among more than 100 
proteins spots detected in 2D-gels, 3 were up-regulated in injured hearts at 3 days post 
amputation (dpa). MS analysis allowed the identification of proteins differentially expressed 
as compared with control, such as: ATP synthase, hyaluronan mediated motility receptor, and 
desmuslin. Information concerning the global alteration protein pattern during heart 
regeneration will be helpful for a better understanding of the therapeutic strategies. 
 
INTRODUCTION 
A prerogative of modern biomedicine is to repair damaged organs, stimulating their 
natural regenerative ability (Scott and Stainier, 2002). Regeneration consists in a complex 
biological process by which animals can restore the shape, structure and function of body 
parts lost after injury, or experimental amputation. Unfortunately, not all of our organs are 
equally competent to regenerate, and it is known that heart and central nervous system are 
particularly resistant to regeneration after injury and that they form scar tissue (Poss et al., 
2002). The amazing capacity of Teleost to regenerate fins, brain, retina or lens, has made 
these animals the preferred subject for research on vertebrate regeneration (Lien et al., 2006; 
Raya et al., 2003). In particular zebrafish (Danio rerio) represents an experimental tractable 
vertebrate model for the study of diseases and heart regeneration (Lepilina et al., 2006; rev. 
Lieschke and Currie, 2007). With the full sequence of the zebrafish genome and mutagenesis 
screens, a lot of genes have thus been examined, and several proteins were identified (Talbot 
and Hopkins, 2000; Amsterdam, 2006) However, only a limited number of studies were done 
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regarding the zebrafish proteome during development, and so far, studies are focused neither 
on regeneration nor in the heart. Previous researches have shown that adult zebrafish can 
effectively regenerate injured hearts in-vivo (Poss et al., 2002; Lepilina et al., 2006). Although 
some indications had pointed on the involvement of several genes, molecular mechanisms and 
expressed proteins that potentially can regulate the regeneration process remains unclear. 
Resolving the proteomic alterations that control these changes can provide important insights, 
undetectable by gene expression analysis alone. Aiming to know the protomic profile of adult 
zebrafish heart regeneration, in the present research Differential Gel Electroforesis (DiGE) 
experiments, combined with MALDI-TOF/TOF tandem mass spectrometry were applied. 
DiGE is a specialized two-dimensional electrophoresis technique that allows to visualize 
those proteins that differ between two samples. More in particular, here were analized 
proteins differentially expressed in the zebrafish heart at 3 days after amputation of around 
20% of the ventricle apex, compared with hearts not injured.  
 
MATHERIALS AND METHODS 
Resection of 20% of ventricular apex of zebrafish heart  
The animal experiments were performed according to protocol approved by the 
Institutional Animal Care and Use Committee (IACUC) at the University of Pittsburgh. The 
surgery was done following the protocol developed by Poss et al. (2002). Brefly, adult 
zebrafish (6-18 months old) were anesthetized for 3 minutes in 0.168 mg/l Tricaine 
(MS222,Sigma) and placed dorsally in a humid sterile sponge, with ventral side up. A small 
incision (scalpel 0.15mm, Fine Science Tools Inc. US.) was made just under the gills, in 
correspondence to where the heart is located. The pericardial sac was isolated and punctured 
to expose the ventricle by gentle abdominal pressure. Approximately 20% of the ventricle 
apex was removed by iridectomy scissors (Fine Science Tools Inc. US). Body wall incision 
was not sutured and in few days the injured part was recovered. With this protocol, 90% of 
fish was survived. After surgery, fish were returned to water and stimulated to breathe with air 
bubbles from an air pump. After 3 days, fish were lethally anesthetized with Tricaine and the 
whole hearts were removed and washed three times in Hank’s solution to remove blood from 
the organs tissues. 
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Proteomics of the Zebrafish heart 
i) Samples preparation 
Difference gel electrophoresis (DiGE) system was used to detect the protein 
expression of 3 adult zebrafish hearts control and 3 hearts at 3 dpa in-vivo, followed by 
MALDI-TOF/MS protein identification. Protein identification was carried out using matrix 
assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry and the 
Mascot and ProFound search engines. Zebrafish hearts of control and operated were removed 
and homogenized (Teflon pestle) in 20 µl of labeling buffer (30 mM Tris, 7 M urea, 2 M 
thiourea, 4% (w/v) CHAPS (3-[(3-cholamidopropyl) dimethylammonio]-2-hydroxy-1-
propanesulfonate), pH 8.5 adjusted with 1N HCl, clarified by ultracentrifugation (100,000 x 
g, 23oC, 1.0 hr) and stored at −80 °C.  
 
ii) CyDye labeling 
Minimal protein labeling with CyDye DiGE fluor, Cy2 was carried out according to 
manufacturer's instructions (GE Healthcare/Amersham Biosciences). Briefly, the sample was 
thawed on ice and centrifuged at 16,000 g for 10 min at 4 °C. After 30 min of incubation on 
ice in the dark, the reaction was terminated with 10 mM ethanolamine.  
 
 iii) 2-D Electrophoresis 
Sample was subjected to isoelectric focusing (IEF) using an Ettan IPGphor (GE 
Healthcare/Amersham Biosciences) and 24 cm linear, pH 3–10 Immobiline DryStrips (GE 
Healthcare/ Amersham Biosciences). The IPGphor system was programmed to perform IEF 
with the following settings: (i) 12 hour rehydration, (ii) 500 V, 1.0 h, “Step-n-hold”; (iii) 1000 
V, 1.0 h, “Step-n-hold”; (iv) 1500 V, 1 h, “Step-n-hold”; (v) 4000 V, 1 h, “Step-n-hold”; and 
(vi) 8000 V, 60,000 Vh, “Step-nhold”. The IPG strip was subjected to two 15-min 
equilibration steps with 1% DTT in SDS buffer (3 M urea, 50 mM Tris-HCl pH 8.8, 30% 
glycerol, 2% SDS and trace bromophenol blue). The 2DE was carried out on a 8-16% SDS-
polyacrylamide gradient gel with a constant current of 30 mA until the tracking dye was 1 cm 
above the bottom of the gel.  
 
 iv) Image acquisition  
Fluorescent images of each CyDye were acquired using a Typhoon 9400 variable 
mode imager (GE Healthcare/Amersham Biosciences). After the acquisition of the fluorescent 
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image, proteins separated by 2D-gel analysis were stained using the Silver Stain Plus Kit 
(Bio-Rad) according to the manufacturer’s instructions. Gel was also stained with Comassie 
Blue (Bioorad). Gel images were created by acquiring digitized images (400-600 dpi) using a 
Canon LiDE 30 flatbed scanner. Once scanned, gels were stored in 1.0% acetic acid (Fisher) 
at 4oC until spots of interest were excised for mass spectrometry. 
 
v) In-gel trypsin digestion of proteins 
Protein spots of interest were manually picked (1.0 mm to 3.0 mm in diameter) and 
rinsed in distilled water. Silver ions were removed by adding fresh destaining solution (15 
mM potassium ferricyanide and 50 mM thiosufate in distilled water) (Invitrogen, Carlsbad, 
CA) to each spot and incubating for 20 min. Samples were then rinsed with distilled water, 
destained for blue commassie bue with 40% methanol 10% acetic acid, and equilibrated with 
200 mM ammonium bicarbonate (Fisher). Samples were rinsed in 50% acetonitrile (Fisher) in 
20 mM ammonium bicarbonate and dehydrated in 100% acetonitrile. Samples were digested 
in situ with 200-300 ng trypsin (Sigma) (14 hours, 37oC) and peptides were extracted 50% 
acetonitrile, 2.5% TFA (Fisher) in distilled water and dried using a CentriVap Speed Vacuum. 
Extracted, dried peptides were mixed with α-cyano-4-hydroxycinnamic acid (CHCA) (ABI) 
and 0.5 µl was spotted onto the target for MALDI-TOF analysis. MALDI-TOF was 
performed using the 4800 Proteomics Analyzer (ABI, Foster City, CA). Mass spectra were 
individually calibrated using internal trypsin peaks (842.51 and 1045.56, m/z) with Data 
Explorer software available from ABI. Proteins were identified using ProteinProspector 
(University of California, San Francisco; http://prospector.ucsf.edu/) set to a mass accuracy of 
+/- 50 ppm to compare unknown mass fingerprints to those of known proteins in the NCBI 
non-redundant database using a species-specific filter for Danio rerio. 
 
RESULTS 
Using a newly developed analytical procedure, here, for the first time, it is reported the 
DiGE of the zebrafish hearts at 3 dpa in-vivo compared to control uninjured hearts (Figure 1). 
The red spots show the up-expression of proteins after the surgery and the green spots 
indicate those that are down-expressed respect to the hearts of control.  
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Figure 1. DiGE of proteins differently expressed in zebrafish hearts of control (green), and at 
3 dpa (red). In yellow there are the proteins that are equally expressed in the two samples. 
Circles indicate the spots picked and processed for MS analisyis. 
With the aim of avoid preferential binding of proteins with the CyDyes, thus control 
the specificy of the reaction, the same DiGE separation was performed, inverting the sample 
labeling. Figure 2 shows the DiGE of the zebrafish hearts at 3 dpa in-vivo compared to the 
hearts control, not subjected to surgery, with label switched respect to Figure 1. In Figure 2, 
the proteins up-expressed after the surgery are labeled with green, and those down-expressed 
respect to the hearts of control are red.  
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Figure 2. DiGE of proteins differently expressed in zebrafish hearts of control (red), and at 3 
dpa (green). In yellow there are the proteins that are equally expressed in the two samples. 
Circles indicate the spots picked and processed for MS analisys. 
Differential expressed proteins spots were picked and processed for MS analysis and 
then analyzed for the peptide identification. The characteristics of picked proteins (name, 
molecular weight, isoelecting point, percentage of coverage and accession number) are 
reported in Table 1. In this study were identified one isoform of the myosin protein, (light 
polypeptide 7, Spot A), corresponding to 19021 Da, and an hypotetical protein of 32220 Da 
(Spot B). Both proteins resulted not significative changing between the two samples 
considered. The three up-regulated proteins at 3 dpa resulted to be: 1) ATP synthase 
(ATPsyn), corresponding to 59744 Da (Spot C); 2) hyaluronan mediated motility receptor 
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(RHAMM), of 104710 Da (Spot D, E), and desmuslin (DMN), with a MW of 122138 Da 
(Spot F).  
Table 1. List and characteristics of the proteins identified in differential gel electrophoresis, 
compairing zebrafish hearts of control and at 3 dpa in-vivo. Spots A and B represented not 
significative changing between the two samples. Spots C, D, E, and F resulted up-regulated at 
3 dpa with respect to the control.  
 
DISCUSSION 
Among the proteome technologies, differential two-dimensional electrophoresis 
(DiGE) followed by mass spectrometric analysis is an innovative, sensitive, and reliable way 
to detect proteins whose expression is altered between control and treated samples (Gozal et 
al., 2009). The present work has identified a number of differentially expressed proteins in the 
adult zebrafish heart subjected to amputation of around 20% of the ventricle area. Three 
proteins showed altered expression between the groups: 1) ATP synthase (ATPase); 2) 
hyaluronan mediated motility receptor (RHAMM), and desmuslin (DMN). All were up-
regulated in the amputated heart at 3 dpa. Here, for the first time, have been isolated more 
than 100 proteins naturally expressed in the heart of the adult zebrafish and some of them are 
differentially expressed (up-regulated) during the regeneration process in-vivo at 3 dpa. 
Switch the labeling of the samples, among identified proteins, myosin, (light polypeptide 7, 
Spot A) and a hypotetical protein (of 32220 Da, Spot B), remained labeled with green. This 
data demonstrates that those specific proteins are more susceptible to bind the Cy3 dye 
(green) respect to the Cy5 (red). For this reason is not possible to consider these changing 
Spot # Protein name 
MW 
(Da) 
pI 
% 
Cov 
Accession # 
A myosin, light polypeptide 7, regulatory 19021 4.7 41.3 29725603 M 
B PREDICTED: hypotetical protein 32220 5 27.8 189526031 
C 
ATP synthase, H+ transporting, mitochondrial F1 
complex, alpha subunit 1, cardiac muscle 
59744 9.1 27.8 116325975 M 
D hyaluronan mediated motility receptor 104710 5.5 20.4 41053824 M 
E hyaluronan mediated motility receptor 104710 5.5 23.1 41053824 M 
F desmuslin 122138 4.9 21.2 113678191 M 
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significative. However, the MS identification was performer for all the 6 spots, even if only 
the spots C, D, E, and F, represented significative changes in proteins levels between the two 
samples. Those spost were identified as ATP synthase (ATPsyn, Spot C), hyaluronan 
mediated motility receptor (RHAMM, Spot D, E), and desmuslin (DMN, Spot F).  
ATP synthase is a general term for an enzyme that can synthesize adenosine 
triphosphate (ATP) from adenosine diphosphate (ADP) and inorganic phoshate by using some 
form of energy (Rev. Velours et al., 2009). Thus, it is a critical enzyme in the energetic 
pathways of cells because it is the enzyme complex that produces the majority of cellular 
ATP. ATPsyn has been shown to be involved in several cardiac phenotypes including heart 
failure and preconditioning, a cellular protective mechanism (Kane and Van Eyk, 2009). 
ATPsyn was previously purified from Bacillus sp. (Cook et al., 2003), Streptomyces lividans 
(Hensel et al., 1991) and from beef heart mitocondria (Deisinger et al, 1993), demonstrating 
to be an evolutionary conserved enzyme and heart-expressed in vertebrates. Several reports 
had pointed on the modulation of the mitochondrial ATPsyn complex in various cardiac 
phenomena (rev. Das, 2003; Grover, 2008), including disease (Marin-Garcia and Goldenthal, 
2008, Murray et al,. 2007). Specifically, it has been observed that there is an increase in ATP 
hydrolysis by the ATP synthase complex in ischemic myocardium (Grover et al., 2004), 
which is hypothesized to contribute to the overall depletion of the cellular ATP pool during 
ischemia. Also, using a proteomic approach, it was demonstrated that in the rabbit heart, 
elevated preload is associated with up-regulation of proteins involved in fatty acid oxidation, 
glucose metabolism, and mitochondrial ATPsyn (Schott et al., 2008). In this research, the up-
regulation of ATPsyn could be explainded by the energy demand that the regenerating system 
needs after the activation. Further studies need to be addressed to know whether ATPsyn 
localizes near the clot, formed after ventricle amputation. It has been suggested that altered 
expression of proteins from metabolic pathways reflects mitochondrial dysfunction as a 
feature of the transition from compensated myocardial hypertrophy to the heart failure 
(Razeghi et al., 2001).  
Here, the hyaluronan mediated motility receptor showed to have different expression 
level during the zebrafish heart regeneration. It has been shown that targeted deletion of the 
hyaluronan synthase-2 (Has2) gene in mice results in an absence of cardiac jelly and 
endocardial cushions, a loss of vascular integrity, and embryonic death at E9.5 (Klewer et al., 
2006). Despite the requirements for Has2 and its synthetic product hyaluronan (HA) in the 
developing cardiovascular system, little is known about the normal expression pattern of Has2 
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or the factors regulating Has2 gene transcription during development. In the same study, 
Klewer et al., (2006) defined the embryonic expression pattern of Has2 in mice and explored 
the regulation of Has2 gene expression by Bmp signaling. In situ hybridization studies 
demonstrated dynamic Has2 expression patterns during myocardial cell development and 
cardiac tube formation, formation of the cardiac endocardial cushions, and cushion invasion 
by valve primordial cells. In zebrafish Has2 is involved in the earliest left-right asymmetric 
movements during cardiac morphogenesis (Smith et al., 2008). In fact, using high-resolution 
2D imaging of cardiac progenitor cells (CPCs), Authors demonstrated that leftward 
displacement and rotation of the tube requires Has2 expression. Here, the up-regulation of 
Has2 could be correlated with the inflammatory changes that occur after the surgery and also 
with the reactivation of developmental cardiac gene. 
Desmuslin is an intermediate filament (IF) and, like other IFs, primarily functions to 
integrate mechanical stress and maintain structural integrity in eukaryotic cells (Mizuno et al., 
2001). While it has been observed in a variety of cell types, it is has been best studied in the 
sarcomere of skeletal myocytes. It was localized at the Z-disk and has been shown to bind to 
α-dystrobrevin, α-actinin, and desmin to act as a mechanical linker in transmitting force 
laterally throughout the tissue, especially between the contractile myofibrils and extracellular 
matrix (Mizuno et al., 2001). Mutations in the desmin gene can cause desmin myopathies 
characterized by muscle weakness, cardiac impairment, and intracytoplasmic accumulation of 
desmin deposits (Dalakas et al., 2000). The up-regulation of the desmuslin founded here in 
the heart at 3 dpa could be correlated with the activation and replacement of contractile 
apparatus. Desmuslin, in fact, could have a determinant role in maintaining the cell integrity 
and restore the ventricle cells damaged near the cut site. 
Taken together, this study had demonstrated that the surgery causes not only a gene 
activation but also a different proteins synthesis. The three proteins resulted up-regulated in 
the hearts at 3 dpa are involved in the energy methabolism, in the signaling and in 
maintaining the structure integrity of the cells, so it is reasonable to think that they are 
involved in the cardiac regeneration process too. Unfortunately, not all the spots that we 
picked and processed for MS identification, gave a hight percentage of coverage because 
some of them were low concentrated or because in the same spot it is possible that there are 
present more than one protein. However, for all the spots we obtained scores > 20 and this 
allows a still good protein identification. 2DE coupled with MS is currently the key approach 
for profiling thousands of proteins of a given proteome simultaneously and offer the 
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possibility to analyze complex biological processes directly on the level of quantitative 
protein expression. However, this method is labour-intensive and not readily interfaced with 
protein identification by MS. In addition, hydrophobic, extremely basic proteins and those 
with a very high or low MW are often difficult to analyze using this approach. In the opposite, 
the DiGE technique results more sensible than the 2DE and offers the possibility to compare 
the proteins levels expression between two samples. Here, it has been demonstrate the utility 
of the DiGE technique as a tool for analyzing the in-vivo heart regeneration process in the 
model organism zebrafish. Indeed, proteome studies have identified important protein sets 
that are involved in the molecular mechanisms of the zebrafish heart regeneration. This might 
consequently lead to the definition of biomarkers correlated with human heart and can give 
the possibility to find novel therapeutic targets for the heart failure. 
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CHAPTER VI: CONCLUSIONS AND DISCUSSIONS 
 
Injury, disease, and aging all result in a loss of tissue and reduced quality of life. 
Numerous human conditions could be significantly improved if therapies that encourage 
tissue regeneration were available. Most adult tissues and organs, especially in humans and 
other mammals, have lost their regenerative potential. As a result, injury to a tissue or organ 
usually results in permanent damage from scarring to disability. For example, myocardial 
infarction (MI) results in large-scale loss of cardiac muscle (often a billion or more 
myocytes) (Laflamme and Murry, 2005). Repair is one of the major mechanisms needed for 
survival and proper functioning; however, defective repair with scar formation is an 
inevitable consequence of tissue damage, compromising the functions of the organ to a 
certain degree (Harding et al., 2007; Li et al., 2007b). The field of regenerative medicine is 
aimed at developing strategies to restore individual cell types, complex tissues, or structures 
that are lost or damaged. Currently, one of the main approaches in the field of regenerative 
medicine is to guide the process of differentiation of stem cells into specific cell types and 
then into complex structures (Li et al., 1996; Solloway and Harvey, 2003). The concept of 
stem cell-based therapies originated with the idea of replenishing damaged tissues with adult 
stem cells to increase tissues potential for repair (Scorsin et al., 1996; Oh et al., 2003; Cai et 
al., 2004; Wu et al., 2006b). Alternatively, another strategy is to determine how certain 
organisms have retained the ability to regenerate their tissues, organs, and appendages 
(Ausoni and Sartore, 2009). Amphibians, mammals and teleosts have different capacities to 
repair lost cardiac tissue, and it is from these differences we can learn best how to minimize 
scarring and maximize regeneration after injury. Zebrafish heart share common structures 
with those of mammals, serving as a simply model for vertebrate animal studies (Wang et al., 
1998; Scott and Stainier, 2002; Sehnert and Stainier, 2002). Regeneration of the zebrafish 
heart appears to differ from that described in other tissues, including the newt limb and 
zebrafish fin, where differentiate cells (muscle, cartilage, and skin) adjacent to the wound 
site, first dedifferentiate to form a blastema or mass of pluripotent cells, which then give rise 
to a fully formed and patterned limb or fin (Scott and Stainier, 2002; Biga and Goetz, 2006). 
The formation of the blastema that regenerates these tissues requires successive process of 
dedifferentiation, transdifferentiation, and pattern formation. The zebrafish myocardium is a 
relatively simple structure, composed of one major cell type, so the initial step of 
dedifferentiation observed during limb regeneration may not be required for cardiac 
126 
 
regeneration (Stainier et al., 1993; Glickman and Yelon, 2002). By following the zebrafish 
regenerative capacity, it is possible to elucidate the transcriptional mechanisms during the 
differentiation, re-differentiation of tissue or simply differentiation of tissue-resident adult 
stem cells. The analysis of regeneration in zebrafish, by using cellular and molecular 
techniques, provides a unique instrument for achieving this goal. 
In this study it has been assessed some important genetic, molecular, and protein 
mechanisms involved in cardiac regeneration in zebrafish. Here, it has been demonstrated 
that microRNAs (miRNAs), genome encoded small RNAs involved in many biological 
processes (Carrington and Ambros, 2003; van Rooij & Olson, 2007), are differently 
expressed during heart regeneration and in hypertrophic conditions. Cardiac hypertrophy, the 
normal response of mammalian hearts to injury or hypoxia, consists of enlargement of 
cardiomyocytes and hyperplasia of other cell types in the heart, such as fibroblasts (Poss et 
al., 2002). Here, for the first time, hypertrophy was induced in zebrafish hearts cultured ex-
vivo, using phenilephrine (PE), and it has been demonstrated that hypertrophy alters the 
cardiac miRNAs levels. Interestingly, the qRT-PCR analysis of the hearts treated for 72h 
with 500 µM of PE revealed a significant decrease of miRNAs, whereas 48h of treatment 
provoked a decrease-trend that resulted not statistically significant. The major decrease was 
observed for miR-133b where the expression was detected about the 75% less as respect to 
controls, whereas the other miRNAs, miR-1 and miR-133a had a decrease as compare with 
controls. In mice and human the down-regulation of miR-133 had a critical role in 
determining cardiomyocytes hypertrophy after in-vitro treatment with PE of neonatal 
cardiomyocytes (Carè et al., 2007).  
It has been demonstrated that zebrafish is a highly useful biological model to 
understand also the cardiac regeneration process (Poss et al., 2002); in fact after a surgical 
amputation of around 20% of the ventricle apex, muscular tissue results completely restored, 
in a process that involves changing in genes, microRNAs and proteins expression. Other 
works showed that zebrafish regenerates complex tissue, including fin, and during these 
processes occur large scale changes in gene expression programs to execute the rapid 
transformation of quiescent, differentiated tissue to proliferating, actively patterned tissue 
(Lien et al., 2006; Schebesta et al., 2006). Here, for the first time, it was investigated the 
miRNAs expression during regeneration. It has been shown that miRNAs are involved in 
basic cell functions and differentiation, including cardiac myocytes (Zhao et al., 2007). Also, 
it is known that miR-133 and miR-1, which are included in the same bicistronic unit, are 
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specifically expressed in skeletal muscle and cardiac myocytes (Chen et al., 2006; Carè et al., 
2007;). Notably, miR-133 and miR-1 play key roles in skeletal myoblast proliferation and 
differentiation, respectively. qRT-PCR experiments revealed a clear down-regulation of miR-
1, miR-133a and miR-133b, reaching the lowest expression at 3 days post amputation (dpa). 
Thus, the data exerted by this research seems to indicate that the activation of genes 
responsible of the regeneration program are linked with the down regulation of the most 
important miRNAs of the vertebrate heart. Similarly in mammals, the role of these miRNAs in 
the myocytes proliferation and differentiation seems to be of negative regulation (Callis and 
Wang, 2008). On the light of the zebrafish data, further studies will be needed to outcoming 
the mechanisms that provoked this miRNAs down-regulation, as for example, if exists a gene 
sequence that encodes for a cis(trans)-transcriptional factor with silencing role of the miRNAs 
transcription. 
Using In Situ Hybridization (ISH) experiments, it was shown that during the in-vivo 
regeneration process many FGFs target genes, as dusp6, erm, pea3, raldh2, and sef, were 
induced starting from 3 hours post amputation (hpa), especially close to the site of resection. 
Between 6 and 12 hpa there is a gene activation of all heart surface suggesting that the surgery 
causes a response of all organ and that FGFs are implied in the regeneration process. At 1 dpa 
all the genes studied, are expressed only at the site of injury, suggesting that the genetic 
response to the injury is very rapid and that all the epicardium of the whole heart is activated 
to react. At 2 dpa is visible only the expression of etv5 and sprouty4 (Spry4), showing that 
they are activated later respect to the other genes and that they remain on for longer time. 
Tsang et al., (2004) identified zebrafish dusp6 from a random in situ screen that showed 
similar expression to fgf3, fgf8, the Ets transcription factors erm and pea3, and the FGF 
inhibitors sef and spry. Sugarman, (2007) showed that although adult mammalian 
cardiomyocytes show very little or no proliferation when cultured, FGF-1 treatment 
concomitant with p38 MPA kinase inhibition can stimulate their proliferation in culture; for 
this reason it is reasonable to think that FGFs are involved in cardiac regeneration process. 
Also, Lepilina et al., (2006) demonstrated that after the surgery, FGF factors are involved in 
the formation of a blastema and in the induction of developmental markers. Comparative gene 
expression analysis revealed significant common gene expression changes in larval fin, adult 
caudal fin, and heart regenerating tissues, suggesting common molecular pathways 
choreographing the regeneration process (Poss et al., 2000; Lien et al., 2006; Schebesta et al., 
2006). The physiological progression of fin regeneration in larvae and adults is similar, as 
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both initiate with the formation of a wound epithelium, blastema formation, and the distal to 
proximal propagation of cell proliferation (Poss et al., 2000; Akimenko et al, 2003).  
Some molecular mechanisms are likely to be shared by embryonic cardiogenesis and 
adult cardiac regeneration (e.g., myocardial differentiation programs) (Raya et al., 2004). 
However, heart regeneration invokes multiple distinct and definitive events, including (1) 
initiation by injury, (2) activation of quiescent tissue, (3) ostensibly local development as 
opposed to organ-and organism wide development, (4) simultaneously healing and growth, (5) 
morphogenesis on large scale to form adult tissue, and (6) possible long-term maintenance or 
de novo creation of progenitor cells.  
In this study zebrafish hearts were cultured ex-vivo with L15, and they were able to 
contract for several months. The mean rate of the adult male zebrafish is 151±30 beats/min 
(Milan et al., 2006). Unlike the human counterpart, in response to ventricular amputation 2 
and 4 dpa ventricular tachycardia or fibrillation was not observed (Sun et al, 2009b) Atrial 
arrhythmia was recordered only after prolonged sedation. Here, in ex-vivo cultures cardiac 
cells were able to duplicate, showing incorporation of BrdU, but the regeneration process was 
not as efficient as in-vivo; in fact the clot was still present at 30 dpa. The failure of 
regeneration can be caused by the fact that an abundance of cells migrates from the heart. In 
some instances, after 5 days around the cultured hearts visible fibroblasts were observed and 
enabled organ attachment to the plate. Even adding singular or combination of growth factors 
to the culture media, the ex-vivo process was not efficient as compared to in-vivo regeneration. 
The regeneration process in ex-vivo is retarded with respect to the natural process that occurs 
in-vivo because (RA) dehydrogenase (raldh2) starts to be expressed at 7 dpa. Expression of 
raldh2 is regulated by Wnt and fibroblast growth factor/ERK signaling. Lepilina et al., (2006) 
proposed that the retinoic acid Raldh2 is involved in RA synthesis, which is required for early 
chamber specification and anterior-posterior cardiac patterning in mouse, chick, and zebrafish, 
is important for myocardial maturation and is targeted by miR-138 (Stainier and Fishman, 
1992). Since FGFs display pleiotropic actions and are appealing candidates for signals it is 
difficult to exactly determine their time of action. A significant diminution of the clot size was 
detected if the heart was removed from the fish at 7 dpa, instead of at 1 dpa, and then cultured 
ex-vivo with BME+L15, suggesting that the fist days after the surgery are critical for the 
regeneration process and that a lot of growth factors are involved. Also, in all cases BrdU+ 
cells were localized not only near the cut site, but also in the total surface of the heart, 
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showing that there is an activation of all the heart and a response the entire organ to replace 
the lost tissue.  
For the first time using a two dimensional gel electrophoresis (2DE), here, were 
identified more than one hundred proteins of the adult zebrafish heart that serve different 
functions. These include energy metabolism, structural, motility, signal transduction pathway, 
cell surface receptors, transcription factors, globin family and novel proteins. The highest 
numbers of proteins identified were metabolic factors followed by novel/predicted proteins. In 
all cases it was noticed a high level of post-transcriptional modifications. More interesting 
was the identification of proteins with functions of signaling, receptor class, and transcription 
factors, because if altered, they are often associated with diseases and pathology.  
Using Differential gel electrophoresis (DiGE) followed by mass spectrometric 
analysis, it was possible identify proteins differentially expressed at 3 dpa. Three proteins 
(ATP synthase, hyaluronan mediated motility receptor, and desmuslin) were up-regulated in 
the amputated heart compared with the uninjured hearts. Here it was demonstrated that the 
surgery caused not only alteration in miRNAs expression, but also alteration of proteins. 
Regeneration involves the deployment of a complex set of de novo mechanisms including 
dedifferentiation of post-mitotic cells, cell proliferation, pattern generation and, in some cases, 
trans-differentiation of adult specialized cells to rebuild parts of the body plan after 
amputation or injury. The three proteins resulted up-regulated in the hearts at 3 dpa are 
involved in the energy metabolism, in the signaling and in maintaining the structure integrity 
of the cells, so it is reasonable to think that they are involved in the cardiac regeneration 
process too. Here, it was demonstrate the utility of the DiGE technique as a tool for analyzing 
the in-vivo heart regeneration process in the model organism zebrafish. Indeed, proteome 
studies have identified important protein sets that are involved in the molecular mechanisms 
of the zebrafish heart regeneration. This might consequently lead to the definition of 
biomarkers correlated with human heart and can give the possibility to find novel therapeutic 
targets for the heart failure. 
Future studies could be directed to isolation and characterization of zebrafish stem cells 
involved in the heart regeneration. Also, it will be interesting to understand if they are already 
present in the heart or if they come from different organs and tissues and are activated to 
respond to the injury in the heart. It will be also interesting try to apply the protocol generated 
in mouse and human by Messina et al., (2004) to generate zebrafish in-vitro cardiospheres, 
tridimensional agglomerations of cardiac stem cells (CSCs), able to generate electric 
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impulses. In fact, CSCs and Cardiospheres are a small fraction of the total cells residing in the 
heart that could be used for autologous heart repair. Multipotent cardiovascular stem and 
progenitor cells have been found in the fetal heart, which give rise to cardiomyocytes, smooth 
muscle cells and endothelial cells. The comparisons of the different molecules expressed in 
cardiospheres within the species will help understanding how restore cardiac functions after 
damage or injury and will constitute a base to generate drugs for myocardial infarction 
therapy. Future studies are also likely to take advantage of lineage tracing tools that have been 
utilized in mice for progenitor cell studies, to define progenitor/progeny relationships during 
heart regeneration. Also, it will be important to examine new cardiac injury models in 
zebrafish. In fact, the current model produces a mechanical injury. While this injury might 
indeed stimulate the strongest possible regenerative response, it will also be interesting to 
better mimic the infarct models utilized in mammals. Additional molecular studies in the 
future will increase the resolution of regenerative pathways and bring the idea of cardiac 
regeneration in humans closer to reality. 
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